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Chloride Intracellular Channel (CLIC) proteins function to modulate Rac1 and 
RhoA downstream of endothelial G-protein coupled receptors signaling 
 
De Yu Mao 
 
Chloride intracellular channel proteins have homology to ion channels and 
omega class of glutathione-S-transferases but channel activity is not well established, 
suggesting roles in other signaling pathways. Among the six CLICs, CLIC1 and CLIC4 
are expressed in endothelial cells (EC) and act to promote EC proliferation, capillary-like 
networks, and lumen formation. We and others determined that Sphingosine-1-
phosphate (S1P) signaling promotes transient CLIC4 membrane localization. We report 
that CLIC1 and CLIC4 have distinct roles in endothelial S1P signaling. In knockdown 
studies, CLIC1 and CLIC4 were independently required for S1PR1-mediated Rac1 
activation, enhanced EC barrier integrity, and EC migration. CLIC1 was uniquely 
required for S1PR2/3-driven RhoA activation and actin stress fiber formation, while 
CLIC4 was uniquely required for thrombin/PAR-driven RhoA activation and endothelial 
permeability. CLICs were not required for other GPCR-mediated pathways measured, 
including S1PR1-mediated cAMP regulation downstream of Gαi, or Ras and ERK 
activation downstream of Gβγ. Endothelial β-adrenergic signaling, which uses Gαs, was 
unaltered by loss of CLICs. Further investigation of receptor tyrosine kinase signaling 
(VEGF, EGF) in endothelial cells reveals their signaling cascades do not depend on 
CLICs as well. We conclude that CLICs mediate S1PR-driven RhoA and Rac1 
regulation, and thrombin/PAR-driven RhoA activation, and a possible mediator for 
endothelial GPCR by modulating Rac1 and RhoA. 
 
 
CLIC N-termini contain membrane insertion motifs and the putative ion channel 
domain, while the C-termini contain two predicted SH domains. Chimeric proteins 
generated by swapping N and C-termini of CLIC1 and CLIC4 were used in rescue 
experiments. The C-terminal domain was determined to confer S1PR1-CLIC-Rac1 
mediated barrier function and migration.  We further characterized N-termini of CLIC4 
and membrane localization of by generating CLIC4 C-termini truncated protein, along 
with CLIC4 C-termini fusing with Lck-peptide for myristylation and plasma membrane re-
localization. CLIC4 C-termini alone fails to rescue S1PR1-CLIC-Rac1 mediated barrier 
function, while membrane localization of the CLIC4 C-terminal domain functions in S1P 
signaling, suggesting the N-terminal domain confers membrane localization but not 
signaling function. Thus, we conclude S1P promotes cell localization of CLIC4 to the EC 
plasma membrane through N-termini, which then regulates Rac1 mediated events 
through C-termini. Through these findings, our work defines a molecular mechanism 
through which CLICs function in endothelium. 
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1.1 Chloride Intracellular Channel Proteins (CLICs) 
 
1.1.1 Chloride Intracellular Channel Family 
 
The chloride intracellular channel (CLIC) protein family is a unique class of intracellular 
ion channels. The first family member of CLIC proteins was named p64 (now known as 
atypical long isoform CLIC5B), and was identified at Columbia University over 25 years 
ago [1]. The protein was purified from bovine kidney microsomes as a protein that binds 
to the putative Cl− channel inhibitor indanyloxyacetic acid-94 (IAA94) [1]. CLICs are 
highly conserved among vertebrates and invertebrates [2, 3]. Since its discovery, it has 
been identified that there are 6 homologs in mammals (CLIC1-6), four in plants 
(DHAR1-4), two in C. elegans (exc4 and exl1), and one each in Drosophila (DmCLIC) 
and Bacteria (SspA). [4, 5] 
 
Mammalian CLICs consist of 6 members, CLIC1-6. The family constitutes a class of 
mammalian channel proteins which can be found as either soluble in cytoplasm or 
membrane bound. [6] They have been established to localize to multiple cellular 
compartments such as the plasma membrane [7], mitochondria [8], nucleus [7], Golgi 
[9], and endoplasmic reticulum [10]. The CLIC family has been implicated in diverse 
biological processes such as apoptosis, differentiation, and migration in a variety of 





1.1.2 CLICs Structures and Implications of Ion Channel Activity  
 
Mammalian CLICs share ~50–60% amino acids sequence homology to each other [4, 
13]. CLICs were initially identified as putative ion channels [1]. However, their property 
in forming ion channels has been controversial for decades. To date, crystal structures 
of CLIC1 and CLIC4, among the six members, have been reported [14, 15]. Both CLIC1 
and CLIC4 are around 250 amino acids in length, and contain a putative 
transmembrane domain in the N-terminus. The N-terminus is believed to undergo 
structural reorganization following redox or pH change, leading to membrane insertion. 
[14, 15] 
 
The belief that CLICs function as ion channels arises largely from the CLIC1 structure 
and binding to Cl− channel inhibitor IAA94 [4, 5, 15]. CLIC1 protein showed reversible 
rearrangement in structure under oxidative conditions [15]. Following oxidation, the 
formation of an intramolecular disulfide bond (Cys24-Cys59) in the N-terminal domain 
exposed a large hydrophobic surface, favoring CLIC1 to oligomerize and interact with 
artificial lipid bilayers [16]. Biophysical studies showed that CLIC1 could form large 
complexes consisting of six to eight subunits [17, 18]. The complex was hypothesized to 
function as a docking interface for membrane insertion. However, there has been no in 
vivo evidence of channel activity to date. In addition, CLIC1 undergoes redox-controlled 
structural change, however, there is no evidence showing that cytosolic CLICs can 




Ion channel activity by CLICs has been shown in vitro with artificial planar lipid bilayers. 
These studies established that CLIC channels can conduct both anions and cations [19, 
20]. A selectivity of anions over cations by CLICs was only observed under ectopic 
channel expression in artificial bilayers [21, 22]. Thus far, there is little to no evidence of 
CLICs functioning as Cl- ion channels in physiological intact cells in culture or in vivo. 
 
1.1.3 CLICs Enzymatic Activity 
 
Another unique feature of the CLIC family is that CLIC proteins contain a C-terminus 
whose structure is homologous to the omega-class of glutathione-S-transferase [14, 
15], suggesting a possible role for them to possess a GST-like enzymatic activity. The 
enzymatic activity of CLICs was investigated extensively with little success over the past 
years. In 2015, Al Khamici et al. [23] established that purified CLIC1, CLIC2, and CLIC4 
displayed glutaredoxin-like activity in vitro. The cysteine residue (Cys 24 in CLIC1 and 
Cys35 in CLIC4) is believed to be the key catalytic residue. Interestingly, they also 
showed this enzymatic activity was blocked by the chloride channel blocker IAA-94 [23], 
suggesting a possible involvement of ion channel function. However, it is still unclear 
how this in vitro finding is physiologically relevant.  
 
1.2 CLICs and Angiogenesis 
 




To develop a circulatory system, two distinct processes, vasculogenesis and 
angiogenesis, are involved. The initial process is vasculogenesis, which occurs during 
early embryonic development. As the first stage of vascular network formation, it occurs 
when endothelial precursor cells merge and differentiate to form the first primitive 
vascular plexus. This vascular plexus is further expanded and remodeled through a 
process called angiogenesis. [24] 
 
Angiogenesis is the process where new blood vessels are formed from pre-existing 
vasculature resulting in the formation of a highly organized vascular network comprised 
of arteries, veins and capillaries. The angiogenesis process is initiated when pro-
angiogenic signals, such as vascular endothelial growth factor A (VEGF-A), stimulates 
endothelial cells to degrade the extracellular matrix surrounding an existing vessel. The 
stimulated endothelial cells are then able to proliferate and migrate into the surrounding 
stroma, and form new sprouts leading to the formation of vessel lumens through the 
tubulogenesis process. The tubes branch and reconnect to form vascular networks, 
followed by recruitment of mural cells including pericytes and smooth muscle cells for 
vessel stabilization. [25] The process is essential to establish a vascular network 
capable of delivering nutrients and oxygen throughout the body. A normal angiogenesis 
process is essential for organ development, tissue growth and repair. Angiogenesis is 
also critical for tumor growth and metastasis. Hence, it is important to investigate 
regulators driving this process for potential therapeutic invention. 
 




Berry et al. in 2003 [26] reported that EXC-4, a C. elegans homolog of mammalian 
CLICs, is essential for the development of the excretory canal. C. elegans mutants for 
exc-4 exhibited lumenal cysts and morphological defects at the surface of the excretory 
canal [26]. As a single-cell tube, the development of the excretory canal requires the 
process of tubulogenesis. One distinction between C. elegans EXC-4 and mammalian 
CLICs is that a putative transmembrane region (PTM) region in EXC-4 constitutively 
localizes the protein at the plasma membrane [3]. They further showed that the human 
CLIC1 fused to this putative transmembrane domain of EXC-4 was able to rescue the 
cystic disruption to the excretory canal presented in the exc-4 mutant, suggesting a 
conservation of function across species [3]. As tubulogenesis is an important step 
during the angiogenic process, it leads to the investigation of CLICs being potential 
angiogenic regulators. 
  
1.2.3 Role of CLICs in Angiogenesis and Endothelial cells 
 
CLICs are involved in endothelial function and vascular development. In endothelial 
cells specifically, only CLIC1 and CLIC4 are highly expressed. [27, 28] Our published 
work has previously identified that both CLIC1 and CLIC4 function in promoting 
endothelial cell growth and morphogenesis.[27, 29] In vitro assays with human umbilical 
vein endothelial cells (HUVEC) have demonstrated that loss of CLIC4 decreased cell 
proliferation, capillary-like sprouting, and capillary network and lumen formation [27]. In 
a separate study, CLIC1 was exhibited to function in endothelial cell migration, 
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proliferation, branching and lumen formation. [29] These studies suggest that CLIC1 
and CLIC4 function in endothelial cells, likely at diverse cellular steps, to promote 
angiogenesis. 
 
Although genetic deletion of Clic1 and Clic4 in mice exhibits minimal phenotype in an 
unstressed environment [28], these mice do show various vascular defects. A mild 
platelet dysfunction and inhibited clotting phenotypes were observed in Clic1 knockout 
mice. [30] Clic4-/- mice demonstrated defects in angiogenesis using the matrigel plug 
angiogenesis assay[28], and retinal vasculature analysis in developing and adult mice 
revealed stunted vasculature in Clic4-/- mice challenged by an oxygen toxicity assay[28]. 
In another study on collateral circulation, compared to wild type, only Clic4-/- mice, but 
not Clic1-/- mice, have fewer collateral vessels in the brain and skeletal muscle. [31] 
Collateral remodeling was unaffected with higher CLIC1 expression in Clic4-/- mice[31], 
suggesting compensation and functional redundancies between the two proteins. 
Additionally, gene deletion of CLIC4 in mice contributes to smaller kidneys with fewer 
glomeruli and a less dense peritubular capillary network.[32] These results suggest that 
CLIC1 and CLIC4 are important factors contributing to vascular development.  
 
1.3 Endothelial G-protein Coupled Receptors (GPCR) Regulating Angiogenesis 
 
G-protein coupled receptors are implicated in multiple aspects of development, 
physiological, and pathophysiological processes throughout the body. As of 2018, 108 
G-protein-coupled receptors (GPCRs) are the targets of 475 (∼34%) Food and Drug 
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Administration (FDA)-approved drugs [33]. As the name suggests, these receptors are 
coupled with heterotrimeric G-proteins (Gα, Gβ, Gγ). Upon ligand binding, the 
heterotrimeric G proteins undergo conformational changes causing the uncoupling of 
the Gα subunit from the Gβγ subunit, leading to activation of downstream effectors. 
Multiple GPCRs are present in endothelial cells, and they have been implicated in 
regulating endothelial cell behavior and the subsequent angiogenesis process. They 
have been shown to play a significant role in physiological, pathological as well as 
tumor angiogenesis. [34] Some well-studied endothelial GPCRs include S1P receptors 
and PAR receptors.  
 
1.3.1 Role of Endothelial Sphingosine-1-Phosphate Receptors in Angiogenesis 
 
Sphingosine-1-phosphate (S1P) is a well-established regulator of angiogenesis and 
vessel development [35]. S1P is a bio-active lipid that binds to and activates a family of 
G protein-coupled receptors in mammals, S1P receptors. The S1P receptors consist of 
5 members, named S1P receptor 1 to 5 (S1PR1-5).  Among these receptors, only 
S1PR1, S1PR2, and S1PR3 are expressed in endothelial cells[36]. S1P signaling has 
been shown to regulate essential processes critical for endothelial function, including 
vascular barrier integrity [37], migration [38], lumen formation [39, 40], and capillary 
network formation [40, 41].  
 
S1P receptors are also believed to play crucial roles in angiogenesis based on genetic 
studies. S1P depletion through genetic ablation of the S1P producing enzyme 
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sphingosine kinase in mice results in embryonic lethality between embryonic day (E) 
E11.5-13.5 due to severe vascular defects, characterized by dilated vessels and 
reduced vascular smooth muscle cell coverage of the dorsal aorta.[42] Mice with S1P 
receptor 1-3 triple knockout die embryonically at E10.5-12.5 with a similar phenotype 
due to severe hemorrhage [36]. S1PR1 and S1PR3 have been shown to have 
redundant functions during vascular development, with S1PR1 being the most important 
receptor based upon severity of phenotype [36]. S1pr1 single knockout mice embryos 
die at E12.5-14.5, slightly later than the triple knockout embryos [43]. The observed 
lethality was attributed to incomplete vascular maturation resulting from deficient 
coverage of vascular mural cells. It was later established that loss of endothelial S1PR1 
increased the retinal vascular sprouting [44, 45]. S1PR1 signaling suppresses 
endothelial hypersprouting through stabilization of junctional VE-cadherin and inhibition 
of VEGFR2 phosphorylation and its downstream signaling [44]. It functions at later 
developmental stages following the establishment of the major vascular networks. It is 
believed to be essential in vascular stabilization after the initiation of flow and 
intraluminal pressure [44]. Blood flow and circulating S1P activates endothelial S1P 
receptors to stabilize blood vessels in development and homeostasis. 
 
S1P regulates different endothelial cell behaviors via distinct branches in the S1P 
signaling cascade (Figure 1.1). Upon ligand binding, conformational changes in the 
receptors leads to activation of their associated Gα subunit. S1PR1 activates the Gαi 
subunit while S1PR2 and S1PR3 mediates their signaling though Gαi, Gα12/13 and 
Gαq subunits. Activation of the S1PR1/Gαi/Gβγ branch leads to activation of Ras 
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signaling through its downstream effector Erk that promotes cell proliferation and 
survival. This branch also activates the PI3K pathway leading to Akt phosphorylation 
and Rac1 activation to promote endothelial cell survival, migration and VE-cadherin 
junction formation necessary for vascular barrier integrity. There are evidences 
indicating that this branch of activation is through Gαi [46], as well as Gβγ subunit [47, 
48] downstream of S1PR1, whereas Cdc42 activation is shown to be through S1PR1-
Gαi activation [46] in endothelial cells. S1P activation of S1PR2/3 and Gα12/13 
stimulates RhoA GTPase that leads to stress fiber formation via the downstream 
effecter ROCK (Rho associated-kinase). RhoA signaling also inhibits Rac-mediated 
functions, such as migration and VE-Cadherin junctions and thus enhances vascular 
permeability. The opposing actions of the different S1P receptors contribute to a tight 
and balanced regulation of endothelial functions, maintaining a healthy vascular barrier. 
 
Figure 1.1  S1P signaling pathway in endothelial cells. S1P activates S1P receptors, 
S1PR1–3, which transmit diverse intracellular signals depending their coupling with different 
heterotrimeric G-protein subtypes, regulating different endothelial cellular functions. (Adapted 




1.3.2 Role of Endothelial Protease Activated Receptors 1 (PAR1) in Angiogenesis 
 
The protease activated receptor (PAR) family has been extensively studied and 
demonstrated to be critical for endothelial cell behaviors [49]. Among the 4 members of 
PAR receptors (PAR1-4), thrombin serves as agonist for the PAR1 [50], PAR3 [51], and 
PAR4 [52] receptors. Of the three thrombin-responsive receptors, PAR1 and PAR4 are 
believed to be expressed in endothelial cells with PAR1 being the predominantly 
expressed receptor [53]. Thrombin is a serine protease which cleaves PAR1 receptor 
between Arg 41 and Ser 42 residues [54]. This event unmasks a new N-terminus, which 
acts as a tethered ligand to bind intramolecularly to the receptor itself, causing a 
conformational change to initiate downstream signaling [54]. Activation of PAR1 results 
in activation of Gα subunits. Of the four major Gα protein subclasses, PAR1 has been 
shown to signal through Gαi, Gαq, and Gα12/13 [55]. The association of PAR1 with 
Gα12/13 promotes the activation of RhoA protein contributing to cytoskeleton 
remodeling and permeability in endothelial cells. Through the involvement of Gαq, PARs 
can trigger phospholipase Cβ-dependent calcium mobilization and protein kinase C 
activation, involved in granule secretion, platelet aggregation and transcriptional 
responses in endothelial cells, while Gαi signaling and Gβγ subunit are mainly 
responsible for the regulation of adenylate cyclase and PI3K activity [54, 56, 57]. 
However, the coupling of PAR1 to Gαi remains controversial [58, 59]. 
 
PAR1 receptor plays an important role in vascular development. Loss of endothelial 
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PAR1 in mice is sufficient to cause vascular defects in mouse embryos, and rescuing 
PAR1 expression reversed the vascular abnormalities [60]. In endothelial cells, thrombin 
can also cross talk to other angiogenic signaling pathways. Thrombin has been shown 
to activate VEGF signaling, to increase VEGF receptor expression, and to promote 
secretion of angiopoietin-2 for cell proliferation and tube formation [61-63]. Thrombin 
can also increase S1P production causing activation of S1P receptors in endothelial 
cells, which contributes to endothelial barrier recovery after induction of barrier 
permeability [64]. These findings exhibit the essential role of thrombin and PAR1 
receptor signaling in regulating angiogenic processes and normal vascular 
development. 
 
1.4 Small GTPases in angiogenesis and endothelial barrier maintenance 
 
Small GTPases are major regulators of diverse cellular functions. They cycle between 
an inactive guanosine diphosphate (GDP) form to an active guanosine triphosphate 
(GTP) form. (Figure 1.2) They act as molecular switches in a variety of signaling 
pathways to regulate a wide array of cellular functions. They are controlled by guanine 
nucleotide exchange factors (GEFs) that catalyze the exchange of GDP to GTP. When 
the enzymes are in their active GTP form, they can be inactivated by GTPase-activating 
proteins (GAPs) that stimulate GTP hydrolysis. [65, 66] Some of these molecules can 
also be maintained in their inactive form by interaction with guanosine-nucleotide-
dissociation inhibitors (GDIs). The GDIs can sequester GTPases within the cytosol and 




Endothelial G-protein coupled receptors can regulate endothelial cell behaviors by 
regulating small GTPases, specifically the Rho family of small GTPases. The Rho family 
of small GTPases has been implicated in regulating endothelial cell behaviors and 
contributing to the angiogenesis process. The Rho family of small GTPases consists of 
20 members, divided into six subfamilies: Rho, Rac, Cdc42, Rnd, RhoBTB, and RhoT. 
[65] Among these members, Rho, Rac, and Cdc42 are the most well studied and 
established to be most related to vascular function and angiogenesis. They are often 
referred to as classical Rho GTPases because they function through GEFs and GAPs 
to alternate their active GTP and inactive GDP form. In contrast, other family members 




Figure 1.2  Small GTPases enzyme function. The small GTPases change from its active GTP 
form and inactive GDP form, which are controlled by GEFs and GAPs. GDIs act by binding to 




1.4.1 Ras-related C3 Botulinum Toxin Substrate 1 (Rac1) 
 
Rac1 protein is a member of the Rho superfamily first described in 1989 [67]. Among 
the three members of Rac protein (Rac1-3), Rac1 is primarily expressed in endothelial 
cells, and they have been involved in the maintenance and stabilization of endothelial 
barrier function as well as the endothelial cell migration process [65]. In endothelial 
cells, many agonists were shown to activate Rac1 including the GPCR agonist S1P, the 
growth factor VEGF, as well as the proinflammatory protein TNFα. [68] Several studies 
show that Rac1 activation recovers or stabilizes decreased endothelial barrier function 
after VEGF [69], thrombin [70] or histamine treatment [71], indicating their protective 
role in endothelial barrier. It is also known to modulate junctional protein distribution, 
especially the adherens junctions (AJs) [72]. It is well established that actin-binding 
protein cortactin accumulates at cell borders, a process regulated by Rac1 activity [73, 
74]. These associations of cortactin and F-actin regulation with Rac1 contributes to it 
strengthening of endothelial barrier. 
 
Rac1 is also established to be involved in the angiogenesis process. Angiogenesis is 
initiated by VEGF induced migration of endothelial cells via lamellipodia induction. It has 
been believed that VEGF activated Rac1 through VEGFR2, is essential to VEGF-
induced endothelial cell migration [75]. The essential role of Rac1 in angiogenesis is 
further supported by genetic studies. Endothelial Rac1 deletion results in embryonic 
lethality with defects in major vessel development and complete lack of small branched 
vessels in embryos and their yolk sacs [76, 77]. In addition, deletion of Rac1 in mouse 
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endothelial cells postnatally exhibited a delayed and aberrant retinal superficial plexus 
at postnatal day 8 (P8), as well as defects in the deeper plexus at P10. It has been well 
established that Rac1 plays an essential role in physiological angiogenesis [76].  
 
1.4.2 Ras Homolog Gene Family, Member A (RhoA) 
 
RhoA was the first member of the Rho GTPase superfamily to be discovered at 
Columbia University in 1985 [78]. It has been identified as an important regulator of 
endothelial function since its initial discovery. It is essential to both focal adhesion 
formation and actin stress fiber assembly [79]. Rho activates the downstream target 
Rho-associated kinase (ROCK) which phosphorylates myosin light chain phosphatase 
(MLC) contributing to direct actin contractility and actin polymerization [79]. This 
cytoskeletal remodeling regulated by Rho is also believed to increase permeability. In a 
thrombin induced model of lung injury, Rho is activated by p115RhoGEF, initiating the 
MLC phosphorylation, stress fiber formation and contraction causing endothelial barrier 
disruption [65]. Hence, RhoA plays an essential role in endothelial barrier regulation, 
and is a central regulator of critical endothelial cellular functions in vascular tissue. It is 
well established that RhoA and Rac1 have opposing effects on endothelial barriers. 
Rac1 is associated with cortactin and F-actin assembly to stabilize endothelial barrier, 
whereas RhoA functions to form stress fibers causing contractility to disrupt endothelial 
barrier. 
 
RhoA/ROCK signaling was shown to play roles in angiogenesis and regulation of 
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endothelial permeability in vivo. Studies in mice showed that endothelial-specific RhoA 
gene deletion postnatally, as well as ROCK inhibitors prevent vascular leakage in vivo 
[80]. In mice with oxygen-induced retinopathy (OIR), ROCK inhibitor ripasudil effectively 
reduced the retinal hypoxic area induced by OIR. Moreover, ripasudil normalizes 
vascularity and increases retinal vascular perfusion [81]. In the corneal micropocket 
assay, another model of angiogenesis in the mouse eye, ROCK inhibitor AMA0526 
efficiently inhibited corneal neovascularization and decreased inflammatory cell 
infiltration [82]. 
 
1.4.3 Cell division control protein homolog 42 (Cdc42) 
 
Cdc42 is believed to be as equally relevant for endothelial barrier maintenance and 
enhancement as Rac1. Some mediators such as prostaglandin (PGE) activate Rac1 
together with Cdc42, causing endothelial barrier strengthening [83]. A recent study also 
showed that S1P, a major physiological barrier stabilizing agent, also activates Cdc42 
as well as Rac1 contributing to cytoskeleton rearrangement [46]. In addition, in the LPS-
induced vascular permeability model in vivo, expression of constitutively active Cdc42 
blunted the permeability response, indicating its role in barrier stabilization [84]. Cdc42 
is also involved in angiogenesis. Endothelial specific knockout of Cdc42 in mice caused 
embryonic lethality. The knockout mice exhibited smaller and swollen embryos with 
fewer vessels compared to wild type, indicating a defect in angiogenesis and increased 




1.5 Rationale, Hypothesis and Significance 
 
Although our previously published work revealed that CLICs are essential and that they 
are novel regulators in angiogenesis and endothelial cell behaviors, the molecular 
mechanisms and endothelial signaling pathways through which CLICs act are not well 
understood. In this thesis, I deciphered specific signaling cascades that CLICs mediate, 
contributing to the regulation of endothelial cell behaviors. 
 
1.5.1 Rationale: Interaction of CLICs with GPCR  
 
CLICs have been suggested to interact with G-protein coupled receptors in other cells. 
CLIC6 has been shown to physically interact with the C-terminus of Dopamine (D2) 
receptors in rat brain cells [86]. It has also been shown that CLIC4 interacts with the 
histamine 3 receptor and caused enhanced H3 receptor surface level expression in 
brain cells as well [87]. Galzi et al. [88] showed that CLIC4 can translocate to the 
plasma membrane upon stimulation of muscarinic 3 receptor and LPA receptors in 
HeLa and HEK293 cells. Ponsioen et al. [89] established that CLICs can translocate to 
the plasma membrane by administration of LPA, S1P as well as thrombin receptor 
peptides in neuroblastoma cells. These studies provide a link between CLIC proteins 
and GPCRs, which lead us to investigate further their involvement in endothelial cells. 
 




In the same study performed by Ponsioen et al. [89], it was shown that the LPA-
stimulated translocation process depends on Gα12/13-RhoA. As both S1P and thrombin 
receptors are essential signaling pathways in regulating angiogenesis, we intended to 
investigate the role of CLICs in endothelial S1P and thrombin receptor signaling. Hence, 
we hypothesize that CLIC1 and CLIC4 function downstream of S1P receptors and 
thrombin (PAR1) receptor to regulate endothelial behaviors through modulating small 
GTPases, such as Rac1, RhoA and Cdc42.  
 
In this thesis, we investigated the roles of CLIC1 and CLIC4 in S1P receptor signaling 
(Chapter 3 and 7) as well as PAR1 receptor signaling (Chapter 7) and their roles in 
regulating small GTPases. We aim to understand whether they play redundant roles in 
regulating endothelial S1P signaling (Chapter 4), as well as the specific domains 
essential for their functional properties (Chapter 5 and 6). This study will lead us to a 
better understanding of how CLICs function in endothelial GPCR signaling, and how 
endothelial GPCR signaling to small GTPases regulates physiological processes. We 
also hope to provide some insights into the ongoing debate of whether CLICs function 
as ion channels or enzymes by investigating the specific functional domains through 

























Primary cells and cell culture 
 
All cells were cultured under standard conditions in a humidified incubator at 37°C, 5% 
CO2. Human Umbilical Vein Endothelial Cells (HUVECs) were isolated from human 
umbilical cords following established protocols [90]. The cells used in experimental 
replicates were isolated from different donors. Cells were grown in EGMTM-2 Endothelial 
Cell Growth Media (Lonza) (including supplements within bullet kits) on culture dishes 
coated with rat tail type I collagen (Corning). The HUVEC cells used in experiments 
were passage 5 or lower. Human Retina Microvasculature Endothelial Cells (HRMECs) 
were purchased from Cell Systems. Cells were maintained on fibronectin (Sigma) 
coated plates (Millipore) and in EGMTM-2 Endothelial Cell Growth Media (Lonza). Cells 
used for experiments were up to passage 8. 293T cells were acquired from ATCC and 
maintained in High Glucose DMEM (Gibco) with 10% Heat Inactivated- Fetal Bovine 
Serum (HI-FBS) and 0.01% penicillin-streptomycin. 
 
Gene silencing of CLIC1 and CLIC4 proteins 
 
Human CLIC1 and CLIC4 shRNA-containing constructs were purchased from Sigma-
Millipore and screened for significant CLIC1 and CLIC4 knockdown in HUVEC by 
immunoblotting as described below. Screenings of the CLIC shRNAs for both proteins 
were performed by previous lab member Jennifer Tung [27, 29]. The shRNA was in 
lentiviral vector PLKO.1-puro, which conveys puromycin resistance allowing for 
selection of shRNA-expressing cells. One CLIC4 shRNA was selected for use in 
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experiments and targets the 5’-UTR region with targeting sequence  
5′-GCCGTAATGTTGAACAGAATT-3′, and one human CLIC1 shRNA was used which 
targets the coding region with targeting sequences 5'-CCTGTTGCCAAAGTTACACAT-
3'. Lentiviral vector pLKO.1-puro expressing scrambled shRNA was used as a control 
and purchased from Sigma-Millipore. 
 
Plasmids and Recombinant DNA 
 
Various recomibinant CLIC plasmids were made through molecular cloning. Table 2.1 
shows a complete list of CLIC variants generated from CLIC1 or CLIC4 for this thesis. 
Recombinant DNA inserts were placed into the lenti-viral pCCL vector multiple cloning 
sites between BamHI (5') and SalI (3’) restriction enzyme sites. DNA inserts were 
generated through polymerase chain reaction (PCR) with primers including the BamHI 
and SalI restriction sites. Wild type CLIC1 and CLIC4 were generated from cDNA of 
human umbilical vein endothelial cells (HUVECs). CLIC1 and CLIC4 variants were 
created by insertion, deletion, or fusion of pCCL-CLIC1 and pCCL-CLIC4 plasmids. The 
DNA inserts were then digested with BamHI and SalI restriction enzyme and ligated into 
pCCL-lentiviral vectors using T4 ligase. DNA sequencing was performed to verify the 






Plasmids  Notes 
CLIC1 Wild-type CLIC1 from HUVECs 
CLIC4 Wild-type CLIC4 from HUVECs 
Flag-CLIC4 Flag epitope tag attached to the N-terminus of CLIC4 
HA-CLIC4 HA epitope tag attached to the N-terminus of CLIC4 
CLIC4-Flag Flag epitope tag attached to the C-terminus of CLIC4 
CLIC4-HA HA epitope tag attached to the C-terminus of CLIC4 
HA-CLIC1 Flag epitope tag attached to the N-terminus of CLIC1 
HA-CLIC4-
CLIC1 
N-terminus of CLIC4 (amino acids 1-95) followed by C-terminus of 




N-terminus of CLIC1 (amino acids 1-84) followed by C-terminus of 
CLIC4 (amino acids 96-253) with HA epitope tag attached to the 
N-terminus 
HA-CLIC4Tr 
CLIC4 truncated protein (amino acids 96-253) with HA epitope tag 
attached to the N-terminus 
Lck-HA-CLIC4 
Full length HA-CLIC4 fused with first 10 amino acids of mouse Lck 
peptide to the N-terminus 
Lck-HA-CLIC4Tr 
HA-CLIC4-Tr truncated protein (amino acids 96-253) fused with 
first 10 amino acids of mouse Lck peptide to the N-terminus 
 
Table 2.1  List of plasmids and recombinant DNA generated. 
 
Lentivirus-mediated stable expression of constructs in primary cells 
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To perform stable knockdown and overexpression studies in primary cells, a lentiviral 
infection system was utilized. For lentiviral gene transfer, 293T cells were transfected 
using the calcium phosphate approach with the following combination of plasmids:  3g 
of pVSVG, 5g of pMDLg/pRRE, 2.5g of pRSV-Rev, and 10g of pCCL/pLKO vector 
encoding genes of interest. Transfected 293T cells were allowed to produce lentivirus 
and the supernatant was collected 48 hours post transfection. The supernatant 
collected was passed through a 0.45m filter and then added onto the target primary 
cells (HUVECs). A Single round of infection was performed for 24hrs. The primary cells 
were allowed to express shRNA or overexpression constructs for at least 48 hours 
before experiments. pCCL-RFP was always performed alongside to ensure infection 
efficiency was 100%. 
 
Reagents and Primary Antibodies 
 
A list of pharmacological reagents and primary antibodies is shown in Table 2.2 and 
Table 2.3 respectively. 
Reagents Company and Catalogue Number 
S1P Enzo Life Sciences, BML-SL140 
Human VEGF R&D, 293-VE 
Human EGF Sigma E9644 
α-Thrombin Enzyme Research Laboratories HT1002a 
Isoproterenol Sigma I5627 
             







Vendor Catalog Number Purpose/Dilution 
CLIC4 Rabbit Abcam Ab76593 
Western Blot: 
1:250 
CLIC1 Rabbit Abcam Ab77214 
Western Blot: 
1:150 
Tubulin Mouse Sigma T6074 
Western Blot: 
1:1000 
VE-cadherin Rabbit Abcam Ab33168 IF: 1:200 
HA Rabbit Cell Signaling C29F4 IF: 1:500 
Phospho-
ERK 
Rabbit Cell Signaling 4370 
Western Blot: 
1:1000 
ERK Mouse Cell Signaling 4695 
Western Blot: 
1:1000 
Rac1 Mouse Abcam Ab33186 
Western Blot: 
1:1000 
RhoA Mouse Abcam Ab54835 
Western Blot: 
1:500 
Ras Rabbit Abcam Ab52939 
Western Blot: 
1:1000 




Table 2.3  List of primary antibodies utilized. 
 
MTT viability assay 
 
HUVEC cells were plated at the same number between cell lines in triplicate in 96-well 
plates, and the viability of HUVECs were measured at 24, 48, 72, and 96-hour time 
point using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) (Sigma-
Millipore). Briefly, at each time point, 100 L of fresh EGM-2 medium (Lonza) were 
changed and 10 L of 12mM MTT were added into each well. After 4 hours of 
incubation at 37oC, 25 L of medium were removed, and 50 L of DMSO were added 
and mixed thoroughly. Following 10 minutes of incubation at 37oC, each sample was 
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read by absorbance at 570nm with a microplate reader. 
 
Apoptosis assessment by FACS 
 
This experiment was done in collaboration with a previous lab member, Irina Jilishitz. 
Annexin V staining was performed using the apoptosis assessment kit from Biovision 
(K101) following the manufacture’s protocol. Briefly, at each time point post lentiviral 
infection 3X105 cells were collected for each cell line and resuspended in 1X binding 
buffer. Cell suspensions were incubated with 1:100 annexin V-FITC conjugated 
antibody (Biovision) and placed on ice for FACS analysis. The BD FACSCalibur was 
used to perform flow cytometry and data analysis was performed using CellQuest Pro 
software. 
 
Trans-endothelial electrical resistance (TEER) assay 
 
An ECIS array plate (Applied Biophysics) containing circular 250μm diameter active 
electrodes connected in parallel on a common gold pad was coated with rat tail type I 
collagen (Corning). HUVEC cells were seeded at 50,000 cells per well and allowed to 
grow overnight. Cells were serum starved (EBM-2, Lonza) for 2 hours, followed by a 30-
min baseline resistance stabilization with the Electrical Cell-Substrate Impedance 
Sensing (ECIS) system (Applied Biophysics, model 1600R). 1M S1P, 50nM of α- 
thrombin, 100ng/mL VEGF or BSA vehicle control were administered, and trans-
endothelial resistance was monitored at a frequency of 4000Hz with measurements 
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taken at 3-min intervals for 2-4 hours. Quantifications were performed by area under the 
curve analysis using GraphPad Prism software. 
 
Immunofluorescence of VE-cadherin, HA-tag, and Actin 
 
Cells were plated on 4-well collagen-coated chamber slides (Millipore). 50,000 cells 
were seeded onto each well overnight. The next day cells were serum starved for 3 
hours prior to S1P treatment. 1M S1P for various times points was used to treat 
HUVECs, followed by fixation with 4% PFA for 15 minutes. Cells were then washed 3 
times with PBS and blocked with 3% BSA, 1% donkey serum and 0.1% TritonX-100. 
Primary antibodies (Table 2.2) were used at the listed dilutions in blocking solution and 
incubated overnight at 4oC. Cells were then washed with 1XPBS, 3 times for 5 minutes 
each and incubated with secondary antibody Alexa Fluor 488 (green) or Alexa Fluor 594 
(red) at 1:1000 in blocking solution for 2hrs. Specifically for actin stress fiber staining, no 
primary antibody was used, and instead phalloidin 546 (red) secondary (dilution 1:200) 
was directly incubated following blocking.  After washing cells 3 times after secondary 
antibody incubation, cells were mounted using VectaShield with DAPI (Vector Labs). 
Slides were imaged using a fluorescent microscope Zeiss AxioImager Z2, as well as by 
confocal microscopy with a Zeiss laser scanning microscope (LSM800). Images 
analysis was done with ZEN software under the same acquisition setting for among all 
cell lines in each experiment. 
 




HUVECs were serum starved in starvation medium (EBM-2 + 0.5%FBS) overnight. 
1X105 cells per well (24-well format, BD-Falcon) were seeded in triplicate in collagen 
coated inserts of a transwell chamber with 8 m sized pores (BD Falcon) with 400l/well 
serum free medium (EBM-2, Lonza) for 3 hours. Following starvation, 1.2 mL of serum 
free media supplemented with stimulant (100 ng/ml hVEGFA or 1M S1P) was placed 
in the lower transwell chamber. Cells were allowed to migrate for 6 hours towards the 
lower chamber stimulant, followed by fixation of the cells with 4% PFA for 15 minutes 
and 10 minutes incubation with 0.1% crystal violet to stain the cells. Cells on top of the 
membrane insert were wiped and cleaned off with a cotton swab and the migrated cells 
at the bottom of the insert were imaged at 10X maginification. Cell migration was 
measured by counting the number of migrated cells per field, 5 fields for each well, and 
3 wells of each condition were averaged for quantification. 
 
3D Collagen Invasion assay 
 
The 3D collagen invasion assay mediated by S1P was performed in the laboratory of 
Dr. Kayla Bayless (Texas A&M) as previously described [91]. HUVEC cells with control 
or CLIC1 and CLIC4 knockdown were incorporated into collagen matrices. Collagen 
gels were prepared to a final concentration of 2.5 mg/mL in a transwell system 
(Corning). Gels were placed into 6mm culture inserts for polymerization and equilibrated 
at 37oC and 5% CO2. HUVEC cells (50,000/well) were seeded in the upper chamber in 
M199 containing reduced-serum supplement (Transferrin, BSA, oleic acid and insulin), 
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bFGF (40ng/mL), VEGF (40ng/mL), ascorbic acid (50 mg/mL), and phorbol ester 
(50ng/mL). 1M S1P was added to the bottom chamber. Cultures were allowed to 
develop for 24 hours followed by changing to fresh medium. Experiments continued for 
48hrs before being fixed in 3% glutaraldehyde in PBS and then stained with 0.1% 
toluidine blue in 30% methanol. Intact cultures were imaged using a Nikon microscope 
and an Olympus camera and Kodachrome 64T color slide film. Three random fields at 
10X magnification were selected for quantification and the number of invading cells per 
high power field (HPF) was counted manually. 
 
G-LISA Rac1, RhoA, Cdc42 and Ras activation assay 
 
Assays were performed using Rac1 (Cytoskeleton, BK128), RhoA (Cytoskeleton, 
BK124), Cdc42 (Cytoskeleton BK 127) and Ras (Cytoskeleton BK131) G-LISA 
Activation Assay Kits. HUVECs were serum starved in EBM-2 with 1% serum overnight 
and with serum-free EBM-2 for an additional 3 hours the following day. The cells were 
then stimulated with 1M S1P for Rac1, RhoA, Ras and Cdc42 activation, 100 ng/mL 
hEGF for 5-10 minutes to activate Ras or 50 nM thrombin for 2-5 minutes to activate 
RhoA. Cell lysates were harvested and snap frozen in liquid nitrogen. The assay was 
then performed based on the manufacturer’s protocol. Briefly, the lysates were added to 
plates containing Rac1/RhoA/Cdc42/Ras GTP binding proteins linked to the wells. 
Inactive GDP-bound protein was washed out during washing steps and the active GTP-
bound form of Rac1/RhoA/Cdc42/Ras was then detected with specific antibodies. 






HUVECs (100,000/plate) were seeded on collagen coated 60mm plates (Corning) and 
allowed to grow overnight. The next day, cells were serum starved for 3 hours. Cells 
were then preincubated for 30 min with 1mM phosphodiesterase inhibitor IBMX (Tocris 
Bioscience) followed by stimulation for 30 min with various doses of S1P, in the 
presence of IBMX (1mM) and adenylate cyclase activator forskolin (20µM) (Tocris 
Bioscience). For Isoproterenol stimulation, 1mM IBMX was present, and forskolin was 
not added. cAMP measurement was then assessed using the Direct cAMP ELISA 
(enzyme-linked immunosorbent assay) kit (Enzo Life Sciences, ADI-900-066) following 
the supplier’s protocol. 
 
Quantitative PCR for CLIC1 and CLIC4 
 
RNA was isolated from cultured cells using the RNeasy Kit (Qiagen). RNA was reversed 
transcribed to cDNA using the Verso cDNA synthesis kit (Fischer Scientific), all 
according to manufacturer specifications. Quantitative Real Time PCR (qRT-PCR) was 
performed using SYBR Green master mix (Applied Biosystem) and primers specific to 
CLIC1 and CLIC4. Mean threshold cycle numbers (Ct) were determined for each gene 






HUVECs were washed with cold PBS, and lysates were collected with TENT lysis buffer 
(50mM Tris pH 8.0, 2mM EDTA, 150mM NaCl, and 1% Triton X-100) containing a 
protease inhibitor cocktail (EMD Chemicals Inc.,). Protein lysates were collected by 
centrifugation at 14000rpm for 10 minutes. Lysates were boiled at 95 oC for 5 minutes 
with addition of sample buffer containing SDS and β-mercaptoethanol. Protein 
concentrations were measured using the Bradford protein assay (Bio-Rad 
Laboratories). Volumes were adjusted to ensure equal amounts of protein loading. 
SDS-PAGE was performed for 2 hours at 100V, followed by wet transfer of proteins 
onto a nitrocellulose membrane for 1 hour at 100V. Blocking of the nitrocellulose 
membrane was with 5% Non-fat dry milk in TBS-Tween solution for 1 hour. Primary 
antibody incubation was done in 2.5% milk overnight at 4oC, and secondary antibody 
incubation was done the next day for 1hr. The membrane was developed using 
Chemiluminescence solution (GE Healthcare), and protein bands were observed. 




For experiments, unless otherwise noted, two-way Analysis of variance (ANOVA) with 
Bonferroni post-hoc analysis was performed on all quantified data to determine 
significant differences between groups. The statistical tests were analyzed in GraphPad 
Prism software. P values less than 0.05 were considered statistically significant. Unless 














Chapter 3. CLIC1 and CLIC4 function in the 

















3.1 Introduction and Rationale 
 
3.1.1 The role of CLICs in endothelial cells 
 
The chloride intracellular channel (CLIC) protein family consists of 6 members in 
humans, CLIC1-6 [22]. The family constitutes a class of mammalian proteins which can 
be found as either soluble in cytoplasm or membrane bound [6]. CLICs are putative ion 
channels and structurally related to the omega-class of the glutathione-S-transferase 
(GST) superfamily. Several CLIC proteins have been shown to form channels in artificial 
bilayers [19-22], however, selectivity for chloride and physiological channel functions 
are still under debate [6, 15, 92]. 
 
The CLIC family have been implicated in diverse biological processes such as 
apoptosis, differentiation, and migration in a variety of different cell types [11, 12, 93]. 
CLICs have been shown to be involved in angiogenesis, a process where new blood 
vessels develop from pre-existing blood vessels [27, 29]. Endothelial cell behaviors 
associated with angiogenesis are regulated through various factors such as VEGF and 
S1P.  We previously reported on a survey of expression of the six CLIC family proteins 
(CLIC 1-6) by RT-PCR that demonstrated CLIC1 and CLIC4 are expressed in 
endothelial cells [27, 29]. We isolated mRNA from both human umbilical vein endothelial 
cells (HUVECs) and human microvascular retinal endothelial cells (HMRECs) and 
subjected the mRNA to RNA sequencing analysis (Figure 3.1). In concordance with 
published RT-PCR results, this analysis shows that CLIC1 and CLIC4 are the two CLIC 
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proteins expressed in endothelial cells. RNA sequencing analysis shows that CLIC4 
mRNA is expressed at higher levels than CLIC1. 
 
 
Figure 3.1  CLIC1 and CLIC4 are expressed in endothelial cells. RNA sequencing on human 
umbilical vein endothelial cells (HUVEC) and human microvascular retinal endothelial cells 
(HMREC) revealed only CLIC1 and CLIC4 are expressed. 
 
Our previously published work using HUVEC showed that CLIC1 and CLIC4 are 
required for in vitro formation of vascular sprouts with lumens and capillary-like network 
formation [27, 29], indicating important functions in endothelial cell behavior required for 
angiogenesis. Clic4 null mice showed minor defects in retinal angiogenesis as well as 
vesicular fusion in endothelial cells in vivo [28]. Unpublished work from our lab 
demonstrated that Clic1 and Clic4 double knockout embryos are not viable and display 
severe cardiac edema indicative of defective vasculature (Figure 3.2). These results 




Figure 3.2  Loss of Clic1 and Clic4 causes embryonic lethality and cardiac edema at 
E10.5. E10.5 Clic1-/- ; Clic4-/- embryos were growth restricted (23 somite; 23S) with cardiac 
edema and pooling of blood around the developing heart as compared to Clic1-/- littermates 
(27S). Scale bars; 400μm. (Jennifer Tung, Irina Jilishitz, Jan Kitajewski, unpublished) 
 
 
3.1.2 S1P receptor signaling in endothelial cells 
 
Sphingosine-1-phosphate (S1P) is a well-established regulator of angiogenesis and 
blood and lymphatic vessel development [35]. S1P is a bio-active lipid that binds to and 
activates a family of G protein-coupled receptors in mammals, S1P receptors. The S1P 
receptors consist of 5 members, named S1P receptor 1 to 5 (S1PR1-5).  Among these 
receptors, S1PR1, S1PR2, and S1PR3 are expressed in endothelial cells and mouse 
mutant for these receptors indicate that these S1P receptors are critical for 
angiogenesis [36]. S1P signaling has been shown to regulate essential processes 
critical for endothelial function, including vascular integrity [37], migration [38], lumen 
formation [39, 40], and capillary network formation [40, 41]. In addition, S1P depletion 
through genetic ablation of S1P producing enzyme sphingosine kinase in mice results in 
embryonic lethality between embryonic day (E)11.5-13.5 due to severe vascular defects 
[42]. Mouse embryos with S1PR1-3 triple knockout die embryonically at E10.5-12.5 with 
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a severe hemorrhaging phenotype [43]. These studies demonstrate that S1P acting 
through S1P receptors is crucial in vascular development.  
 
S1P regulates diverse endothelial cell behaviors via distinct biochemical activities that 
function as distinct branches of the S1P signaling cascade [35]. As a circulating biolipid 
in blood, S1P binds to S1P G-protein coupled receptors on the surface of endothelium. 
Upon ligand binding, conformational changes of the receptors lead to activation of their 
associated Gα subunits. S1PR1 has been noted to be the most highly expressed S1P 
receptor in endothelial cells and it has several critical functions. As shown in Figure 3.3, 
S1PR1 exclusively couples with the Gαi subunit [94, 95]. Activation of S1PR1/Gαi/Gβγ 
leads to activation of Ras signaling through its downstream effector Erk that promotes 
cell proliferation and survival. S1PR1/Gαi/Gβγ also activates the PI3K pathway leading 
to Akt phosphorylation and Rac1 activation to promote endothelial cell survival, 
migration and VE-cadherin junction formation necessary for vascular barrier integrity. 
[35] There are evidences showing this branch activation could be through Gαi [46], and 
also has selectivity for Gβγ subunit [47, 48] downstream of S1PR1 (Figure 3.3). One 
recent study also showed activation of Cdc42 by S1P through Gαi in endothelial cells 




Figure 3.3  S1P signaling through S1PR1 in endothelial cells. S1P1 receptor (S1PR1) is the 
most expressed S1P receptor in endothelial cells. S1P activates S1PR1 and downstream 
heterotrimeric G proteins, regulating endothelial cell behaviors. (Adapted from Blaho, Hla 2011 
[35]) 
 
S1PR2 and S1PR3 can also be activated by S1P, although these receptors appear to 
play accessory or partially redundant roles with S1PR1 [36]. Both receptors are 
expressed at significantly lower levels than S1PR1 in endothelial cells, and mediate 
signaling through Gαi, Gα12/13 , and Gαq. S1PR3 is expressed at higher levels than 
S1PR2 in endothelial cells, and is believed to positively regulate vascular barrier similar 
to S1PR1, whereas S1PR2 has been shown to negatively regulate vascular barrier 
through RhoA activation. Their roles in endothelial cells will be further discussed and 
reviewed in Chapter 7. 
 






















Although CLIC proteins have been involved in a variety of cellular functions in different 
cell types, the molecular mechanism through which CLICs mediate the signaling 
pathways that CLICs act in are not well understood. For instance, after decades of 
study, no definitive study has demonstrated that CLICs have physiological ion channel 
activity. CLICs have been noted to reside in cytosolic, nuclear, vesicular and plasma 
membrane compartments of the cell [7-10]. 
 
In vitro, CLIC1 and CLIC4 are essential for multiple endothelial cell behaviors such as 
proliferation, migration, tube formation and vascular morphogenesis [27, 29]. Many of 
these functions are also regulated by S1P signaling indicating a potential link between 
the two pathways. In 2009, Ponsioen et al. [89] showed that S1P induces the re-
localization of CLIC4-GFP fusion proteins from cytoplasm to plasma membrane in 
neuroblastoma cells, establishing the preliminary link between CLIC4 and the S1P 
signaling pathway. 
 
In mouse embryos, loss of Clic1 and Clic4 led to severe cardiac defects and 
hemorrhage and resulted in embryonic lethality at E10.5 (Figure 3.2). Mice with S1P 
receptor 1-3 triple knockout also die embryonically at E10.5-12.5 with a phenotype that 
includes severe hemorrhage [36, 43]. This point in development is characterized by 
significant angiogenesis, suggesting both CLICs and S1P signaling are vital to 
embryonic vascular development. As both CLICs and the S1P pathway regulate 
similar functions in endothelial cells and vascular development, and CLIC4 changes its 
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cellular localization in response to S1P stimulation, we hypothesized that CLICs 
function as effectors in the S1P signaling cascade to promote angiogenesis. This 
Chapter describes a study to address the hypothesis that CLICs function in S1P 
receptor signaling to regulate endothelial cell functions. 
 
3.2 Results: CLIC1 and CLIC4 are essential for endothelial cell survival 
 
3.2.1 shRNA successfully reduces CLIC1 and CLIC4 proteins in endothelial cells 
 
We aim to investigate the roles of CLIC1 and CLIC4 in S1P signaling through loss of 
function studies in human umbilical vein endothelial cells (HUVEC). In order to perform 
the loss-of-function study of CLICs in endothelial cells, we used lentivirus-mediated 
shRNAs, which has been widely shown as an efficient and stable knockdown system in 
primary ECs for many proteins. Study of endothelial cells in vitro requires use of primary 
cells, such as HUVEC. Our lab has previously screened 5 shRNA for CLIC4 and CLIC1, 
revealing the most efficient and least toxic shRNA constructs [27, 29]. Western blot and 
quantitative PCR showed that levels of either CLIC1 and CLIC4 are successfully 
reduced by this approach. Although reduction of mRNA of one protein caused a slight 
elevation of the other CLIC of about ~1.5 fold (Figure 3.4 A-B), loss of CLIC1 or CLIC4 
protein did not alter the other’s expression at protein level by densitometry study, which 
was normalized to tubulin (Figure 3.4 C). These results indicate loss of CLIC1 and 
CLIC4 through shRNA is successful and specific, and thus we can use this system for 




Figure 3.4  CLIC1 and CLIC4 were successfully knocked down in HUVECs. HUVECs were 
lenti-virally infected with CLIC1 and CLIC4 shRNA. mRNA for CLIC1 (A) and CLIC4 (B) were 
assessed with qPCR. ANOVA statistical test was used, and the significance was presented 
against control cells (*p<0.05, ***p<0.001). Protein expressions of CLICs (C) were measured, 
and quantification were achieved through densitometry analysis. CLIC1 and CLIC4 band 
intensity was analyzed against tubulin as control. 
 
3.2.2 CLIC1 and CLIC4 are important for cell survival in endothelial cells 
 
Loss of CLIC1 or CLIC4 protein in HUVECs was achieved through lentiviral infection 
described above. We have seen by using a GFP or RFP expressing lentiviral vector, 
that at 48hrs following infection close to 100% of HUVEC cells are expressing genes 
from the lentiviral integrant (data not shown). Loss of either CLIC1 or CLIC4 modified 
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the cell shape, as both knockdown cells exhibited more rounded features compared to 
the standard cuboidal shape of HUVEC in control (Figure 3.5A), a possible cytoskeleton 
rearrangement phenotype. Loss of individual CLIC proteins, CLIC1 or CLIC4, led to 
more rounded and floating cells, indicating potential cellular death. Loss of both CLIC1 
and CLIC4 in HUVEC led to more than a 60% loss of endothelial cells 48hrs following 
infection, indicating CLIC1 and CLIC4 are essential for endothelial cell survival (Figure 
3.5 A-B). 
 
Figure 3.5  CLIC1 and CLIC4 are required for viability in HUVECs. HUVECs were lenti-
virally infected with CLIC1 and CLIC4 shRNA. A) Images of all cell lines (Control, CLIC4 
knockdown (CLIC4-KD), CLIC1 knockdown (CLIC1-KD), double knockdown (dKD) were shown 
48 hours after infection. B) Quantification of apoptosis as percent annexin V-positive HUVEC 
assessed at 24, 36, and 48 hours post infection. C) Quantification of MTT viability assay with 
absorbance at 570nm were assessed at 48, 72, and 96 hours post infection in single loss of 
CLIC4 and CLIC1. ANOVA tests were utilized, and the significance was presented against 




To assess the importance of CLIC1 or CLIC4 in cell survival, we utilized an apoptotic 
assay through Annexin V staining, as well as the MTT viability assay (Figure 3.5 B-C). 
Apoptotic assay for CLIC1-KD and CLIC4-KD, referred to as “CLIC-KD”, showed 
increases in apoptosis for CLIC1-KD and CLIC4-KD HUVECs. At 24 and 36 hours 
post infection, the apoptotic marker annexin V was significantly increased in 
double knockdown HUVECs (dKD), as compared to single CLIC1 or CLIC4 
knockdown cells. By 48 hours post infection, annexin V levels were induced in more 
than 60% of double knockdown HUVECs, while only 20% of cells with single CLIC1 or 
CLIC4 expressed annexin V (Figure 3.5B). We used the MTT viability assay to 
assess cell viability 48hrs after infection to further evaluate cell survival after single 
loss of CLIC proteins. Single loss of CLIC1 exhibited more severe loss of viability 
compared to loss of CLIC4, suggesting a more essential role of CLIC1 in HUVEC cell 
survival. These results indicate that both CLIC1 and CLIC4 are essential for 
endothelial cell viability. 
 
3.3 Results: CLIC1 and CLIC4 are required for S1P-mediated endothelial cellular 
functions  
 
3.3.1 CLIC1 and CLIC4 are required for S1P-mediated increase in endothelial barrier 
integrity, and VE-cadherin junction formation. 
 
Tight control of endothelial permeability is essential for normal, healthy vasculature. 
Factors such as S1P and VEGF are important in maintaining a healthy endothelial 
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barrier[44]. To investigate whether CLIC1 or CLIC4 regulate S1P-dependent endothelial 
cell functions, we generated CLIC4-KD and CLIC1-KD HUVEC cells described above. 
To assess their role in S1P-driven endothelial barrier integrity, we used trans-
endothelial electrical resistance (TEER) measurements and monitored endothelial 
barrier change in response to S1P (Figure 3.6). In control cells, administration of 1µM of 
S1P increased endothelial barrier resistance within minutes of addition, compared to 
vehicle control (Figure 3.6 A). HUVECs with either CLIC1 or CLIC4 knockdown 
exhibited significant reduction of the S1P barrier response (Figure 3.6 B-C). 
Quantification of TEER measurements were done by determining the area under the 
curve (AUC) analysis, and showed significant reduction of the S1P response in both 
CLIC1-KD and CLIC4-KD cells (Figure 3.6E), indicating that CLIC1 and CLIC4 are 






Figure 3.6  CLIC1 and CLIC4 are required for S1P-mediated endothelial barrier integrity. 
HUVECs were starved for 2hrs and stimulated with 1μM S1P or vehicle control at time 0min. 
Trans-endothelial electrical resistance (TEER) were monitored for 2hrs post S1P treatment (A-
C). All cell lines with S1P treatment were combined (D) and area under curve were calculated 
for quantification (E). ANOVA statistical test was utilized for significance analysis. *p<0.05, ns: 
not significant. 
 
VE-cadherin is critical for endothelial cell barrier maintenance, and VE-Cadherin 
junctions are controlled by S1P signaling [44]. Thus, we hypothesize that CLICs 
function to promote vascular barrier integrity through S1P mediated assembly of VE-
cadherin junctions. To test this hypothesis, we examined VE-cadherin localization by 
immunofluorescence analysis 30 minutes after addition of S1P (Figure 3.7). Upon 
serum starvation, VE-cadherin levels were visibly low, as expected. After S1P 
treatment, VE-cadherin were visible at the cell membrane, likely in junctions, in all 
HUVEC cell lines. In control cells, VE-Cadherin junctions were evident, tightly and 
linearly controlled by S1P stimulation. However, in CLIC4-KD and CLIC1-KD cells, 
although VE-cadherin levels were visibly increased, there were significantly lower 
fluorescent intensity formed between endothelial cells. The VE-cadherin junction pattern 
in knockdown cells exhibited an abnormal zig-zag pattern compared to control cells, 
suggesting unstable and abnormal junctions. These results are consistent with the S1P-






Figure 3.7  CLIC1 and CLIC4 are required for S1P-mediated VE-cadherin junction 
formation. HUVECs were starved for 3hrs and stimulated with 1μM S1P for 30 minutes. 
Immunofluorescent studies were performed on HUVECs with loss of CLIC1 or CLIC4 using VE-
cadherin antibody. Images taken were under identical acquisition settings among cell lines. 
 
3.3.2 CLIC1 and CLIC4 are required for S1P-driven migration and matrigel invasion.  
 
S1P promotes endothelial cell migration. To assess the role of CLICs in S1P-mediated 
endothelial cell migration we utilized the Boyden chamber cell migration assay, 
described in Chapter 2. Following serum starvation in the top chamber, HUVECs were 
allowed to migrate towards 1µM S1P in the bottom chamber (Figure 3.8). We found that 
HUVECs with either CLIC1 or CLIC4 knockdown exhibited a defect in migration towards 
S1P. Migration towards full serum of CLIC1-KD or CLIC4-KD cells was comparable to 
control HUVECs. This indicates the migration defects in knockdown cells was specific to 





Figure 3.8  CLIC1 and CLIC4 are required for S1P-mediated migration. HUVECs were 
seeded at the top chamber and starved for 3hrs. 1μM S1P was added in the bottom chamber 
after starvation allowing 6hrs of migration (A). The number of migrated cells per field were 
counted and quantified (B).  ANOVA statistical test was utilized for significance analysis. 
****p<0.001, ns: not significant.  
 
Furthermore, we studied whether S1P-driven invasion into collagen matrix required 
CLIC1 or CLIC4. HUVECs were seeded on top of a collagen matrix containing S1P 
and cells were allowed to invade for 24 hours. Invasion assay of HUVECs after 24 
hours showed both CLIC1-KD and CLIC4-KD cells formed fewer invading sprouts in 
response to S1P than control cells (Figure 3.9). These results indicate that invasion 





Figure 3.9  CLIC1 and CLIC4 are required for S1P-mediated invasion. CLIC1-KD, CLIC4-KD 
or Scramble control HUVEC are overlaid in collagen matrices laced with 1μm S1P and allowed 
to invade into the matrix. A) After 72 hours the collagen matrix is fixed and stained with toluidine 
blue to allow visual morphological analysis of sprouts. B) Quantification of number of branching 
sprouts invaded into collagen matrix from top to longest sprout. *p<0.05, **p<0.01. 
 
3.3.3 CLIC1 and CLIC4 are not required for VEGF-mediated endothelial barrier 
regulation and endothelial cell migration.  
 
S1P receptor signaling is an essential G-protein coupled signaling pathway in 
endothelial cells and is important for endothelial barrier maintenance and migration.  
However, endothelial permeability and migration can be regulated by multiple signaling 
pathways, including via the receptor tyrosine kinase VEGF receptor signaling. We have 
established that CLIC1 and CLIC4 function in G-protein coupled receptor signaling, and 





Trans-endothelial electrical resistance (TEER) was measured and monitored following 
VEGF addition to HUVECs (Figure 3.10). Administration of VEGF increased 
permeability and caused a decrease in resistance over time. Although there is a brief 
increase in barrier in response to VEGF addition, the physiological response is related 
to the longer duration increase in permeability that is evident after several minutes of 
VEGF addition. The VEGF-response in endothelial barrier is known to be slower as 
compared to the rapid response to S1P. The VEGF response was comparable in both 
control and knockdown cells (CLIC1-KD and CLIC4-KD) with no significant differences, 
indicating that loss of CLIC1 or CLIC4 did not alter VEGF-driven barrier change. We 
also tested VEGF-mediated migration through the Boyden chamber assay. VEGF 
promoted HUVEC migration towards the bottom chamber and this was not altered in 
CLIC1-KD or CLIC4-KD cells (Figure 3.11). These results indicated that CLIC1 and 
CLIC4 are not required for VEGF-mediated barrier and migration responses, in contrast 





Figure 3.10  CLIC1 and CLIC4 are not required for VEGF-mediated endothelial barrier 
integrity. HUVECs were starved for 2hrs and stimulated with 100ng/mL VEGF or vehicle 
control at time 0min. Trans-endothelial electrical resistance (TEER) were monitored for 3hrs (A-
C). Combined graphs for all cell lines are shown in D. 
 
Figure 3.11  CLIC1 and CLIC4 are not required for VEGF-mediated migration. HUVECs 
were seeded at the top chamber and starved for 3hrs. 100ng/mL VEGF were added in the 
bottom chamber after starvation allowing 6hrs of migration (A). Quantification were shown in 
(B), and ANOVA statistical tests were used to analyze significance (ns: not significant). 
 
49  
 3.4 Results: CLIC1 and CLIC4 regulate S1P mediated endothelial cell behavior 
through S1P-mediated Rac1 activation. 
 
3.4.1 CLIC1 and CLIC4 are required for S1P-mediated Rac1 activation. 
 
We demonstrated that CLIC1 and CLIC4 are required for S1P-mediated barrier 
regulation and migration, both of which are through S1P-driven Rac1 activation 
downstream of S1PR1-Gβγ signaling (Figure 3.3). We sought to investigate whether 
activation of Rac1 by S1P requires CLIC1 or CLIC4 in HUVECs. To examine Rac1 
activation downstream of S1PR1, we employed the G-LISA Rac1 activation assay [96]. 
A time-course analysis revealed that S1P activated Rac1 within minutes and reached 
maximum significant response within 5 minutes (Figure 3.12). Hence, we tested for 
CLIC function in Rac1 activation at 5min after S1P addition using CLIC1-KD and CLIC4-
KD HUVECs. Both CLIC1-KD and CLIC4-KD cells did not exhibit significant change in 
basal Rac1 activation in the starved condition before S1P administration (Figure 3.13A), 
suggesting that Rac1-GTP levels were initially comparable. Following S1P addition, 
Rac1-GTP levels were increased in control cells, whereas Rac1-GTP levels were not 
stimulated in CLIC1-KD or CLIC4-KD cells (Figure 3.13 A-B). Total Rac1 protein levels 
were assessed, showing no significant difference in knockdown cell lines (Figure 
3.13C). We thus demonstrated that loss of CLIC1 or CLIC4 diminished S1P-Rac1 
response. We conclude that CLIC1 and CLIC4 each function in the S1P receptor 





Figure 3.12  S1P induced Rac1 activation within 5 minutes. Control HUVECs were starved 
for 3hrs, and stimulated with 1µM S1P at 2min, 5min, 10min, 15min, and 20min. Rac1-GTP 
were measured using Rac1 G-LISA assay. ANOVA statistical tests were used to analyze 
significance, and the significance level was compared to time 0. *p<0.05  
 
Figure 3.13  CLIC1 and CLIC4 are required for S1P mediated Rac1 activation. HUVECs 
were starved for 3hrs, and lysates were collected following 1μM S1P stimulation for 5 minutes. 
(A) G-LISA assay was performed and Rac1 activation was measured at 490nm absorbance. (B) 
Normalized fold changes compared to unstimulated cells within each condition were presented. 
ANOVA statistical tests were used to analyze significance ***p<0.001 (C) Total levels of Rac1 
were assessed with western blot. 
 
3.4.2 CLIC1 and CLIC4 are not required for S1P-Gαi-mediated cAMP regulation or 
Isoproterenol-Gαs mediated cAMP regulation  





















S1PR1 is a G-protein coupled receptor that is exclusively coupled with the Gαi subunit. 
Migration and endothelial barrier maintenance are regulated downstream of S1PR-Gαi-
Gβγ-Rac1 activation. Gαi inhibits adenylyl cyclase (AC) resulting in decrease in cAMP 
production which affects downstream signaling proteins. In order to test whether CLIC1 
and CLIC4 are required for Gαi activity, we measured the role of CLIC1 and CLIC4 in 
cAMP regulation by using an immuno-competitive ELISA assay. Time-course and dose 
response tested showed that S1P decreased cAMP levels with maximum response at 
30min and 1µM S1P (Figure 3.14A-B). Loss of CLIC1 or CLIC4 did not alter total cAMP 
levels before addition of S1P (Figure 3.14C). Following S1P administration after 30min, 
HUVECs with CLIC1-KD or CLIC4-KD responded to S1P by decreasing cAMP to a 
comparable level to control cells, indicating that CLICs are not required for cAMP 
change in response to S1P.  
 
 
Figure 3.14  CLIC1 and CLIC4 are not required for S1P mediated cAMP regulation. 
HUVECs were starved for 3hrs, and treated with 1mM IBMX (phosphodiesterase inhibitor) for 
30 minutes. 20µM Forskolin was administered for eliciting maximum cAMP production before 
S1P addition. Various doses of S1P treated with 30 minutes (A) and time course analysis for 
1µM (B) revealed the optimal stimulation of HUVECs with S1P. (C) HUVECs were treated with 
1µM S1P for 30 minutes, and lysates were collected with 0.1M HCl, and cAMP levels were 
measured using competitive immunoassay. ANOVA statistical tests were used to analyze 




To further prove that CLIC1 and CLIC4 do not function to modulate cAMP, we 
measured cAMP induction by Isoproterenol (ISO) through the β2 adrenergic receptor 
which is coupled to Gαs. Gαs activates Adenylyl Cyclase (AC) and increases levels of 
cAMP [97]. Dose response and time-course studies showed that HUVECs maximally 
increase cAMP in response to 1µM of ISO with 30min incubation (Data not shown). 
Loss of CLIC1 or CLIC4 did not alter the response to ISO to increase cAMP, indicating 
that CLIC1 and CLIC4 are not required for cAMP regulation in endothelial cells (Figure 
3.15). 
 
Figure 3.15  CLIC1 and CLIC4 are not required for Isoproterenol-mediated cAMP 
regulation. HUVECs were starved for 3hrs, and treated with 1mM IBMX (phosphodiesterase 
inhibitor) for 30 minutes. HUVECs were treated with 1µM Isoproterenol for 30 minutes, and 
lysates were collected with 0.1M HCl, and cAMP levels were measured using competitive 
immunoassay. ANOVA statistical tests were used to analyze significance *** p<0.001 
 





As shown in Figure 3.3, S1P can also activate Ras and Erk downstream of Gβγ. We 
further investigated whether CLIC1 and CLIC4 are required for S1P-driven Ras or Erk 
activation. Ras-GTP activation in response to S1P was measured using the Ras G-LISA 
assay. Total Ras protein levels were not altered in CLIC1-KD or CLIC4-KD cell lines 
compared to control. (Figure 3.16C) Basal Ras-GTP levels before S1P addition were 
also comparable among cell lines. GLISA assay revealed that loss of CLIC1 or CLIC4 
did not alter S1P-Ras response significantly. In both CLIC1-KD and CLIC4-KD cells, 
Ras-GTP was stimulated ~2 fold which is comparable to control cells (Figure 3.16A-B).  
Erk phosphorylation downstream of Ras was determined by western blot using 
phospho-Erk antibody. Consistently, phosphorylation of Erk protein levels also did not 
change significantly among cell lines (Figure 3.16D). These results indicated that CLIC1 
or CLIC4 are not required for S1P-mediated Ras or Erk activation.  
 
Figure 3.16  CLIC1 and CLIC4 are not required for S1P mediated Ras activation and Erk 
activation. HUVECs were starved for 3hrs, and lysates were collected following 1μM S1P 
stimulation for 5 minutes. (A) G-LISA assay were performed and Ras activation were measured 
at 490nm absorbance. (B) Normalized fold changes compared to unstimulated cells within each 
condition were presented. ANOVA statistical tests were used to analyze significance *p<0.05 
(C) Total levels of Ras were assessed with western blot. (D) Lysates were collected following 




3.4.4 S1P failed to induce Cdc42 in HUVEC cells with G-LISA assay 
 
It has been shown that Cdc42 is also induced in endothelial cells and works to regulate 
endothelial cell cytoskeleton rearrangement upon S1P stimulation through the 
S1PR1/Gαi branches [46]. We further tested whether Cdc42 was activated upon S1P 
stimulation. However, we did not observe significant changes in Cdc42 activation 
following S1P treatment in HUVECs using the G-LISA assay (Figure 3.17). This may be 
because the level of induction was small, and the assay was not sensitive enough to 
detect the subtle changes. New methodology will be further discussed in the discussion 
section.  
 
Figure 3.17  S1P failed to induce Cdc42 activation. Control HUVECs were starved for 3hrs, 
and stimulated with 1µM S1P at 2min, 5min, 10min, 15min, and 30min. Cdc42-GTP were 
measured using Cdc42 G-LISA assay. ANOVA tests were used, and no significance was 
detected for all time points. 
 




CLIC1 or CLIC4 are not required for VEGF-mediated barrier or migration change as 
shown in Figure 3.10. We investigated whether VEGF Receptor activation requires 
CLICs by investigating tyrosine-phosphorylation of VEGFR2 mediated by VEGF. 
Phosphorylation of VEGFR2 induced by VEGF-A was examined by western blot. 
Interestingly, total VEGFR2 levels in knockdown cells were different from control cells. 
CLIC1-KD cells exhibit higher levels of VEGFR2 expression, possibly due to a critical 
role of CLIC1 in other signaling pathways that may affect VEGFR2 expression (Figure 
3.18 A). However, after normalization of the phospho-VEGFR2 against the total 
VEGFR2 (Figure 3.18 B), the level of phosphorylation exhibited no significant difference 
between CLIC-KD cells and control cells. In concordance with the cellular migration and 





Figure 3.18  CLIC1 and CLIC4 are not required for VEGF-mediated VEGFR2 
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phosphorylation or EGF-mediated Ras activation. (A) HUVEC lysates were collected 20 
minutes after 100 ng/mL VEGF treatment, and phosphorylation of VEGFR2 at Y951 and Y1175 
were analyzed in western blot. (B) Densitometry and normalization were performed against total 
VEGFR2 in each condition, and the ratio of p-VEGFR2 to total VEGFR2 were presented (n=3). 
(C) HUVEC lysates were collected 10 minutes after 100 ng/mL EGF treatment, G-LISA of Ras-
GTP were measured, and normalized fold changes compared to unstimulated cells within each 
condition were presented. ANOVA statistical tests were used to analyze significance. *p<0.05 
 
3.4.6 CLIC1 and CLIC4 are not required for EGF-mediated Ras activation 
 
To further elucidate the potential roles of CLIC proteins in receptor tyrosine kinase 
signaling, we tested another tyrosine kinase pathway that functions in endothelial cells, 
EGF signaling pathway. EGF (epidermal growth factor) activates receptor tyrosine 
kinase EGF receptor and stimulates Ras activation in endothelial cells to mediate cell 
proliferation. We explored whether CLICs function to regulate this pathway in HUVEC. 
Ras G-LISA assay in Figure 3.18C showed Ras activation in response to EGF in both 
CLIC1-KD and CLIC4-KD HUVECs was comparable to control HUVECs, indicating that 




We sought to investigate the role of CLIC proteins in regulating endothelial S1P 
signaling, primarily through the S1PR1 signaling pathway and its downstream cellular 
functions. We demonstrated that loss of both CLIC1 and CLIC4 resulted in rapid 
endothelial cell death, within hours, which could be a possible explanation for Clic1-/-
;Clic4-/- mouse embryonic lethality at E10.5. Single loss of CLIC1 or CLIC4 in HUVECs 
exhibits a defect in endothelial cell viability and morphology changes that is apparent 
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when following cells over several days after knockdown. Morphology changes are seen 
in HUVEC with CLIC knockdown and may be due to cytoskeleton rearrangement, 
suggesting an involvement of small G-protein signaling in CLIC function. We specifically 
monitored small G-protein activities in CLIC KD cells and showed loss of either CLIC1 
or CLIC4 protein in HUVECs reduced S1P-mediated Rac1 activation, and impaired their 
downstream functions, including vascular barrier integrity, migration, and invasion. 
Immunofluorescent study of VE-cadherin also exhibited lower intensity after S1P 
stimulation as well as abnormal zig-zag pattern, indicating unstable junctions. The zig-
zag pattern of VE-cadherin junctions is also observed in endothelial cells with loss of 
Rac1 [77], which is consistent with the reduced S1P-Rac1 activation in CLIC 
knockdown HUVECs. Thus, we conclude that both CLIC1 and CLIC4 are essential 




Table 3.1  CLIC1 and CLIC4 are required in endothelial S1PR-Gαi signaling pathway. 
 
Interestingly, VEGF-mediated permeability change, migration, and VEGFR2-
phosphorylation, and EGF-mediated Ras activation were not altered with loss of CLIC1 
or CLIC4. (Table 3.1) These results suggested that CLIC1 and CLIC4 do not play a 
significant role in endothelial VEGF or EGF signaling. Further signaling systems need to 
be investigated such as IGF and FGF signaling in endothelial cells to fully understand 
their actions and to exclude essential roles in receptor tyrosine kinase signaling 
pathways. We investigated the regulation of cAMP through S1PR1/Gαi and β2-
adrenergic receptor (β2R)/Gαs by S1P and Isoproterenol respectively. CLIC1 and 
CLIC4 are not required for cAMP regulation in either pathway. This suggested that 
CLICs are not regulating Gαi or Gαs subunit, but possibly through the Gβγ subunit, and 
downstream small G-proteins such as Rac1 proteins. The involvement of Gαi or Gβγ 
with CLICs in regulating Rac1 will be addressed with future investigation. 
 
Rac1, Cdc42, and RhoA are small G-proteins involved in cytoskeleton reorganization 
and their activities mediate growth, barrier formation, migration and other processes in 
endothelial cells. Morphology changes in CLIC-KD cells suggested potential 
involvement with small G proteins. We have shown that S1P-Rac1 activation depends 
on CLIC1 and CLIC4. One recent study [46] suggested S1P could activate Cdc42 
through S1PR1 in HUVECs. However, Cdc42 activation by S1P was not observed 
through G-LISA study, possibly due to low levels of induction and the assay not being 
sensitive enough to detect subtle changes. FRET (Fluorescence Resonance Energy 
Transfer) technology is able to capture the transient and subtle change of S1P-Cdc42 
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activation [46]. Future studies could be conducted using FRET analysis to observe the 
activation of S1P-mediated Cdc42 activation and further investigate the role of CLIC1 
and CLIC4 in these branches of the S1PR1 pathway. As briefly mentioned in the 
introduction, S1PR2 and S1PR3, although expressed at low levels, are an important 
part of S1P signaling. In vitro analysis conducted in this Chapter focused on S1P-
Gαi/Gβγ, however, S1P can also work to activate S1PR2 and S1PR3 in endothelial 
cells which exhibit unique branches of signaling. Both receptors can couple with Gαi, 
Gα12/13 and Gαq. RhoA is an important effector downstream of Gα12/13 which will be 



















Chapter 4. CLIC1 and CLIC4 have unique and 






4.1 Introduction and Rationale 
 
CLIC1 and CLIC4 are the most widely expressed and best-studied family members 
among the 6 members of the CLIC family[22]. They are the major CLIC proteins 
expressed in endothelial cells and have been shown to function to regulate endothelial 
behaviors. However, the specific mechanisms of action of CLIC1 and CLIC4 in 
endothelial cells remains unclear. Crystal structures of CLIC1 and CLIC4 have been 
reported, revealing what is believed to be the structure of their cytosolic forms and 
exhibiting similarities to the omega-class of glutathione-S-transferases (GSTs) [14, 15]. 
Structural analysis also demonstrated a conformational switch induced under oxidative 
conditions to expose a large hydrophobic surface. This oxidation-induced switch was 
hypothesized to promote membrane insertion and formation of a multimer that has ion 
channel activity [14, 15]. However, both CLIC1 and CLIC4 structure and function have 
been under extensive debate, as it has been difficult to establish physiological activities, 
which may be as an ion channel, a GST enzyme, a nuclear factor, or another type of 
biochemical or signaling effector activity. 
 
The study of CLIC1 has provided the strongest support for ion channel function among 
CLIC family proteins. It was shown that following oxidation, CLIC1 can undergo a 
reversible rearrangement of the GST-like fold forming a disulfide bond (Cys24-Cys59) 
and exposing a large hydrophobic surface. Some biophysical studies suggested that 
CLIC1 can in turn oligomerize, and it has been hypothesized to associate with the 
membrane upon oxidation. [15, 92] Electrophysiological experiments showed ion fluxes 
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across artificial bilayers mediated when one overexpresses or adds CLIC1 protein. The 
ion channel activity measured displays poor selectivity of Cl- [6]. However, by over-
expressing CLIC1 protein, it is unclear whether the over-expression could activate other 
effectors to regulate ion channels. In addition, as mentioned, there has not been a 
definitive study of physiological CLIC function that demonstrates a requirement of ion 
channel activity of CLICs.  
 
Both CLIC1 and CLIC4 were recently shown to display glutaredoxin-like activity in 
vitro[23]. These assays were performed using purified CLICs [23], it is still unclear how 
this in vitro study relates to in vivo analysis. Intriguingly, the enzymatic activity of CLIC1 
was blocked by IAA-94, a poorly characterized chloride channel inhibitor, suggesting a 
possible involvement of CLIC1 in channel activity [23]. Furthermore, mutations of CLIC4 
on residues believed to be essential for GST substrate binding, showed disruptive 
localization upon agonist stimulation in vitro [89]. Compared to CLIC1, studies have 
suggested that CLIC4 could possibly have enzymatic activity, rather than being an ion 
channel or regulating ion channels.  
 
CLIC1 and CLIC4 are both required for promoting angiogenesis in endothelial cell 
culture [27, 29], but genetic studies with loss of Clic1 and Clic4 in mice showed distinct 
phenotypes. Clic4-null mice are smaller and show more still-births than wild-type 
animals [28, 98]. Deficiency of CLIC4 also results in impairment of tubulogenesis and 
vacuole formation in endothelial cells [28]. Clic1-null mice on the other hand showed 
mild platelet dysfunction [30]. Loss of Clic1 in mice was also believed to be involved in 
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regulation of immune cell function including macrophages and dendritic cells [99, 100]. 
Overall, the predicted mechanisms of CLIC1 and CLIC4 functions as well as genetic 
studies suggest that there are distinct and non-overlapping roles between CLIC1 and 
CLIC4 proteins. 
 
We have shown that both CLIC1 and CLIC4 are required for S1PR1-mediated signaling, 
including migration, barrier maintenance as well as Rac1 activation. However, whether 
CLIC1 and CLIC4 are functionally redundant is unclear. Genetic studies showed distinct 
phenotypes in Clic1-null and Clic4-null mice. Furthermore, as shown in Chapter 3, loss 
of CLIC1 or CLIC4 protein in HUVECs failed to increase the protein expression of the 
other, indicating no compensatory mechanism. Thus, we hypothesized that CLIC1 and 
CLIC4 have distinct functions to regulate S1PR1-Rac1 activation and downstream 
endothelial cellular function. To study whether they play unique roles, we ectopically 
expressed wild type CLIC1 or CLIC4 in endothelial cells that have lost CLIC expression 
(CLIC-KD cells) to see whether they can successfully rescue the S1P-mediated 
endothelial deficiencies observed in CLIC4-KD or CLIC1-KD respectively.  
 
4.2 Results: Developing a rescue system to study endothelial CLIC function and 
CLIC functional domains  
 
4.2.1 Screening epitope tags appropriate for the study of CLIC protein function. 
 
In order to study CLIC1 and CLIC4 protein biochemically, we sought to develop a 
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system where we could detect ectopic expression of CLIC proteins. Current biochemical 
approaches such as immunofluorescent or immunoprecipitation studies have been 
challenging, because many current commercial antibodies failed to distinguish between 
CLIC1 and CLIC4 proteins. The antibodies utilized in Chapter 3 are specific for CLIC1 
and CLIC4 in western blot analysis, but their application in immunofluorescent studies 
have not been successful. Hence, to investigate the unique nature of CLIC1 or CLIC4 
proteins respectively, we have expressed epitope-tagged CLIC proteins. 
 
Both CLIC1 and CLIC4 proteins consist of around 250 amino acids [14, 15]. Epitope 
tagging of proteins may alter function or cause unexpected protein modifications to 
CLIC proteins. Therefore, we screened two small epitope tags for their ability to function 
as tags without compromising function. We engineered forms of CLIC4 with a Flag or 
HA tag, either at the N or C-terminus, and assessed their expression levels as well as 
functional properties compared to wild-type CLIC4. Protein expression of Flag-CLIC4 
(Flag on N-terminus), CLIC4-Flag (Flag on C-terminus), HA-CLIC4 (HA on N-terminus), 
and CLIC4-HA (HA on C-terminus) are shown in Figure 4.1. It was shown that a Flag 
tag on the N-terminus caused an unexpected size shift compared to expressing Flag at 
the C-terminus. On the other hand, the C-terminus HA tag for CLIC4 was not expressed 
at levels comparable to wild type CLIC4. Thus, we found potential post-translational 
modifications when Flag was tagged on the N-terminus of CLIC4, whereas translation 
was affected with HA tag on the CLIC4 C-terminus.  We found that either expressing 
Flag on the CLIC4 C-terminus (CLIC4-Flag) or HA on the CLIC4 N-terminus (HA-
CLIC4) lead to comparable expression to wild type CLIC4 with no unanticipated 
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modifications based upon size. We have decided to adopt HA-tag on N-terminus of 




Figure 4.1  Protein expression of CLIC4 with different epitope tags. HUVECs were lenti-
virally infected with ectopic CLIC4 plasmids with different tags at either N-terminus or C-
terminus. These include control (empty vector), CLIC4 (wild type CLIC4), Flag-CLIC4 (Flag on 
N-terminus), CLIC4-Flag (Flag on C-terminus), HA-CLIC4 (HA on N-terminus), CLIC4-HA (HA 
on C-terminus). 25μg of lysates were loaded and immunoblot was analyzed with CLIC4 
antibody, and α-tubulin as loading control. 
 
4.2.2 Ectopic HA-CLIC4 and HA-CLIC1 rescued endothelial viability in CLIC4 or CLIC1 
knockdown.  
 
To establish that HA-CLIC4 and HA-CLIC1 function the same as wild type CLIC4 and 
CLIC1, we expressed the epitope-tagged forms in CLIC4-KD or CLIC1-KD respectively. 
Expression levels of HA-CLIC4 or HA-CLIC1 are restored following lentiviral infection of 
CLIC4-KD or CLIC1-KD HUVECs (Figure 4.2). To test whether endothelial viability was 
rescued an MTT viability assay was performed, and Figure 4.3 revealed significant 
improvement in endothelial cell survival in both CLIC4-KD and CLIC1-KD cells after the 
ectopic HA-tagged CLIC protein was expressed. These results showed that ectopic HA-
CLIC4 and HA-CLIC1 could successfully rescue survival defects in HUVECs due to the 
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loss of endogenous CLIC4 and CLIC1 respectively.  
 
 
Figure 4.2  Expression levels were restored by ectopically expressing HA-CLIC4 and HA-
CLIC1 in CLIC4-KD and CLIC1-KD respectively. HUVECs were lenti-virally infected with 
CLIC4 and CLIC1 shRNA to generate CLIC4-KD and CLIC1-KD cells respectively. Ectopic HA-
CLIC4 and HA-CLIC1 were co-infected in CLIC4-KD and CLIC1-KD cells. mRNA levels of 




Figure 4.3  HUVEC cell viability were rescued by ectopically expressing HA-CLIC4 and 
HA-CLIC1 in CLIC4-KD and CLIC1-KD respectively. HUVECs were lenti-virally infected with 
CLIC4 and CLIC1 shRNA to generate CLIC4-KD and CLIC1-KD HUVECs respectively. Ectopic 
HA-CLIC4 and HA-CLIC1 were expressed in CLIC4-KD (A) and CLIC1-KD (B) cells. 
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Quantification of MTT viability assay with absorbance at 570nm were assessed at 48, 72, and 
96 hours post infection. ANOVA statistical tests were used, and the significance levels were 
presented against control HUVECs. *p<0.05, ***p<0.001. 
 
4.2.3 Over-expression of HA-CLIC4 did not change S1P-driven physiological response 
of HUVEC.  
 
HA-CLIC4 and HA-CLIC1 ectopic expression successfully rescued HUVEC cell survival 
defects in CLIC4-KD and CLIC1-KD cells. Ectopic expression of HA-CLIC4 or wild-type 
CLIC4 protein via lentiviral vectors showed super-physiological levels compared to 
endogenous HUVEC CLIC4. We examined whether the high, over-expression of CLIC4 
stimulates Rac-1 activation, even in the absence of agonists required to activate Rac1, 
such as S1P. Over-expressing HA-CLIC4 did not alter basal levels of Rac1-GTP or 
S1P-mediated Rac1 activation (Figure 4.4). Furthermore, endothelial barrier integrity 
measured by trans-endothelial electrical resistance exhibited comparable baseline 
measurements and S1P-mediated responses compared to control cells (Figure 4.5). 
These results suggested that over-expressing CLIC4 in HUVEC to levels higher than 
endogenous CLIC4 did not alter endogenous S1P-driven responses. Thus, we 
concluded that one can use this system to study rescue of endothelial deficiency in 




Figure 4.4  Ectopic CLIC4 over-expression (CLIC4-OE) does not alter S1P-mediated Rac1 
activation. HUVECs were starved for 3hrs, and lysates were collected following 1μM S1P 
stimulation for 5 minutes. G-LISA assay was performed and Rac1 activation was measured at 
490nm absorbance. ANOVA statistical tests were used. *p<0.05 
 
Figure 4.5  Ectopic CLIC4 over-expression (CLIC4-OE) does not alter S1P-mediated 
barrier response. HUVECs were starved for 2hrs and stimulated with 1μM S1P or vehicle 
control at time 0min. Trans-endothelial electrical resistance (TEER) were monitored for 2hrs 
post S1P treatment. 
 
4.3 Results: CLIC1 and CLIC4 have non-overlapping functions in S1P signaling 
pathway 
 



































As shown in Chapter 3, both CLIC4 and CLIC1 are essential for S1P-mediated 
endothelial barrier integrity, migration, and Rac1 activation. We previously showed that 
loss of CLIC4 expression with KD did not alter expression of endogenous CLIC1, and 
vice versa, see Figure 3.4. These results suggested that no compensation of protein 
expression is observed. Hence, we hypothesize that CLIC1 and CLIC4 have non-
overlapping roles in mediating S1P response and tested this hypothesis using the 
rescue system that we developed.  
 
In order to investigate their roles in S1P signaling, we tested whether ectopic HA-CLIC1 
would rescue S1P-mediated endothelial deficiencies in CLIC4-KD cells. In CLIC4-KD 
cells, S1P-mediated endothelial barrier response was reduced, and HA-CLIC4 rescued 
the endothelial barrier phenotype caused by the loss of CLIC4 (Figure 4.6). 
Interestingly, ectopic HA-CLIC1 failed to induce enhancement of barrier resistance after 
S1P treatment in CLIC4-KD cells (Figure 4.6), indicating that CLIC1 failed to overcome 





Figure 4.6  Ectopic HA-CLIC1 fails to rescue S1P-mediated barrier response in CLIC4-KD 
cells. HUVECs were starved for 2hrs and stimulated with 1μM S1P or vehicle control at time 
0min. Trans-endothelial electrical resistance (TEER) were monitored for 2hrs post S1P 
treatment (A-D). All cell lines with S1P treatment were combined (E) and area under curve were 
calculated for quantification (F). ANOVA statistical tests were used. * p<0.05 
 
We examined S1P-mediated migration (Figure 4.7) and Rac1 (Figure 4.8) activation in 
CLIC4-KD cells to determine whether CLIC1 could rescue the deficiencies of lost 
CLIC4. The migration and Rac-1 activation responses to S1P both were significantly 
reduced due to loss of CLIC4. Consistent with S1P-driven endothelial barrier response, 
we showed that ectopic HA-CLIC4 expression could rescue deficiency in S1P-mediated 
migration, as well as Rac1 activation. However, ectopic HA-CLIC1 expression failed to 
rescue the deficient S1P migration and Rac1 activation in CLIC4-KD cells. These 
results demonstrate that CLIC1 fails to rescue S1P-mediated endothelial deficiencies 
due to loss of CLIC4. Thus, CLIC1 does not function similarly to CLIC4 in mediating 




Figure 4.7  Ectopic HA-CLIC1 fails to rescue S1P-mediated migration in CLIC4-KD cells. 
HUVECs were seeded at the top chamber and starved for 3hrs. 1μM S1P was added in the 
bottom chamber after starvation allowing 6hrs of migration (A). The number of migrated cells 
per field were counted and quantified (B).  ANOVA statistical tests were used to analyze 




Figure 4.8  Ectopic HA-CLIC1 fails to rescue S1P-mediated Rac1 activation in CLIC4-KD 
cells. HUVECs were starved for 3hrs, and lysates were collected following 1μM S1P stimulation 
for 5 minutes. G-LISA assay was performed and Rac1 activation was measured at 490nm 
absorbance. Normalized fold changes compared to unstimulated cells within each condition 
were presented. ANOVA statistical tests were used to analyze significance. ***p<0.001 
 





We further explored whether CLIC4 could function similarly to CLIC1 in S1P-driven 
endothelial cell functions. We utilized a similar approach and ectopically express HA-
CLIC4 to investigate whether it can restore S1P-mediated endothelial deficiencies due 
to loss of CLIC1. As shown in Chapter 3, loss of CLIC1 in HUVECs caused reduced 
endothelial barrier, migration, as well as Rac1 activation in response to S1P. Here, we 
showed that ectopic HA-CLIC1 successfully restored the S1P responses in CLIC1-KD 
cells comparable to control cells. However, HA-CLIC4 expression fails to rescue S1P-
driven endothelial barrier enhancement (Figure 4.9), migration (Figure 4.10) or Rac1 
activation (Figure 4.11). These results showed that CLIC4 does not function similarly to 
CLIC1 in mediating S1P responses in HUVECs, and further confirmed non-overlapping 
functions for both CLIC proteins in the endothelial S1P signaling pathway.  
 
 
Figure 4.9  Ectopic HA-CLIC4 fails to rescue S1P-mediated barrier response in CLIC1-KD 
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cells. HUVECs were starved for 2hrs and stimulated with 1μM S1P or vehicle control at time 
0min. Trans-endothelial electrical resistance (TEER) were monitored for 2hrs post S1P 
treatment (A-D). All cell lines with S1P treatment were combined (E) and area under curve were 




Figure 4.10  Ectopic HA-CLIC4 fails to rescue S1P-mediated migration in CLIC1-KD cells. 
HUVECs were seeded at the top chamber and starved for 3hrs. 1μM S1P was added in the 
bottom chamber after starvation allowing 6hrs of migration (A). The number of migrated cells 
per field were counted and quantified (B). ANOVA statistical tests were used to analyze 
significance. ****p<0.001 
 
Figure 4.11  Ectopic HA-CLIC4 fails to rescue S1P-mediated Rac1 activation in CLIC1-KD 
cells. HUVECs were starved for 3hrs, and lysates were collected following 1μM S1P stimulation 
for 5 minutes. G-LISA assay was performed and Rac1 activation was measured at 490nm 
absorbance. Normalized fold changes compared to unstimulated cells within each condition 






In this chapter, we investigated whether CLIC1 and CLIC4 function in a similar fashion 
in their common ability to regulate S1P-mediated endothelial barrier integrity, migration 
and Rac1 activation. By ectopically expressing CLIC1 and CLIC4, we were able to 
rescue S1P-driven endothelial deficiencies due to loss of endogenous CLIC1 and 
CLIC4 respectively. However, CLIC1 fails to rescue deficiency in CLIC4-KD cells, and 
CLIC4 fails to rescue deficiency in CLIC1-KD cells. These results suggested that 
although both CLIC1 and CLIC4 are required for common S1P-mediated endothelial 
responses, they function uniquely in S1P signaling. The non-overlapping functions of 
CLIC1 and CLIC4 may also explain the variations in mouse genetic studies. However, it 
is still unclear how CLIC1 and CLIC4 function differently in the S1P signaling pathway. 
Here, we propose two working hypotheses for a potential mechanism for CLICs. 
 
4.4.1 Working Model #1: CLIC1 and CLIC4 function as a heterodimer to regulate S1P-
mediated endothelial responses 
 
CLIC1 and CLIC4 fail to rescue the loss of the other CLIC in S1P signaling. One 
possible explanation is that they exist as a heterodimer, and that existence of both 
proteins is required for proper function of the S1P signaling cascade. This hypothesis 
also partially explains why over-expression of CLIC4 did not alter endogenous S1P 
signaling. To test this hypothesis, future studies may determine if expression of both 
CLIC1 and CLIC4 to high levels in HUVEC increases the basal level of Rac1 activity in 
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a ligand-independent fashion. 
 
Although the crystal structures of the presumably cytosolic form of CLIC1 and CLIC4 
has been resolved [14, 15], the question of whether CLICs exist as dimers or oligomers 
is still under debate. The ion channel activity elicited by purified CLIC proteins inserted 
into artificial membranes requires oligomerization to occur following the insertion of the 
CLIC protein into the membrane [15]. Trimeric forms of CLIC4 were observed in crystals 
[101], but the physiological relevance of these multimeric forms remains unclear. 
Proteomic analysis on CLIC4-interacting proteins in human pulmonary artery endothelial 
cells (HPAECs) revealed that CLIC1, though not abundant, is an interacting partner of 
CLIC4 [102]. Thus, evidence suggests possible multimeric forms may be important for 
CLIC function in S1P signaling. 
 
In order to study whether CLICs function as a heterodimer, co-immunoprecipitation 
studies could be utilized, and have recently been initiated. However, it is possible that 
the hetero-dimerization process only occurs upon S1P stimulation, making it challenging 
to capture this transient event. FRET analysis could be used to study whether they 
interact with each other in this time-sensitive event.  
 
4.4.2 Working Model #2: CLIC1 and CLIC4 function to regulate different Rac1-GEFs 
converging to activate S1P-mediated Rac1 
 
A possible explanation for the observation that CLIC1 and CLIC4 are each required for 
 
76  
S1P signaling but do not compensate for each other is that these CLICs may regulate 
distinct Rac1-GEFs, each of which converge to activate Rac1. The mechanism of Rac1 
activation by S1P signaling in endothelial cells is not completely understood. Studies in 
human pulmonary artery endothelial cells (HPAECs) [103] and bovine aortic endothelial 
cells (BAECs) exhibited that the Rac1-GEF Tiam1 regulates Rac1 through S1P 
signaling [104]. Another study in HUVECs showed the Rac1-GEF PREX2 as the key 
regulator of S1PR1-Rac1 activation [105]. It is possible that Rac1 activation in S1P 
signaling is regulated by multiple guanine exchange factors, and that CLIC1 and CLIC4 
regulate different GEFs, and both converge to activate Rac1 separately. 
 
In order to address this hypothesis, we could perform loss of function studies of Tiam1 
and PREX2 to examine whether S1P signaling is defective as in CLIC-KD cells. Then, 
we could assess for Tiam1 GEF activity and PREX2 phosphorylation in CLIC-KD cells 
to see which CLIC is required for their proper function. These assays will provide us 
insights on how CLICs function and regulate the S1P signaling pathway, and how they 

















Chapter 5.  CLICs utilize the C-terminal domain 





5.1 Introduction and Rationale 
 
The chloride intracellular channel (CLICs) protein family is structurally homologous to 
the omega-class of glutathione-S-transferase family. Among the 6 members, the 
structures of CLIC1 and CLIC4 are the most studied [14, 15]. Schematic 
representations of the structures of CLIC1 and CLIC4 are shown in Figure 5.1. Both 
proteins include the N-terminus (~100 amino acids) thought to be important for 
membrane localization and their hypothesized ion channel activity. Residues from both 
N-terminal and C-terminal domains are thought to be essential for their thioredoxin 
enzymatic activity.  
 
CLIC1 consists of 241 amino acids and CLIC4 is 253 amino acids, and they share a 
high level of amino acid sequence similarity. Both CLIC1 and CLIC4 have a putative 
transmembrane domain (PTM) located in the N-terminus that is thought to be 
responsible for membrane insertion upon oxidation [14, 15]. The conserved cysteine 
residue within the putative transmembrane domain of both proteins has been 
characterized as highly reactive for thioredoxin-like enzymatic activity in vitro [23].  
 
Unlike CLIC1, CLIC4 has a nuclear localization signal (NLS), which has been well 
established to be required for CLIC4 in translocation to the nucleus in various types of 
cells [12, 106]. Another main distinction between CLIC1 and CLIC4 is found in their 
different protein-protein interaction motifs. Based on amino acid sequence analysis, only 
CLIC4 has a consensus Src-homology 3 (SH3) binding motif [6, 107]. Interestingly, 
 
79  
tyrosine phosphorylation at a consensus site in both CLIC1 (Y233) and CLIC4 (Y244) 
could create a potential SH2 binding domain [107]. This tyrosine is also shown to serve 
as a key residue for agonist induced translocation in tumor cells [89]. However, the SH3 
and SH2 binding motifs are predicted solely on amino acid sequence and it remains 
unclear what their role in CLIC proteins are physiologically.  
 
 
Figure 5.1  Comparison between predicted protein structures for CLIC1 and CLIC4. 
Alignment of CLIC1 and CLIC4 structures based on predicted amino acid sequence. Predicted 
trans-membrane domain region, Ion Channel - Ion channel similarity region, NLS - nuclear 
localization signal, SH3-Src homology 3 predicted binding motif, SH2-Src homology 2 predicted 
binding motif with tyrosine residue. Asterisks represent highly reactive cysteine residue. 
 
It remains unclear how CLIC1 and CLIC4 functions in S1P signaling, and whether their 
unique functional domains contribute to their functional specificity. It was revealed 
through protein alignment evaluation that CLIC1 and CLIC4 differs more in C-terminus 
sequence than in the N-terminus (Data not shown). Thus, we hypothesize the C-
terminus may confer unique functions for CLIC1 and CLIC4 in S1PR1-Rac1 signaling. 
In this chapter, we sought to characterize the specific domains in both CLIC1 and 
CLIC4, and explore which functional domains in CLICs defines their unique functions in 


































5.2 Results: Design of CLIC1 and CLIC4 chimeric protein 
 
CLIC1 and CLIC4 are highly conserved and shared 67% amino acid sequence 
homology through BLAST protein alignment analysis (Data not shown). Interestingly, 
both CLIC1 and CLIC4 proteins function in regulating S1P-mediated endothelial barrier 
maintenance, migration, and Rac1 activation, while they regulate the pathway in unique 
fashion. The different roles of regulating similar pathway and responses, as well as their 
highly conserved structure provides us the advantage to study the critical domains for 
their specific functions.  
 
The N-terminus of CLIC1 and CLIC4 proteins encodes what is thought to be a 
transmembrane domain and this domain is thought to facilitate membrane insertion. In 
contrast, the C-terminus of CLICs contains several residues hypothesized to be the 
catalytic domain for their predicted GST enzymatic function, although N-terminal 
residues are thought to be important for GST function. We decided to switch the N-
terminus and C-terminus of the two proteins to characterize which of these two parts of 
CLICs contributes to their unique functions in S1P signaling. CLIC4-CLIC1 (C4-C1) 
chimeric proteins were expressed in HUVEC that had CLIC-KD.  In the C4-C1 protein, 
the N-terminus of CLIC4 (AA 1-95) is followed by the C-terminus of CLIC1 (AA 85-241), 
whereas C1-C4 were generated with the N-terminus of CLIC1 (AA 1-84) followed by the 
C-terminus of CLIC4 (AA 96-253) (Figure 5.2). Both proteins were HA-tagged at the N-
terminus, and both HA-C4-C1 and HA-C1-C4 proteins were found to be expressed at 
 
81  
similar levels as that of ectopically expressed CLIC4 and CLIC1 (Figure 5.3).   
 
 
Figure 5.2  Generation of Chimeric Protein CLIC4-CLIC1 (C4-C1) vs. CLIC1-CLIC4 (C1-C4). 
Schematic representation of CLIC4 and CLIC1 protein with swapping site at CLIC4 amino acid 
95, and CLIC1 amino acid 84 (A) to generate chimeric protein CLIC41-95-CLIC185-241 (C4-C1) 
with N-terminus of CLIC4 and C-terminus of CLIC1 (B), and chimeric protein CLIC11-84-CLIC496-
253 (C1-C4) with N-terminus of CLIC1 and C-terminus of CLIC4 (C). 
 
Figure 5.3  Protein expression of chimeric proteins. HUVECs were lenti-virally infected with 
different CLIC variants. These include control (empty vector), CLIC4-OE (wild type CLIC4), 
CLIC1-OE (wild-type CLIC1), HA-CLIC1-CLIC4, HA-CLIC4-CLIC1. 25µg of lysates were loaded 
and immunoblot were analyzed with CLIC4 antibody, CLIC1 antibody and α-tubulin as loading 
control. Both CLIC4 and CLIC1 antibody recognizes C-terminus of respective protein. 
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To determine which CLIC domains confer specificity in the S1P pathway, we utilized 
chimeric proteins, schematized in Figure 5.2, to rescue the S1P-mediated endothelial 
deficiencies due to the loss of either CLIC1 or CLIC4. 
 
5.3.1 HA-CLIC1-CLIC4 (C1-C4) rescued S1P-mediated endothelial deficiency in CLIC4-
KD cells. 
 
We investigated whether S1P-driven endothelial deficiency could be overcome by 
expressing the chimeric proteins in HUVECs with loss of CLIC4. S1P treatment 
increased endothelial electrical resistance in control cells, and loss of CLIC4 attenuated 
this response. HA-CLIC4 rescued the attenuation of barrier resistance caused by loss of 
CLIC4. Interestingly, in CLIC4-KD cells, HA-CLIC1-CLIC4 (C1-C4) rescued S1P-
mediated barrier response, whereas HA-CLIC4-CLIC1 (C4-C1) failed to rescue. (Figure 
5.4) These results suggested that S1P-driven barrier maintenance requires CLIC4, and 





Figure 5.4  CLIC1-CLIC4 (C1-C4) rescued S1P-mediated barrier response in CLIC4-KD 
cells. HUVECs were starved for 2hrs and stimulated with 1μM S1P or vehicle control at time 
0min. Trans-endothelial electrical resistance (TEER) were monitored for 2hrs post S1P 
treatment (A-E). Area under curve were calculated for quantification (F). HA-C4 (HA-CLIC4), 
C4-C1 (HA-CLIC4-CLIC1), C1-C4 (HA-CLIC1-CLIC4), C4KD (CLIC4-KD). ANOVA statistical 
tests were used to analyze significance. * p<0.05 
 
We further examined the rescue of S1P-mediated migration in CLIC4-KD cells by 
expressing the different chimeric proteins. Similar to endothelial barrier integrity, HA-
CLIC1-CLIC4 (C1-C4), and not HA-CLIC4-CLIC1 (C4-C1), rescued the S1P-mediated 
migration (Figure 5.5) in CLIC4-KD cells. We examined the chimeric proteins in S1P-
mediated Rac1 activation as both S1P-mediated endothelial barrier maintenance and 
migration are regulated by Rac1, and S1P-driven Rac1 activation also requires CLIC4. 
We showed that in CLIC4 knockdown cells, S1P-driven response of Rac1 activation 
could be restored by C1-C4 but not by C4-C1 (Figure 5.6). Altogether, these results 
revealed that C1-C4 with the C-terminus of CLIC4 functions similar to the native CLIC4 
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protein, indicating that the C-terminus of CLIC4 is the critical domain for its function in 
endothelial S1P signaling. 
 
 
Figure 5.5  CLIC1-CLIC4 (C1-C4) rescued S1P-mediated migration in CLIC4-KD cells. 
HUVECs were seeded at the top chamber and starved for 3hrs. 1μM S1P was added in the 
bottom chamber after starvation allowing 6hrs of migration (A). The number of migrated cells 
per field were counted and quantified (B).  HA-C4 (HA-CLIC4), C4-C1 (HA-CLIC4-CLIC1), C1-
C4 (HA-CLIC1-CLIC4), C4KD (CLIC4-KD). ANOVA statistical tests were used to analyze 




Figure 5.6  CLIC1-CLIC4 (C1-C4) rescued S1P-mediated Rac1 activation in CLIC4-KD 
cells. HUVECs were starved for 3hrs, and lysates were collected following 1μM S1P stimulation 
for 5 minutes. G-LISA assay was performed and Rac1 activation was measured at 490nm 
absorbance. Normalized fold changes compared to unstimulated cells within each condition 
were presented. HA-C4 (HA-CLIC4), C4-C1 (HA-CLIC4-CLIC1), C1-C4 (HA-CLIC1-CLIC4), 
C4KD (CLIC4-KD). ANOVA statistical tests were used to analyze significance. * p<0.05 
**p<0.01 
 
5.3.2 HA-CLIC4-CLIC1 (C4-C1) rescued S1P-mediated endothelial deficiencies in 
CLIC1-KD cells. 
 
We have shown that the C-terminus of CLIC4 is critical for CLIC4 functions in regulating 
endothelial S1P-mediated responses. Thus, we hypothesize that the C-terminus of 
CLIC1 functions similarly for the CLIC1 protein, and that the chimeric protein HA-CLIC4-
CLIC1 will rescue S1P-mediated endothelial responses in HUVECs with loss of CLIC1. 
 
In CLIC1-KD cells, S1P-mediated Rac1 activation, increase in barrier integrity, and 
migration were diminished compared to control cells. The deficiency was rescued by 
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ectopically expressing HA-CLIC1, but not CLIC4 (shown in Chapter 4). Here, we 
ectopically expressed HA-CLIC4-CLIC1 (C4-C1) and HA-CLIC1-CLIC4 (C1-C4) 
chimeric proteins to investigate whether the chimeric proteins could restore the S1P 
response. HA-CLIC4-CLIC1 rescued S1P-mediated endothelial barrier response (Figure 
5.7), migration (Figure 5.8), and Rac1 activation (Figure 5.9). The restoration of the 
response was comparable to ectopically expressing HA-CLIC1. On the contrary, 
endothelial cell barrier, migration, and Rac1 responses to S1P remained deficient in 
HUVECs ectopically expressing HA-CLIC1-CLIC4 with loss of endogenous CLIC1. 
These results together suggest that HA-CLIC4-CLIC1 with the C-terminus of CLIC1 
functions similar to the CLIC1 protein, and that the C-terminus of CLIC1 controls CLIC1 
function in endothelial S1P signaling. 
 
 
Figure 5.7  CLIC4-CLIC1 (C4-C1) rescued S1P-mediated barrier response in CLIC1-KD 
cells. HUVECs were starved for 2hrs and stimulated with 1μM S1P or vehicle control at time 
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0min. Trans-endothelial electrical resistance (TEER) were monitored for 2hrs post S1P 
treatment (A-E). Area under curve were calculated for quantification (F). HA-C1 (HA-CLIC1), 
C4-C1 (HA-CLIC4-CLIC1), C1-C4 (HA-CLIC1-CLIC4), C1KD (CLIC1-KD). ANOVA statistical 
tests were used to analyze significance. * p<0.05 
 
  
Figure 5.8  CLIC4-CLIC1 (C4-C1) rescued S1P-mediated migration in CLIC1-KD cells. 
HUVECs were seeded at the top chamber and starved for 3hrs. 1μM S1P was added in the 
bottom chamber after starvation allowing 6hrs of migration (A). The number of migrated cells 
per field were counted and quantified (B).  HA-C1 (HA-CLIC1), C4-C1 (HA-CLIC4-CLIC1), C1-
C4 (HA-CLIC1-CLIC4), C1KD (CLIC1-KD). ANOVA statistical tests were used to analyze 




Figure 5.8  CLIC4-CLIC1 (C4-C1) rescued S1P-mediated Rac1 activation in CLIC1-KD 
cells. HUVECs were starved for 3hrs, and lysates were collected following 1μM S1P stimulation 
for 5 minutes. G-LISA assay was performed and Rac1 activation was measured at 490nm 
absorbance. Normalized fold changes compared to unstimulated cells within each condition 
were presented. HA-C1 (HA-CLIC1), C4-C1 (HA-CLIC4-CLIC1), C1-C4 (HA-CLIC1-CLIC4), 




CLIC1 and CLIC4 have unique functions in regulating S1PR1-Rac1 pathway based 
upon the rescue experiments described in Chapter 4. Here, we utilized chimeric 
proteins to identify the functional domains essential for their specific functions, focusing 
on identifying roles for an N-terminal domain of CLICs, which we define at the 
approximately first 80-90 amino acids of CLICs and roles for a C-terminal domain, which 
we define as the last approximately 160 amino acids of CLICs. The N-terminal domain 
has structural elements critical for membrane insertion and for putative ion channel 
structure and function. We generated chimeric proteins by swapping the N-terminus and 
C-terminus in CLIC1 and CLIC4 and then ectopically expressed the chimeric proteins in 
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HUVEC and asked if they overcame deficiencies in S1P response in CLIC4-KD and 
CLIC1-KD endothelial cells. S1P-mediated endothelial barrier integrity (TEER), 
migration, and Rac1 activation were assessed. We showed that both CLIC4 and CLIC1-
CLIC4 rescued S1P-mediated responses in CLIC4-KD HUVECs, whereas CLIC1 and 
CLIC4-CLIC1 rescued CLIC1-KD HUVECs (Summary Table 5.1). Thus, we conclude 
that CLIC1-CLIC4 functions similarly as the wild type CLIC4 protein, and CLIC4-CLIC1 
shares the same function as CLIC1 in the endothelial S1PR1-Rac1 pathway, suggesting 
that the C-terminus of CLIC4 and CLIC1 are essential for their functional specificity.  
 
 
Table 5.1  C-terminus of CLICs is critical for its function in endothelial S1PR1-mediated 
response. S1P-mediated responses in CLIC4-KD (A) and CLIC1-KD (B) cells were examined 
by ectopically expressing various CLIC variants. Red highlights indicate the response were 
comparable to control cells, and S1P-responses were restored. +: level of S1P response, - : no 
S1P response. 
 
The conclusion that the C-terminus of CLICs controls their specific functions in S1P-
mediated responses points to several distinct features of CLIC1 versus CLIC4 identified 
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sub-domains that reside at the C-terminus. The CLIC4 C-terminus has a consensus 
SH3 binding motifs, which is not observed in CLIC1. Numerous signaling kinases such 
as Src and FAK proteins contain SH3 domains that bind to SH3 binding motifs [108]. 
The presence of a SH3 binding motif may allow for binding to certain kinases or GEF 
proteins contributing to its specific function compared to CLIC1. 
 
Both CLIC1 and CLIC4 contain a possible SH2 binding motif with a key tyrosine 
residue. The S1PR1-Rac1 signaling branch consists of a key signaling mediator, PI3K, 
downstream of S1P and upstream of Rac1 [109]. PI3K contains both SH3 and SH2 
binding domains [110]. However, the interaction of PI3K and CLIC proteins remains 
unclear. One hypothesis is that PI3K with its SH3 and SH2 binding domains may bind to 
SH3 and SH2 binding motifs. The differences of predicted protein interaction domains in 
CLICs may cause different structural conformation changes. This may lead to 
recruitment or regulation of different Rac1-GEFs leading to activation of Rac1 
downstream of S1P. These are hypotheses that could be further tested in future studies. 
 
We defined that the C-terminus of CLICs are critical for the S1PR1-Rac1 signaling 
branch and defining the specificity of the contribution of CLIC1 or CLIC4. These results 
suggest that the N-terminus is not critical for defining CLIC functional specificity in S1P-
mediated responses. The N-terminus of the proteins consists of a putative 
transmembrane domain which is believed to be responsible for membrane insertion and 
subsequent ion channel formation. Hence, our findings provide evidence that the ion 
channel activity of CLIC proteins is not important for their functional specificity in 
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S1PR1-Rac1 signaling. However, this does not exclude the N-terminus as being 
important for CLIC function as both chimeric proteins contain an N-terminus, either from 
CLIC1 or CLIC4. The N-terminus of both proteins share a high level of sequence 
similarity. In addition, the highly reactive cysteine residue required for enzymatic activity 
or membrane insertion is present in both CLIC1 (Cys-24) and CLIC4 (Cys-35), as well 
as in the chimeric proteins. It is possible that the N-terminus of CLIC1 and CLIC4 share 
similar functions and are still required for S1P-mediated endothelial responses. 
Therefore, we will further investigate the importance and requirement of the CLIC N-
















Chapter 6. N-terminus of CLIC4 is important for 
membrane localization and C-terminus is 




6.1 Introduction and Rationale 
 
CLICs have been shown to translocate to the plasma membrane upon ligand 
stimulation, in particular in response to agonists of G-protein coupled receptors[88, 89]. 
CLIC4 has been shown to translocate to the plasma membrane in response to S1P, 
LPA, and the thrombin receptor peptide in N1E115 neuroblastoma cells [89] and HeLa 
cells [111], as well as in response to Acetylcholine (Muscrinic 3 receptors) in HEK293 
cells [88]. CLIC1 translocation to the plasma membrane was also observed in response 
to LPS in macrophage[112], as well as β-Amyloid protein in microglia [113]. Interestingly, 
the translocation of CLIC4 to the plasma membrane with LPA and S1P were transient events 
lasting within 15 minutes [89].  
 
CLIC1 and CLIC4 have been implicated in angiogenesis and tubulogenesis [27-29]. One 
study found that CLIC-like protein EXC-4 in C. elegans plays a critical role in both the 
proper development and maintenance of the C. elegans excretory canal [26]. In C. 
elegans, the formation and development of excretory canal is involved with the process 
of tubulogenesis and exc-4 mutants exhibited lumenal cysts indicative of failed 
tubulogenesis of the excretory canal [26]. Compared to CLIC proteins, one distinct 
function of EXC-4 is that it resides at the plasma membrane and is constitutively active 
[3]. Further, this study using C. elegans showed that human CLIC1 fused to the putative 
transmembrane domain of EXC-4 was able to rescue the cystic disruption to the 
excretory canal presented in the exc-4 mutant, suggesting a conservation of function 




The CLIC protein family is structurally homologous to the omega-class of glutathione-S-
transferase. CLIC1 and CLIC4 were shown to exhibit glutaredoxin enzymatic activity in 
vitro [23]. The same study showed a highly reactive and essential cysteine residue in 
the N-terminus of CLIC1 and CLIC4 which is required for their enzymatic activity [23]. 
Protein alignments of C. elegans EXC-4 and CLIC proteins showed an absence of this 
cysteine residue in the EXC-4 protein [2, 3]. The absence of this cysteine residue in 
EXC-4 argues against the importance of glutaredoxin enzymatic activity in regulating 
tubulogenesis in C. elegans.  
 
In mammalian cells, CLIC proteins reside largely in the cytoplasm as a soluble protein 
[14, 15]. It is shown in several studies that upon ligand stimulation, CLICs translocate 
transiently to the membrane, and reach maximum membrane recruitment within minutes 
[89, 111]. Compared to mammalian cells, the EXC-4 protein resides at the membrane 
constantly and is constitutively active [3]. Hence, we hypothesize that CLIC proteins 
need to translocate to the plasma membrane upon S1P stimulation to initiate 
downstream signaling. Furthermore, the absence of cysteine residues in C. elegans 
suggested that enzymatic activity is not required for tubulogenesis. We also aim to 
investigate whether the putative transmembrane domain in CLICs contain important 
properties for the functioning of CLICs in endothelial S1P signaling. In this chapter we 
will investigate the requirement of the CLIC N-terminus for their proper function in 




6.2 Results: CLIC4 re-localizes to cell membrane transiently upon S1P stimulation 
in endothelial cells 
 
We have established that CLICs are required for endothelial S1P signaling, and that 
the C-terminus of the proteins are critical for their unique functions through chimeric 
studies. Ponsioen et al [89] showed that CLIC4 re-localizes to the plasma membrane 
upon S1P stimulation in glioblastoma cells. To examine how S1P affects CLIC4 
localization in endothelial cells, we ectopically expressed an epitope-tagged form 
of CLIC4 protein in HUVECs and examined its cellular localization upon S1P 
treatment by isolating plasma membrane portion of HUVEC cells at different timepoints 
following 1µM S1P addition. S1P stimulation caused increased CLIC4 protein level at 
plasma membrane. We found the re-localization occurred in a transient manner 
(Figure 6.1). The CLIC4 protein levels in plasma membrane were quantified through 
densitometry, and it was revealed that the maximum translocation occurred at 1min 
post S1P treatment and dissipated by 5min of treatment. The transient manner of 
CLIC4 translocation was in fact similar to what has been reported in tumor cells [89, 






Figure 6.1  CLIC4 protein is enriched at plasma membrane transiently upon S1P 
stimulation. HUVEC cells were starved for 3hrs followed by 1µM S1P stimulation at different 
time points (0, 30s, 1min, 2min, 5min). Cells lysates were collected and plasma membrane 
portion of HUVECs were isolated. CLIC4 expression were assessed from plasma membrane 
portion and cytosolic portion with CLIC4 antibody. Na+/K+ ATPase levels were measured as 
positive control for plasma membrane. Densitometry and quantification for plasma membrane 
CLIC4 were performed against Na+/K+ ATPase. (n=3) 
 
We further investigated maximum re-localization event at 1min after S1P treatment 
using both plasma membrane isolation and immunofluorescent studies. Following S1P 
treatment for 1 minute, we isolated the plasma membrane portion of HUVEC cells, and 
CLIC4 protein levels were assessed. Protein levels of CLIC4 at the plasma membrane 
were increased after S1P treatment compared to the non-treated condition (Figure 
6.2A). In addition to this plasma membrane isolation method, we ectopically expressed 
HA-CLIC4 and immuno-stained cells with HA-antibody following S1P treatment. After 
S1P treatment, there was a strong accumulation of CLIC4 at the plasma membrane in 
HUVEC cells compared to untreated HUVECs (Figure 6.2B). Both approaches 
indicated an enrichment of CLIC4 in the plasma membrane portion upon S1P 





Figure 6.2  CLIC4 protein localized to plasma membrane upon S1P stimulation. HUVEC 
cells were starved for 3hrs followed by 1µM S1P stimulation for 1min. A) Plasma membrane 
portion of HUVECs were isolated. CLIC4 was assessed from plasma membrane portion and 
cytosolic portion with CLIC4 antibody. Na+/K+ ATPase: positive control for plasma membrane. 
Densitometry for plasma membrane CLIC4 were against Na+/K+ ATPase. B) HUVECs were 
infected with HA-CLIC4, and immunofluorescent studies using HA-antibody were performed. 
Arrows indicate HA-CLIC4 protein at plasma membrane. 
 
6.3 Results: N-terminus of CLIC4 is required for S1P signaling 
 
CLIC4 re-locates to the plasma membrane upon S1P stimulation and in Chapter 5 we 
have shown that the C-terminus of CLIC4 is important for its specific function in S1P-
Rac1 signaling. However, the chimeric protein HA-CLIC1-CLIC4 created in Chapter 5 
consists of the N-terminus of the CLIC1 protein, which includes the reactive cysteine 
residue as well as the putative transmembrane domain. The highly conserved N-
terminus in both CLIC1 and CLIC4 may play similar roles in regulating endothelial S1P-
Rac1 signaling. Hence, we investigate the importance of the N-terminus for the 
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relocation process of CLIC4 in this section.  
 
6.3.1 Design and generation of truncated form of CLIC4 (HA-CLIC4Tr) 
 
In order to study the importance of the putative transmembrane domain and N-terminus 
of CLIC4 in the S1P-Rac1 pathway, we created a truncated form of CLIC4 protein with 
only the C-terminus present. We generated truncated CLIC4 protein (HA-CLICTr) that 
starts at amino acid 96 of CLIC4, and is HA-tagged at the N-terminal side. (Figure 6.3) 
Protein expression of HA-CLIC4Tr was assessed using HA antibody, and the detected 
protein is of the expected size compared to wild type CLIC4. 
  
Figure 6.3  Generation of Truncated CLIC4 protein. (A) Schematic representation of the 
truncated CLIC4 protein compared to full length CLIC4 protein, HA-CLIC4Tr (CLIC4 truncated 
form) was generated with C-terminus of CLIC4 (AA96-253) (B) Protein expression of the 
truncated CLIC4 protein were analyzed with CLIC4 antibody and tubulin as loading control. 
 





In order to investigate whether the N-terminus of CLIC4 is important for endothelial 
S1P-Rac1 signaling, HA-CLIC4Tr was ectopically expressed in an attempt to rescue the 
S1P-mediated responses in CLIC4-KD cells. We investigated S1P-mediated Rac1 
activation and S1P-mediated barrier response. Consistent with previous results, full-
length CLIC4 expression rescued defects in the S1P-mediated barrier response due to 
loss of CLIC4. However, HA-CLIC4Tr fails to rescue the phenotype, as quantified by 
area under curve analysis (Figure 6.4). The Rac1 G-LISA assay was performed to 
examine S1P-Rac1 activation. The presence of HA-CLIC4 in CLIC4-KD cells restored 
S1P-Rac1 response comparable to control cells, Figure 6.5. Consistent with the S1P-
mediated barrier response, HA-CLIC4Tr fails to overcome the defects in S1P-Rac1 
activation seen in CLIC4-KD endothelial cells, Figure 6.5. Taken together, this suggests 
that HA-CLIC4Tr does not function like the full-length CLIC4 protein, indicating that the 
C-terminal CLIC4 alone loses its functional ability. The N-terminus is essential for the 





Figure 6.4  HA-CLIC4Tr failed to rescue S1P-mediated barrier response in CLIC4-KD cells. 
HUVECs were starved for 2hrs and stimulated with 1μM S1P or vehicle control at time 0min. 
Trans-endothelial electrical resistance (TEER) were monitored for 2hrs post S1P treatment (A-
D). Area under curve were calculated for quantification (E). HA-C4 (HA-CLIC4), C4KD (CLIC4-
KD), C4Tr/HA-CLIC4-Tr (Truncated form of CLIC4). ANOVA statistical tests were used to 
analyze significance. * p<0.05 
 
Figure 6.5  HA-CLIC4Tr failed to rescue S1P-mediated Rac1 activation in CLIC4-KD cells. 
HUVECs were starved for 3hrs, and lysates were collected following 1μM S1P stimulation for 5 
minutes. G-LISA assay was performed and Rac1 activation were measured at 490nm 
absorbance. Normalized fold changes compared to unstimulated cells within each condition 
were presented. HA-C4 (HA-CLIC4), C4KD (CLIC4-KD), C4Tr/HA-CLIC4-Tr (Truncated form of 
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CLIC4). ANOVA statistical tests were used to analyze significance. ***p<0.001 
 
6.4 Results: Membrane localization of the CLIC4 C-terminal domain functions in 
S1P signaling, suggesting the N-terminal domain confers membrane localization 
but not signaling function.  
 
We established the requirement of the N-terminus of CLIC4 for its proper function in the 
S1P-Rac1 pathway. The specific function of the N-terminus remains unclear. The CLIC4 
N-terminus contains a putative transmembrane (PTM) domain and a reactive cysteine 
residue established to have enzymatic activity. The N-terminus of CLIC4 could serve 
either as a membrane docking domain using the PTM or as a functional domain with the 
cysteine residue contributing to enzymatic activities in S1P signaling. Hence, we aim to 
investigate the mechanism of the N-terminus of CLIC4 and resolve its functional 
property in S1P signaling. 
 
6.4.1 Design and generation of membrane-tethered form of CLIC4 (Lck-HA-CLIC4Tr) 
 
We have shown that CLIC4 translocated to the plasma membrane upon S1P 
stimulation. We aim to determine how the CLIC4 N-terminus plays a role in this process. 
To explore whether the N-terminus serves as a functional domain rather than solely 
required for membrane localization we created a CLIC4 variant that consists of the 
truncated C-terminal CLIC4 combined with a membrane tethered peptide that promotes 





The first 10 amino acids of the Lck protein has successfully been utilized as a 
membrane targeting peptide to bring fusion proteins to the plasma membrane [114]. 
LCK is a non-receptor tyrosine kinase. The second amino acid Glycine immediately 
following the initiating Methionine serves as a myristylation site. The myristylation of 
glycine is able to bring the protein to the plasma membrane [115]. This approach was 
successfully utilized to create fusion proteins targeting membranes in various types of 
cells [114, 115]. Compared to other membrane targeting peptides, such as peptides 
derived from p63 or Src, our collaborator showed Lck peptides shows the highest 
efficiency and selectivity to the plasma membrane with low targeting to the 
endomembrane [116]. 
 
Here, we utilized the first 10 amino acids of mouse Lck protein and created fusion 
proteins of CLIC4 with this peptide. We generated fusion proteins with both the CLIC4 
C-terminus and full length CLIC4 attached to the Lck peptide, and epitope tagged the 
fusion protein with HA immediately following the Lck peptides. Schematic 
representations of CLIC4 fusion proteins are shown in Figure 6.6. Protein expression 
was assessed compared to protein lacking the Lck myristylation domain in Figure 6.6. 
We expressed these proteins in the presence of CLIC4 shRNA, the knockdown of 
endogenous CLIC4 did not affect the fusion protein expression. These fusion proteins 





Figure 6.6  Generation of membrane-tethered Lck CLIC4 fusion protein. (A) Schematic 
representation of the CLIC4 protein (full length and truncated) fused with Lck peptides, Lck-HA-
CLIC4 (full length) and Lck-HA-CLIC4Tr (truncated form) were generated fused with membrane 
tethered peptide Lck (B) Protein expression of the fusion proteins in CLIC4-KD cells with CLIC4 
and HA antibody, tubulin as loading control. 
 
To validate that the Lck fusion protein brings CLIC4 to the plasma membrane, we 
examined their localization through immunofluorescent studies with HA antibody. As 
shown in Figure 6.7, HA-CLIC4 appeared throughout the HUVEC cell cytoplasm. By 
fusing Lck-peptide with HA-CLIC4 (Lck-HA-CLIC4), the fusion protein accumulated 
strongly at the plasma membrane, even in the absence of S1P. In addition, the 
truncated form of C-terminal CLIC4 (HA-CLIC4Tr) exhibited signal accumulation 
strongly in the nucleus, consistent with the fact that the truncated C-terminal CLIC4 
protein lacks the putative transmembrane domain and exposes the nuclear localization 
signal. The truncated CLIC4 fused with Lck-peptide (Lck-HA-CLIC4Tr) showed strong 
plasma membrane localization. These results showed that CLIC4 proteins were 
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successfully brought to the plasma membrane by fusing with the Lck-peptide.  
 
 
Figure 6.7  Lck-HA-CLIC4 and Lck-HA-CLIC4Tr protein localized to plasma membrane. 
Immunofluorescent studies with HA antibody were performed on HUVECs ectopically 
expressing HA-CLIC4, LCK-HA-CLIC4 (A), HA-CLIC4Tr, LCK-HA-CLIC4Tr (B). Strong 
accumulation at plasma membrane were shown in Lck-fusion proteins (bottom panels). 
 
6.4.2 Lck-HA-CLIC4Tr rescues S1P-mediated endothelial deficiency in CLIC4-KD cells. 
 
To investigate the functionality of these membrane-tethered CLIC4 fusion proteins, their 
ability to rescue deficiencies of S1P-Rac1 signaling in CLIC4-KD cells were explored. 
Figure 6.8 shows the changes in S1P-mediated endothelial barrier responses in CLIC4-
KD cells when expressing different CLIC4 variants. Consistent with results shown 
earlier, ectopic HA-CLIC4 restored the S1P-mediated barrier defects seen in CLIC4-KD 
cells. The truncated form of HA-CLIC4Tr failed to function similarly to the wildtype 
CLIC4 and the endothelial barrier was not rescued. Both CLIC4 C-terminal fused with 
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Lck peptide and CLIC4 full length fused with Lck peptide overcame the deficiency in 




Figure 6.8  Lck-HA-CLIC4 and Lck-HA-CLIC4Tr rescue S1P-mediated barrier response in 
CLIC4-KD cells. HUVECs were starved for 2hrs and stimulated with 1μM S1P or vehicle control 
at time 0min. Trans-endothelial electrical resistance (TEER) were monitored for 2hrs post S1P 
treatment (A-F). Area under curve were calculated for quantification (G). HA-C4 (HA-CLIC4), 
C4KD (CLIC4-KD), HAC4Tr/HA-CLIC4-Tr (Truncated form of CLIC4) LckHAC4 (CLIC4 full 
length fused with Lck), LckHAC4Tr (CLIC4 truncated form fused with Lck) ANOVA statistical 




Interestingly, we noticed Lck-HA-CLIC4 and Lck-HA-CLIC4Tr protein caused 
endothelial barrier increase over time in vehicle treatment group, rather than the stable 
barrier presented by other cell lines. Lck localized CLIC protein to plasma membrane, 
the constant presence might suggest a constitutive activation of barrier promoting 
activities. Hence, we measured the basal and total level of Rac1 protein activity (Figure 
6.9). Basal Rac1-GTP level prior S1P treatment was not altered among cells lines, and 
total Rac1 protein level stays comparable. Rac1 activity was not changed before S1P 
stimulation. 
 
Figure 6.9  Lck-HA-CLIC4 and Lck-HA-CLIC4Tr did not alter Rac1 levels in HUVECs. 
HUVECs were starved for 3hrs, and lysates were collected. G-LISA assay were performed for 
basal Rac1-GTP measurement in starved condition at 490nm absorbance (A). Total level of 
Rac1 protein were analyzed for each HUVEC cell lines with Rac1 antibody and tubulin as 
loading control (B). HA-C4 (HA-CLIC4), C4KD (CLIC4-KD), HAC4Tr/HA-CLIC4-Tr (Truncated 
form of CLIC4) LckHAC4 (CLIC4 full length fused with Lck), LckHAC4Tr (CLIC4 truncated form 




We further biochemically investigated S1P-Rac1 activation using the G-LISA assay in 
these cell lines. In concordance with results shown for S1P-driven endothelial barrier 
response, S1P-mediated Rac1 activation in CLIC4-KD cells was also restored with Lck-
HA-CLIC4 as well as Lck-HA-CLIC4Tr (Figure 6.10). Furthermore, the basal levels of 
Rac1-GTP prior to S1P treatment remains comparable across cell lines, indicating no 
basal activation of Rac1 with any CLIC4 variant (Figure 6.9). Taken together, these 
results indicate that both Lck-HA-CLIC4 and Lck-HA-CLIC4Tr have similar functions as 
wild-type CLIC4 in regulating the S1P-Rac1 pathway.  
 
 
Figure 6.10  Lck-HA-CLIC4 and Lck-HA-CLIC4Tr rescue S1P-mediated Rac1 activation in 
CLIC4-KD cells. HUVECs were starved for 3hrs, and lysates were collected following 1μM S1P 
stimulation for 5 minutes. G-LISA assay was performed and Rac1 activation was measured at 
490nm absorbance. Normalized fold changes compared to unstimulated cells within each 
condition were presented. HA-C4 (HA-CLIC4), C4KD (CLIC4-KD), HAC4Tr/HA-CLIC4-Tr 
(Truncated form of CLIC4) LckHAC4 (CLIC4 full length fused with Lck), LckHAC4Tr (CLIC4 





6.5 Discussion  
 
In this chapter, we investigated the importance of the N-terminus of CLIC4 and of 
membrane localization of the C-terminus of CLIC4 in S1P-Rac1 signaling through 
generating multiple CLIC4 variants. The interesting results provide us with several 
insights in understanding the role of CLIC4 protein in the endothelial S1P-Rac1 
signaling cascade.  
 
First, CLIC4 re-localizes to the plasma membrane upon S1P stimulation. This process is 
transient and the presence of CLIC4 at the plasma membrane dissipates within 5 
minutes. This transient translocation process is consistent with observations reported in 
neuroblastoma cells and HeLa cells [89, 111]. In addition, the transient re-localization of 
CLIC4 in response to S1P coincides with the timing of the maximum S1P-mediated 
barrier enhancement as well as Rac1 activation observed in our studies. S1P-mediated 
endothelial barrier resistance increases occur rapidly and reach maximum response to 
S1P within minutes (Figure 6.4 A). Our time-course study of S1P-Rac1 response 
reaches maximum induction at 5 minutes (Chapter 3, Figure 3.12). The rapid S1P-
driven response along with CLIC4 translocation pattern suggests that CLIC4 needs to 
be present at the membrane for its proper function. Hence, we hypothesize that 





Secondly, we created a CLIC4 variant with truncation of the N-terminus. We showed in 
Chapter 5 that the C-terminus of CLIC4 confers its specificity in S1P-Rac1 signaling 
through chimeric studies. It was still unclear whether the CLIC4 C-terminus alone will 
retain its function. Here, we reported that the CLIC4 C-terminus alone failed to function 
comparably to the CLIC4 full length, suggesting that the N-terminus is essential for its 
proper function. The truncated form of CLIC4 lacks the putative transmembrane domain 
(PTM), which is believed to be involved in membrane localization [14], as well as the 
reactive cysteine reported to be essential for glutaredoxin enzymatic activity [23]. We 
sought to determine whether the requirement of the CLIC4 N-terminus was to serve as 
a membrane docking domain or if it possessed functional activity in S1P-Rac1 signaling.  
 
Lastly, we engineered a fusion protein with Lck-peptide to re-localize CLIC4 proteins to 
the plasma membrane with a heterologous membrane tethering mechanism. These 
engineered proteins remain constantly at high levels in the plasma membrane 
compared to wild type CLIC4. Interestingly, we observed that both fusion proteins, Lck-
HA-CLIC4 and Lck-HA-CLIC4Tr, have similar function as wild-type CLIC4 in regulating 
the S1P-Rac1 pathway. Several conclusions and implications can be derived: 
 
1) Lck-HA-CLIC4Tr functions similarly to full-length CLIC4, indicating that the 
importance of the C-terminus is that it serves as a key domain for regulating 
endothelial S1P-Rac1 signaling. The absence of the N-terminus suggests that it 




2) In Lck-HA-CLIC4Tr fusion protein the reactive cysteine residue is absent due to 
truncation. This indicates that the cysteine residue is not important for 
physiological function in S1P-Rac1 signaling. Thus, the glutaredoxin enzymatic 
activity of CLIC4 is not required for S1P-Rac1 signaling pathway in endothelial 
cells. 
3) The N-terminus of CLIC proteins is believed to insert into the membrane and 
form ion channels. The absence of the entire N-terminus with substitution of Lck-
peptide also provides evidence that CLIC4 does not function as an ion channel in 
endothelial S1P-Rac1 signaling.  
 
In C. elegans, EXC-4 resides constantly at the plasma membrane of the excretory 
canal, and it also lacks the cysteine residue [26]. This is consistent with our engineered 
Lck-HA-CLIC4Tr protein, suggesting that CLIC4 or EXC-4 do not function as GST-like 
enzymes. Moreover, Lck-HA-CLIC4Tr is constantly at membrane but cannot form ion 
channels yet still functions in S1P-Rac1 signaling. Hence, we conclude that CLIC4 does 
not have either ion channel or enzymatic activity in S1P-Rac1 signaling, and 
translocation to plasma membrane is required upon S1P stimulation for its function.  
 
Surprisingly, we noticed endothelial barrier increase over time for both proteins without 
S1P treatment, although Rac1 activity was not altered. This suggests the presence of 
CLIC4 protein at plasma membrane indeed have functional activity for barrier 
regulation, but this regulation is independent of Rac1. In addition, although Lck-HA-
CLIC4Tr and Lck-HA-CLIC4 full length are able to function like the wild type CLIC4 and 
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are present constantly at the plasma membrane, they both remain S1P-dependent. This 
indicates that CLIC4 at the plasma membrane does not solely initiate the downstream 
S1P-Rac1 signaling pathway. S1P stimulation is still required for its proper regulation in 
Rac1 activation. There are studies suggesting that RhoA functions upstream of CLIC4 
in tumor cells [89, 111]. An upstream mediator is possibly needed upon S1P stimulation 
to initiate signaling for CLIC4 regulation to properly occur. This upstream regulator could 
be hetero-trimeric complex (Gα/Gβγ) or other small G-proteins, such as RhoA.  
 
The experimental results described in this chapter on CLIC4 protein provides us with 
some insights on how CLIC4 protein may function in regulating Rac1. CLIC1 and CLIC4 
both depend on the C-terminus for their specific function. However, it is possible that 
CLIC1 has its own unique features compared to CLIC4 and may adopt a completely 
different mechanism of action. Future studies will be conducted to explore the role of 
membrane tethered Lck-HA-CLIC1 full length or truncated CLIC1 protein in their 






















Chapter 7. CLICs modulate RhoA through 





7.1 Introduction and Rationale 
 
7.1.1 Role of S1PR2 and S1PR3 receptors in endothelial cells 
 
In endothelial cells, three S1P receptors are expressed, S1PR1, S1PR2, and S1PR3 
[36]. S1PR1 has been extensively studied, and believed to be the primary S1P receptor 
in endothelial cells with the highest expression [36]. S1P preferentially binds to S1PR1, 
which couples exclusively with the Gαi subunit and regulates Rac1 activation [117]. On 
the other hand, S1PR2 and S1PR3 are expressed with lower expression in endothelial 
cells, where S1PR3 is expressed at a higher level than S1PR2[36]. Both receptors 
couple to three different G-protein subunits, Gαi, Gα12/13, Gαq. Their signaling through 
Gαi is believed to be redundant to S1PR1 signaling, whereas Gα12/13 and Gαq are 
unique branches compared to S1PR1. Gα12/13 activates downstream small G-protein 
RhoA, initiating actin stress fiber formation and Gαq activates PLC leading to calcium 
signal transduction and endothelial cell contractility [35]. RhoA activation has an 
opposite effect to Rac1 activation on endothelial cell barrier, suggesting that S1PR2/3-
Gα12/13-RhoA activation would have an opposing effect to S1PR1-Rac1 in endothelial 
cell behavior. Over-expression of S1PR2 receptor in HUVECs indeed induced 
endothelial permeability, and S1PR2 serves as a regulatory pathway for S1PR1 
signaling in endothelial cells [37]. Although both have unique branches in S1P receptor 
activation, S1pr2 or S1pr3 single null mice exhibit no apparent angiogenic defects 
compared to S1pr1 null mice [36], indicating their physiological roles in angiogenesis is 




Figure 7.1  S1P signaling through S1PR2 and S1PR3 in endothelial cells. S1P2 receptor 
(S1PR2) and S1P3 receptor (S1PR3) are expressed at low levels in endothelial cells. Activation 
of S1PR2 and S1PR3 leads to distinct S1P signaling branch activation involving different G-
protein subunits. (Adapted from Blaho et al., 2011 [35]) 
 
7.1.2 Role of Thrombin and PAR receptors in endothelial cells 
 
Protease activated receptor (PAR) has been extensively studied in endothelium and 
shown to be critical for endothelial cell behavior, especially for their regulation in 
endothelial permeability [49]. To date, there are four PAR receptors that have been 
discovered, PAR1-4. Among the 4 members of PAR receptors, thrombin serves as an 
agonist for PAR1 [50], PAR3 [51], and PAR4 [52]receptors. Of the three thrombin-
responsive receptors, PAR1 and PAR4 are believed to be expressed in endothelial cells 
[53]. RNA sequencing results collected from HUVEC cells revealed high expression of 

















mainly addressed in this chapter using HUVEC cells. 
 
Thrombin, as a serine protease, cleaves the PAR1 receptor between Arg 41 and Ser 42 
residues [54]. The cleavage of the peptide unmasks a new N-terminus, which acts as a 
tethered ligand to bind intramolecularly to the receptor itself, causing a conformational 
change to initiate downstream signaling [54]. Activation of PAR1 results in activation of 
various Gα subunits. Of the four major Gα protein subclasses, it has been shown to 
signal through Gαi, Gαq, and Gα12/13 [55]. However, the coupling of PAR1 to Gαi 
remains controversial [58, 59]. (Figure 7.2B) 
 
 
Figure 7.2  Thrombin signaling through PAR1 in endothelial cells. A) RNA sequencing on 
human umbilical vein endothelial cells (HUVEC) for mRNA levels for all four PAR receptors. B) 
Thrombin signaling through PAR1 in endothelial cells, mediating Gα12/13 and Gαq subunit. 
(Adapted from Komarova et al. 2007 [118]) 
 
Acute PAR1 activation is shown to cause an increase in vascular permeability in animal 
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models [49]. It is believed to be the effect of its coupling with the Gα12/13 subunit. 
Gα12/13 mediates cytoskeletal responses inducing the shape change and increase in 
permeability in endothelial cells through the small G-protein RhoA. [49, 54] This event 
causes direct endothelial contraction responses that break endothelial junctions and 
increase permeability.  
 
Endothelial PAR1 has been shown to play a key role in vasculogenesis in mice. 
Approximately half of PAR1-deficient mouse embryos die at mid-gestation from severe 
defects in blood vessel formation [60]. The embryonic lethality can be rescued by 
expressing PAR1 in endothelial cells alone. [119] Hence, PAR1 signaling in endothelial 
cells is necessary for vessel development.  
 
7.1.3 Rationale to study role of CLICs in Gα12/13-RhoA pathway 
 
Ponsioen and colleagues [89] initially showed CLIC4 re-localization to the plasma 
membrane upon LPA stimulation. LPA receptors couple with the Gα12/13 subunit to 
regulate RhoA activation. In the same study, they revealed that CLIC4 re-localization in 
response to LPA was diminished with knockdown of Gα13 or RhoA. A second study 
performed by the same group [111] showed that CLIC4 functions in a RhoA-mDia2-
regulated signaling network to integrate cortical actin assembly and membrane 
protrusion in HeLa cells. These studies indicate a potential link between CLIC4 and 




In this chapter, we aim to establish the link between CLICs and S1P-RhoA or Thrombin-
RhoA activation through loss of function studies. We hypothesize that CLICs function to 
regulate RhoA activation in endothelial cells through G-protein coupled receptors, such 
as S1P receptors and PAR receptors.  
 
7.2 Results: CLIC1, not CLIC4, is required for S1P-Gα12/13-RhoA activation  
 
We have established that CLIC1 and CLIC4 regulated S1P-mediated Rac1 activation, 
subsequently mediating endothelial barrier maintenance and migration. These 
responses upon S1P stimulation are mediated through the Gαi/Gβγ heterotrimeric 
complex downstream of the S1P receptor. S1P can regulate different endothelial cell 
behaviors through distinct branches of the S1P signaling cascade. In addition to the 
S1PR1-Gαi-Rac1 pathway, signaling through S1PR2/S1PR3 results in induction of 
RhoA leading to actin stress fiber formation and cell contractility. We sought to 
determine whether endothelial CLICs function to promote cellular functions through the 
S1PR2/3-Gα12/13-RhoA pathway.  
 
7.2.1 CLIC1, not CLIC4, is required for S1P-mediated stress fiber formation 
 
S1P preferentially binds to S1PR1 and mediates S1P-Rac1 activation and increases 
endothelial barrier resistance. Therefore, the large amount of S1PR1 present and high 
S1PR1 signaling in endothelial cells masks the effect of endothelial barrier response by 
S1PR2 and S1PR3. We thus investigated S1P-mediated stress fiber formation, which is 
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specific to the S1P-Gα12/13-RhoA signaling pathway. 
 
In order to test the role of endothelial CLICs in S1P-Gα12/13-RhoA activation, we 
utilized immunofluorescent analysis with phalloidin actin to assess S1P-induced actin 
stress fiber formation (Figure 7.3). In control and CLIC4 knockdown cells, actin stress 
fibers were formed normally following S1P treatment for 30 minutes, whereas 
endothelial cells with loss of CLIC1 exhibited a severe impairment in actin stress fiber 
formation.  
 
Figure 7.3  CLIC1, not CLIC4 is required for S1P-mediated actin stress fiber formation. 
HUVECs were starved for 3hrs and stimulated with 1μM S1P for 30min. Immuno-fluorescent 
study of actin phalloidin for stress fibers (red) were measured, nuclear stain (Dapi) in blue. 
 
7.2.2 CLIC1, not CLIC4, is required for S1P-RhoA activation 
 
Stress fibers in endothelial cells are mediated by RhoA activation. Hence, we further 
explored whether this S1P-driven response through RhoA depends on CLIC1 or CLIC4. 
To assess RhoA activation in HUVECs with or without CLIC knockdown, we utilized the 
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G-LISA assay and followed S1P stimulation of RhoA activity (Figure 7.4). Consistent 
with the CLIC1 knockdown stress fiber phenotype, loss of CLIC1 caused loss of 
induction of RhoA after S1P treatment compared to control. Loss of CLIC4 failed to alter 
S1P-mediated RhoA activation compared to control cells. Thus, we established that 
only CLIC1 is required for S1P-Gα12/13-RhoA activation and downstream actin stress 
fiber formation in endothelial cells. 
 
Figure 7.4  CLIC1, not CLIC4, is required for S1P mediated RhoA activation. HUVECs were 
starved for 3hrs, and lysates were collected following 1μM S1P stimulation for 5 minutes. (A) G-
LISA assay was performed and RhoA activation was measured at 490nm absorbance. (B) 
Normalized fold changes compared to unstimulated cells within each condition were presented. 
ANOVA statistical tests were used, and the significance presented was against No S1P 
stimulation in each cell line. **p<0.01 (C) Total levels of RhoA were assessed with western blot 
using RhoA antibody. 
 
7.3 Results: CLIC4, not CLIC1, is required for Thrombin-Gα12/13-RhoA activation 
 
We showed above that in addition to the S1P-Gαi-Rac1 pathway, endothelial CLICs 
also play a role in the S1P-Gα12/13-RhoA pathway. We hoped to further investigate 
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whether CLICs serve as regulators in a S1P receptor specific manner, or if they function 
as a general G-protein coupled receptor regulator. Here, we tested another endothelial 
GPCR, the PAR1 receptor in response to thrombin, which is known to play an essential 
role in regulating endothelial barrier integrity. 
 
CLICs re-localize to the plasma membrane upon administration of thrombin receptor 
peptide (TRP) in neuroblastoma cells N1E115 [87]. As a key regulator in endothelial cell 
behavior, thrombin can activate PAR receptors to induce RhoA and disrupt endothelial 
barrier integrity. Previous studies showed that RhoA can mediate re-localization of 
CLIC4, whereas we have shown that CLIC1 functions to regulate S1P-RhoA activation. 
Here, we investigated the important role of endothelial CLIC proteins in Thrombin-RhoA 
responses, and whether they play a role in barrier disruption by thrombin.  
 
7.3.1 CLIC4, not CLIC1, is required for thrombin-mediated endothelial barrier disruption. 
 
Thrombin-mediated PAR1 activation causes an increase in permeability. Hence, we 
investigated the role of endothelial CLICs in mediating this permeability response 
through loss of function studies. HUVECs were lenti-virally infected with CLIC4 or 
CLIC1 shRNA. Trans-endothelial electrical resistance was monitored over time after 
thrombin treatment. (Figure 7.5) In control cells, trans-endothelial resistance decreases 
after addition of 50nM thrombin, indicating an increase in endothelial permeability. In 
CLIC4-KD cells, the decrease in resistance was attenuated compared to control cells. 
However, CLIC1-KD cells exhibited a comparable level of thrombin response to control 
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HUVEC cells. This suggests that loss of CLIC4 causes defects in thrombin-mediated 




Figure 7.5  CLIC4, not CLIC1, is required for thrombin-mediated endothelial barrier 
decrease (A-C). HUVECs were starved for 2hrs and stimulated with 50nM Thrombin or vehicle 
control at time 0min. Trans-endothelial electrical resistance (TEER) were monitored for 3hrs. 
Recovery rate on each cell lines were calculated as the slope of recovery curve (Average speed 
for resistance to recover from lowest point to baseline). (D) Combined graphs for all cell lines 
were shown. 
 
Endothelial barrier changes following thrombin treatment exhibited a rapid decrease of 
endothelial resistance followed by recovery back to baseline. Interestingly, in the CLIC4-
KD cells, the recovery process is slower in contrast to a quick recovery observed in 
control cells. In CLIC1-KD cells, the recovery was completely defective, as it did not 
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return to baseline during the monitored time. The recovery of endothelial resistance has 
been demonstrated to be via cross-talk of PAR1 receptor and S1P receptor [64]. PAR1 
receptor activation through thrombin increases S1P production, followed by S1P-Rac1 
activation to strengthen endothelial barrier [64]. We further identified the rate of recovery 
by calculating the average speed of endothelial resistance to recover from lowest 
resistance back to baseline (Figure 7.5A-C Recovery Rate). The recovery phenotype is 
consistent with what was observed in earlier chapters. In CLIC1-KD or CLIC4-KD cells, 
the rate of recovery was slower compared to control, indicating a deficient S1P-
response with loss of either CLIC1 or CLIC4.  
 
7.3.2 CLIC4, not CLIC1, is required for thrombin-mediated RhoA activation. 
 
Thrombin-mediated increase in permeability is mediated by PAR1-Gα12/13-RhoA 
activation. We showed that only CLIC4 is required for endothelial permeability increases 
by thrombin. Hence, we hypothesized that thrombin-mediated RhoA activation also 
depends on CLIC4, and not CLIC1. We used the G-LISA assay to test RhoA activation 
in response to thrombin. (Figure 7.6) In control cells, RhoA was activated upon thrombin 
stimulation by 5-fold compared to baseline. In CLIC4-KD cells, the induction of RhoA 
was diminished. In CLIC1-KD cells, thrombin-mediated RhoA activation was not altered. 
This indicates that CLIC4 is required for thrombin-mediated RhoA activation, which is 





Figure 7.6  CLIC4, not CLIC1, is required for thrombin-mediated RhoA activation. HUVECs 
were starved for 3hrs, and lysates were collected following 50nM Thrombin stimulation for 5 
minutes. G-LISA assay was performed and RhoA activation was measured, and normalized fold 
changes compared to unstimulated cells within each condition were presented. ANOVA 
statistical tests were used, and the significance presented was against No Thrombin stimulation 




We established the role of endothelial CLICs in RhoA regulation in S1P receptors and 
PAR1 receptor through loss of function studies. We showed that endothelial CLIC1, not 
CLIC4, is required for S1P-Gα12/13-RhoA activation and stress fiber formation. 
Surprisingly, only endothelial CLIC4 is required for PAR1-Gα12/13-RhoA activation 
regulating thrombin-mediated endothelial barrier disruption. Both G-protein coupled 
receptors associate with the Gα12/13 subunit and subsequent RhoA activation. 
However, different CLIC proteins were involved in RhoA regulation in these pathways. 
 
The requirement of distinct CLIC proteins in Gα12/13-RhoA regulation through different 



































functions. Rho proteins can be regulated by Rho guanine exchange factors (GEF) 
proteins. There are several RhoGEFs that are direct effectors downstream of the 
Gα12/13 subunit, such as PDZ-RhoGEF, LARG and p115RhoGEF [120, 121]. These 
RhoGEFs can be activated upon agonist stimulation and regulate Rho proteins in 
various types of cells [120, 121]. It remains unclear which RhoGEFs are specific for 
RhoA activation by S1P receptors or thrombin receptors in endothelial cells. Some 
studies showed that p115RhoGEF is responsible for thrombin-mediated PAR1-RhoA 
activation [122]. There are also studies showing LARG (leukemia associated RhoGEF) 
and PDZ-RhoGEFs are essential for thrombin and LPA receptors [123]. The specific 
RhoGEFs associated with S1PR2 or S1PR3 receptors is still yet to be determined, 
however there is in vitro evidence showing that S1PR2 actively suppressed angiogenic 
sprouting through LARG activation of RhoC [124]. Moreover, studies have also revealed 
that S1PR3 can couple to Gαq/11, which can activate Rho through p63RhoGEF and the 
TRIO family of Rho-GEFs [125, 126], suggesting a possibility of CLIC proteins in 
mediating Gαq instead of Gα12/13 for Rho regulation. 
 
Ponsioen and colleagues [89] showed that CLIC4 re-localization to the plasma 
membrane upon agonist (LPA) stimulation depends on RhoA. This study placed CLIC4 
as a downstream effector regulated by RhoA. However, our loss of function study 
revealed that CLIC1 and CLIC4 acted upstream of RhoA, where RhoA activation is 
attenuated with loss of CLIC1 in S1P-RhoA activation and with loss of CLIC4 in 
thrombin-RhoA activation. Our findings could be reconciled with that of Ponsioen and 




1) CLIC4 and CLIC1 have distinct functions in these pathways. Although both 
appear to play key roles in regulating endothelial agonist-induced Gα12/13-RhoA 
signaling, they may play different roles in different types of GPCRs. Ponsioen et 
al. [89] studied the role of CLIC4 in LPA receptors in tumor cells, showing CLIC4 
translocates to plasma membrane transiently upon LPA stimulation through 
RhoA activation. It is possible that CLICs play entirely different roles in S1P 
receptors and thrombin receptors in regulating endothelial cell behavior. 
 
2) RhoA acts upstream of CLIC4 to regulate S1P-mediated signaling. RhoA acting 
upstream of CLIC4 in regulating CLIC4 relocation might uncover a potential 
mechanism of CLIC4 and CLIC1 in regulating the endothelial S1P pathway. We 
showed only CLIC1 is required for S1P-mediated RhoA activation, indicating 
CLIC1 acts upstream of RhoA. It is possible that RhoA subsequently mediates 
CLIC4 re-localization to the plasma membrane. This sequence of events then 
initiates downstream S1P-Rac1 activation and mediates endothelial barrier 
changes and migration. In fact, this serves as a possible explanation for our 
results in Chapter 6. We observed that the membrane-tethered form of full length 
CLIC4 (Lck-HA-CLIC4) failed to elicit Rac1 activation or endothelial responses on 
its own, and still needs S1P-stimulation for its proper function. This may be 
because RhoA needs to be activated first for S1P-mediated downstream 




This chapter provides us with evidence that CLICs can function in different endothelial 
GPCRs, such as S1PR and PAR receptors. We identified that CLIC1 or CLIC4 play 
roles in mediating regulation of RhoA protein. In addition to S1P-Gαi/Gβγ-Rac1 
activation, Gα12/13 signaling is also involved in CLIC functions. The role of CLICs in 
Gαq function is still unknown, and we plan to investigate the role of CLICs in Gαq-
mediated endothelial responses in future studies. The reason for the distinct 
requirement of CLIC1 or CLIC4 in RhoA activation by different agonists remains 
unclear. We hypothesize that different RhoA regulators, such as RhoGEF proteins, 
might be involved with different CLICs. We plan to utilize interaction studies such as 
FRET and immunoprecipitation in the future to unmask the specific mechanism of action 




























8.1 Summary and Conclusion 
 
This thesis work aims to investigate the role of CLIC proteins in endothelial GPCR 
signaling. We established that CLICs function in endothelial G-protein coupled receptor 
signaling, specifically CLIC1 and CLIC4, which are expressed in endothelial cells. Using 
in vitro assays, we established a critical role for endothelial CLICs in regulating the 
small GTPases (Rac1 and RhoA) and place CLICs function upstream of Rho/Rac. By 
characterizing the functional domains of endothelial CLICs we established two key 
principles about their roles in GPCR signaling; first, CLIC1 and CLIC4 have unique, and 
in some cases, non-overlapping roles and second that a C-terminal domain that cannot 
engage in ion channel activity or GST-like enzymatic activity can still engage in linking a 
GPCR to Rac1. These studies establish a unique role for CLICs in linking GPCR 
signaling to RhoA and Rac1.  The findings serve to assist us in understanding the role 
of CLIC proteins in angiogenesis, as well as the mechanism of actions of CLICs in 
regulating G-protein coupled receptor signaling.  
 
8.1.1 CLICs function downstream of endothelial GPCR signaling 
 
Our findings indicate that CLICs are critical for signaling downstream of endothelial G-
protein coupled receptors S1P receptors and the thrombin-mediated PAR1 receptor. 
Our strategy was to employ a variety of in vitro assays with HUVECs to determine 
CLICs involvement in several distinct endothelial cell signaling pathways. The 
requirements of CLIC1 and CLIC4 that we discovered for several GPCR and receptor 
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tyrosine kinase signaling pathways is presented in Table 8.1. CLIC1 and CLIC4 are 
each required in S1PR1 signaling and their activity is critical for downstream functions 
including endothelial barrier maintenance and migration. Only CLIC1 is required for 
S1PR2/3-mediated actin stress fiber formation. Only CLIC4 is required for thrombin-
mediated endothelial barrier disruption. We conclude that CLIC1 and CLIC4 function in 
both S1PR and thrombin-PAR signaling. In contrast, we found that neither CLIC1 nor 
CLIC4 is required for β-adrenergic-mediated cAMP regulation, VEGF-mediated 
endothelial barrier integrity, and migration or EGF-mediated Ras regulation. This 
indicates that CLICs function in select endothelial G-protein coupled receptors and are 
not required for the receptor tyrosine kinases we investigated. If this trend was seen in 
more widespread analysis of signaling pathways, one may conclude that CLICs function 
critically in select GPCR signaling pathways. 
 
Table 8.1  CLIC1 and CLIC4 are required in endothelial GPCRs. S1P1-3 receptors (S1PR1-
3), protease activated receptor (PAR), β2-adrenergic receptor (β2-AR), VEGF receptor 




CLICs function as new effectors for select GPCR signaling. Several studies have 
previously demonstrated interactions of CLIC proteins with GPCR signaling. Plasma 
membrane translocation of CLIC4 proteins from cytosol was observed upon GPCR 
ligand stimulation, including LPA for LPA receptors in tumor cells (neuroblastoma [89] 
and HeLa cells [111]) and Acetylcholine (ACh) for muscarinic 3 (M3) receptor in 
HEK293 cells [88].  Interactions of CLIC4 with histamine 3 (H3) receptors increased H3 
receptor expression at brain cell surface [87]. CLIC6 was also shown to interact with 
Dopamine (D2) receptors in rat brain cells [86]. These GPCRs investigated in literature 
and our study with S1P and PAR receptors are coupled with Gαi, Gα12/13, and Gαq 
subunit. Thus far, no GPCR coupled with Gαs has been shown to be associated with 
CLIC proteins, consistent with our findings that endothelial β2AR-Gαs-mediated cAMP 
regulation is independent of CLIC expression. Based upon limited survey of GPCRs 
associated with CLICs, we can infer some general features of specificity of CLICs in 
GPCR signaling. We conclude that CLICs function downstream of select G-protein 
coupled receptors and have specificity for GPCRs or heterotrimeric G-protein (Gα/Gβγ). 
Future studies will be conducted to decipher which proteins (GPCRs or Gα/Gβγ) are 
responsible for selectivity of CLIC proteins through investigation of CLIC interacting 
partners. 
 
CLICs do not function as effectors in the endothelial tyrosine receptor kinase pathways 
that we analyzed. Although there is evidence showing CLIC4 exerts influences 
upstream of HIF-1α-VEGF signaling by regulating VEGF expression in vivo [31], we saw 
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no direct evidence indicating CLIC4 is critical for VEGF-stimulated endothelial cell 
behaviors. That includes VEGF-mediated endothelial barrier integrity, migration, and 
VEGFR2 phosphorylation. EGF-mediated Ras activation in endothelial cells also do not 
depend on CLICs (Table 8.1).  Thus, we conclude endothelial barrier regulation and 
migration by tyrosine receptor kinase signaling do not depend on CLIC protein, 
suggesting a more limited role for CLICs in GPCRs but not tyrosine kinase signaling. 
The studies we performed in VEGF signaling assays utilized single knockdown of either 
CLIC1 or CLIC4, due to rapid endothelial cell death when both CLICs are lost. It 
remains possible that CLIC1 and CLIC4 may have functional redundancy in endothelial 
VEGF or EGF signaling. Detailed analysis of CLIC proteins in VEGF-signaling or EGF-
signaling, as well as other receptor tyrosine kinase signaling such as IGF-signaling, will 
be further performed to investigate whether CLICs functions only in endothelial GPCR 
signaling.  
 
8.1.2 CLICs act upstream of Rac1 and RhoA in endothelial cells 
 
We showed that CLICs function in S1P receptors and PAR1 receptors by modulating 
Rac1 and RhoA activation (Table 8.2). Thus, they act upstream of Rac1 and RhoA in 
these pathways. Consistent with endothelial cell behavior phenotypes, both CLIC1 and 
CLIC4 are required for S1P-mediated Rac1 activation. CLIC1 is required for S1P-
mediated RhoA activation, and CLIC4 is required PAR1-mediated RhoA activation. 
S1P-mediated Ras activation was not altered with loss of either CLIC protein, neither 
was S1P-mediated cAMP regulation. Hence, we conclude that for the receptors we 
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analyzed CLICs function to modulate small Rho-GTPases such as Rac1 and RhoA in 
endothelial GPCRs. We did not detect Cdc42 activation by S1P, possibly due to the 
assay utilized being not sensitive enough to detect subtle and transient changes. It is 
important to conduct a survey of potential roles in Cdc42 activity, thus future studies will 
be performed using FRET technology established for S1P-Cdc42 activation [46].  
 
 
Table 8.2  CLIC1 and CLIC4 are required in regulating endothelial small GTPases. 
 
We discovered CLICs act upstream of Rac1 and RhoA to modulate their activity, 
however the published literature describes roles for CLICs both upstream or 
downstream of RhoA or Rac1. CLICs were reported to be involved with small Rho-
GTPases in several studies in a variety of cell types. It was shown CLIC4 translocation 
to plasma membrane was driven by RhoA activation downstream of LPA receptors in 
tumor cells [89]. In kidney, CLIC5A was shown to stimulate podocyte Rac1, but not 
RhoA and Cdc42, to protect against hypertension-induced glomerular injury [127]. It 
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was also shown in human pulmonary arterial smooth muscle cells (hPASMCs) that 
suppression of CLIC4 delayed Rac1 and RhoA (not Cdc42) activation by S100A4/Mts1 
and BMP-2 signaling, a TGF-β signaling pathway [128]. These studies suggested CLIC 
proteins are involved in regulation of small Rho-GTPases (Rac1, RhoA, not Cdc42) in 
complex arrangements. Our studies also provided direct evidence showing that loss of 
CLICs leads to loss of Rac1 and RhoA activation by endothelial GPCR ligands, 
indicating CLICs act as effectors upstream of Rac1 and RhoA to regulate endothelial 
behaviors.  
 
Our initial studies suggest that CLICs do not regulate Rho and Rac proteins in all 
settings, having found regulation downstream of select GPCRs but possibly not 
downstream of VEGF receptor signaling. VEGF-mediated migration does not depend on 
CLICs (Table 8.1), and this process is driven by VEGF-mediated Rac1 activation 
through VEGFR2 in endothelial cells [75]. Furthermore, RhoA was established to be 
activated by VEGF in bovine retinal capillary endothelial cells (BRECs) [129]. We 
showed VEGFR2 phosphorylation in endothelial cells was only modestly changed in 
CLIC1 or CLIC4 knockdown cells, and that change was an increase in VEGFR2 levels. 
However, time course study of Rac1 and RhoA activation by VEGF were not observed 
with G-LISA assay up until 1 hour in HUVECs (Data not shown). The failure of detection 
of VEGF-mediated Rac1 or RhoA activation may be because Rac1 and RhoA 
responses are slow response (1 hour or more) and need to be examined at later time 
points.  
 
8.1.3 CLICs have unique functions in endothelial GPCR signaling pathway and C-
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terminus of CLICs confers its specificity.  
 
CLIC1 and CLIC4 have unique and non-overlapping functions in regulating endothelial 
S1P signaling pathway. In Chapter 4, we established that ectopic CLIC1 fails to rescue 
S1P-Rac1 pathway in CLIC4 knockdown HUVECs, whereas ectopic CLIC4 fails to 
rescue S1P-Rac1 pathway in CLIC1 knockdown HUVECs. Further structure-function 
analysis with chimeric study in Chapter 5 reveals C-terminus of CLICs rescued the S1P-
Rac1 signaling defects in respective CLIC knockdown HUVECs. Hence, we conclude 
that CLIC1 and CLIC4 have unique functions in S1P signaling with C-terminus of CLICs 
essential for its specificity. 
 
CLIC1 and CLIC4 are highly similar in amino acid sequences, and the schematic 
comparison between CLIC1 and CLIC4 in Chapter 5 (Figure 5.1) showed high similarity 
in the N-terminus as both consists of transmembrane domain and highly reactive 
cysteine residues (Cys24 in CLIC1 and Cys35 in CLIC4). The C-termini of CLIC1 and 
CLIC4 are more unique in terms of functional domains. Although both CLICs have 
nuclear localization signal and predicted SH2 binding motif [89], CLIC4 has a predicted 
SH3 binding motif which is absent in CLIC1 protein. Numerous signaling kinases such 
as Src and FAK proteins contain SH3 domains that bind to SH3 binding motifs [108]. 
The presence of a SH3 binding motif may allow for binding to certain kinases (such as 
Src, FAK) or GEF proteins contributing to its specific function compared to CLIC1. 
Future studies will focus on specific residues and functional domain analysis (SH3 
binding motifs) to further address the critical domains of CLICs required for specificity 
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and function in endothelial S1P-Rac1 signaling.  
 
8.1.4 CLICs do not require ion channel or GST enzyme activities to function in GPCR 
signaling. 
 
In Chapter 4, we established that CLIC1 and CLIC4 function uniquely in regulating the 
common S1PR1-Rac1 pathway. We generated CLIC chimeric proteins in Chapter 5 and 
discovered that the C-termini of CLIC proteins confers their specificity in Rac-1 
regulation. In Chapter 6, we further explored the requirement of the CLIC4 N-terminus 
and characterized its requirement for membrane localization upon ligand stimulation. 
We documented that a CLIC4 C-terminal domain (lacking the membrane associating N-
terminus) fused with membrane tethering Lck peptide is able to function as CLIC4 
protein regulating S1P-Rac1 signaling. Thus, membrane localization is required for 
CLIC function in GPCR signaling. Table 8.3 shows a summary of how CLIC4 variants 





Table 8.3  The role of CLIC4 variants in rescuing S1P-Rac1 activation in HUVECs with 
loss of CLIC4. 
 
These studies provide us with evidence and insights for the ongoing debate of whether 
CLICs exist as ion channels or enzymes. Our analysis of CLIC4 function in GPCR 
signaling demonstrates that they do not function as ion channels in endothelial S1P 
signaling. Although CLIC crystal structures and biophysical analysis provide evidences 
for both ion channel and enzyme activities[14, 15], their functions were under debate for 
decades. For ion channels, CLIC1 was shown to undergo structural reorganization upon 
oxidation to expose a large hydrophobic domain to allow for insertion into the 
membrane. Oligomerization of these membrane inserted monomers was hypothesized 
to form an ion channel. [15] Some of these evidences were obtained when using 
artificial bilayers where CLIC addition can induce ion channel activity [19-22]. We 
showed Lck-CLIC4Tr successfully rescued the S1P-Rac1 signaling defects in CLIC4 
knockdown cells, and the essential domains responsible for both membrane insertion 
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and structural rearrangement in CLIC4 N-terminus are absent in Lck-CLIC4Tr protein. 
This suggests that Lck-CLIC4Tr protein cannot form a functional ion channel, indicating 
CLIC4 does not function as ion channel in S1P-Rac1 signaling cascade. 
 
Our analysis excludes GST enzyme activity as a requirement for CLIC4 function in 
endothelial S1P signaling. The CLIC protein family is structurally homologous to the 
omega-class of glutathione-S-transferases [14], and purified CLIC protein indeed 
exhibited glutaredoxin enzymatic activity in vitro [23]. Our findings showed that N-
terminus truncation of CLIC4 leads to loss of Rac1 activation, indicating the requirement 
of the N-terminus for its function. However, when we fused the truncated CLIC4 protein 
with a membrane-targeting Lck peptide, S1P-Rac1 signaling was restored. This fusion 
protein (Lck-CLIC4Tr) lacks the catalytic cysteine residue for proper enzyme functions 
and does not have the capacity to have glutaredoxin enzymatic activity. Our results 
indicate that the C-terminus is sufficient for CLIC proteins to regulate Rac1 when 
arbitrarily brought to plasma membrane. Thus, we conclude that CLICs do not function 
as glutaredoxin-like enzymes in order to couple endothelial GPCRs to Rac1.  
 
Based on our findings, we uncover an exciting new mechanism for CLIC protein as a 
regulator for endothelial G-protein coupled receptor signaling. The absence of reactive 
cysteine residue indicates that it does not have glutaredoxin-like enzymatic activity. This 
does not rule out the possibility of CLICs may have other enzymatic activity with C-
terminus alone. In addition, through amino acid sequence analysis, CLIC C-terminus 
consists of multiple predicted phosphorylation sites, including phosphorylation sites for 
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protein kinase C (PKC), protein kinase A (PKA), casein kinase II and tyrosine kinases 
[107, 130]. Among these phosphorylation sites, the tyrosine residue (Tyr233 in CLIC1 
and Tyr244 in CLIC4) was shown to be important in re-localization of CLIC4 to plasma 
membrane in tumor cells, and the tyrosine residue is a potential phosphorylation site for 
tyrosine kinases [130]. Future mutagenesis study on these potential phosphorylation 
site such as tyrosine will uncover their role in endothelial GPCR signaling. 
 
8.2 Discussion and Working Models  
 
8.2.1 Working Model: N-terminal of CLIC4 is required for plasma membrane localization 
upon S1P stimulation followed by Rac1 activation by CLIC4 C-terminus. 
 
Our findings provide us with interesting aspects for how CLICs may function in the 
endothelial S1P pathway. Through investigating the functional domains of CLIC proteins 
by generating CLIC variants, we have gained understanding of their specific roles and 
can propose a working model of their function. In this model CLIC4 is recruited to the 
plasma membrane upon S1P stimulation and the N-terminus is essential for this re-
localization process. It is still unknown whether CLICs insert into the plasma membrane 
or remain soluble but associate with the plasma membrane. Once CLIC4 is recruited to 
the plasma membrane, the C-terminus of CLIC4 protein confers its specificity, where it 





Figure 8.1  Working Model: CLIC4 functions in S1PR1-Rac1 signaling pathway. CLIC4 
resides in cytoplasm under physiological condition. S1P stimulation causes CLIC4 re-
localization to plasma membrane. While CLIC4 are at the membrane, C-terminus of CLIC4 (red 
highlights) will functionally regulate S1P-Rac1 activation. 
 
8.2.2 Working Model: CLICs function as either regulators for unique GEFs or 
heterodimers in S1P-Rac1 signaling 
 
How CLIC1 and CLIC4 regulate the S1P-Rac1 signaling pathway remains unanswered. 
CLIC1 and CLIC4 function uniquely in mediating the S1P-Rac1 pathway. Based upon 
our chimeric study, the C-terminus is responsible for their unique functions. The unique 
feature of CLICs and possible mechanism of action have been discussed in detail in 
Chapter 4.4. To summarize, as a general working model for CLIC specificity (Figure 
8.2A), we propose that CLIC1 and CLIC4 may function through different Rac1-GEFs in 
endothelial cells, such as Tiam1 and PREX2 [103-105], converging to activate Rac1 
separately. This hypothesis could also explain why CLIC1 and CLIC4 are uniquely 
required for S1P-RhoA and Thrombin-RhoA respectively, as they may function to 
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modulate different Rho-GEF proteins as well.  
 
Another working model (Figure 8.2B) posits that CLIC1 and CLIC4 may function as 
heterodimers, and the presence of both partners is required for proper function of the 
S1P signaling cascade. Thus far, the existence of CLICs as multimers have not been 
addressed in a physiological environment, although evidence from crystal structures 
has been presented to support a dimeric complex [14, 23, 101]. There is also evidence 
showing CLIC1 may interact with CLIC4 from proteomic analysis in human pulmonary 
artery endothelial cells (HPAECs) [102]. In addition, CLICs are structurally similar to 
glutathione S-transferases (GSTs) and the GSTs exist largely as dimers in the 
cytoplasm [131]. Therefore, it is possible for CLIC proteins to dimerize, with themselves 
or with each other. To address these two hypotheses, future studies investigating 
specific interaction partners for CLIC proteins will be explored. 
 
Figure 8.2  Proposed model for unique functions of CLIC1 and CLIC4 in S1P-Rac1 
signaling. A) Unique Guanine Exchange Factor Model: CLIC4 and CLIC1 may regulate 
different Rac1-GEFs converging common Rac1 activation. B) Heterodimer Model: CLIC4 and 




8.2.3 Working Model: CLIC1 functions to re-localize CLIC4 through RhoA to regulate 
S1P-Rac1 signaling 
 
CLIC1 is solely required for S1P-mediated RhoA activation. This provides us with 
another unique hypothesis that the regulation of S1P-Rac1 activation arises from a 
sequential event with RhoA function upstream of CLIC4. We observed that CLIC4 re-
localizes to the plasma membrane upon S1P stimulation, but what drives this process 
remains unclear. As shown in the working model for CLIC-Rac-Rho relationships 
(Figure 8.3), the occurrence of membrane insertion or structural rearrangement upon 
S1P stimulation is unknown. There is evidence that the Gα12/13-RhoA pathway 
mediated by LPA drives the re-localization of CLIC4 to plasma membrane in tumor cells 
and HEK293 cells [89, 111]. Hence, this hypothesis builds upon these observations to 
propose that CLIC1 functions through S1P-Gα12/13 to regulate RhoA which is followed 
by re-localization of CLIC4 and activation of downstream signaling events. In this model, 






Figure 8.3  Proposed model: CLIC1 functions upstream of CLIC4. S1P stimulation requires 
CLIC1 to regulate RhoA activation through S1PR2/3. RhoA activation regulate re-localization of 
CLIC4 to plasma membrane, where C-terminus of CLIC4 function to regulate Rac1 activation. 
 
In summary, we uncovered a new role of CLICs in regulating endothelial cell behavior 
through GPCR signaling. CLICs function as regulators of S1P signaling and PAR1 
signaling modulating small GTPases such as Rac1 and RhoA. CLIC1 and CLIC4 are 
expressed throughout the body and implicated in multiple cellular functions [5, 6], and 
their roles in endothelial GPCR signaling and Rho-GTPase family presented in this 
thesis may lead to exciting discovery of CLICs being general regulators for GPCR 
signaling in other cell types. It is evident that they play important roles in endothelial 
cells and angiogenesis [27, 29], and their roles in GPCR signaling in mural cells such as 
pericytes and smooth muscle cells may be further investigated in the future.  
 




8.3.1 Investigating Interacting Partners of CLICs in endothelial GPCR signaling 
 
We have shown that CLICs function in endothelial GPCRs such as S1P signaling and 
thrombin signaling. As we discussed above, the specific mechanism of action is still 
unknown. The proposed models and hypotheses above described the potential binding 
partners of CLICs, and investigating their interacting partners becomes crucial to 
understand their roles in regulating Rac1, RhoA and GPCR signaling.  As shown in 
Figure 8.4 in S1PR1 signaling, we can explore where CLICs interact in the S1PR1 
pathway. They might interact with the S1P receptor (A), heterotrimeric G proteins (B) or 
different GEFs (C) to regulate Rac1 activation. They may also interact with each other 
forming heterodimers or among themselves forming homodimers. Hence, exploring the 
interacting partners of CLIC proteins could provide us with evidence and specific 
mechanisms of action of CLIC proteins in endothelial GPCRs.  
 
 
Figure 8.4  Future study: possible CLIC interacting partners in S1P-Rac1 signaling. CLIC 





8.3.2 Genetic study of the role of Clics in endothelial GPCR signaling in vivo  
 
This thesis focused on exploring the role of CLICs in endothelial GPCR signaling in 
vitro. It remains to be seen whether their roles in S1P receptors or PAR1 receptors can 
translate to vascular functions in vivo. Genetic studies using endothelial loss of Clic1 
and Clic4 protein in S1PR1 or PAR1 loss-of-function and gain-of-function mice will 
provide us with insights into their specific roles in angiogenesis in a physiological 
system. Moreover, genetic studies of endothelial S1P signaling and PAR1 signaling also 
revealed defects in endothelial barrier maintenance [132-134]. Endothelial CLICs may 
also play an important role in regulating endothelial permeability in homeostasis and 
pathological processes. The interactions of mouse endothelial Clic1 and Clic4 with S1P 
receptors or PAR1 receptors in vivo will further assist us in understanding the role of 


















1. Landry, D., et al., Molecular cloning and characterization of p64, a chloride 
channel protein from kidney microsomes. J Biol Chem, 1993. 268(20): p. 14948-
55.  
2. Littler, D.R., et al., Comparison of vertebrate and invertebrate CLIC proteins: the 
crystal structures of Caenorhabditis elegans EXC-4 and Drosophila 
melanogaster DmCLIC. Proteins, 2008. 71(1): p. 364-78. DOI: 
10.1002/prot.21704 
3. Berry, K.L. and O. Hobert, Mapping functional domains of chloride intracellular 
channel (CLIC) proteins in vivo. J Mol Biol, 2006. 359(5): p. 1316-33. DOI: 
10.1016/j.jmb.2006.04.046 
4. Gururaja Rao, S., et al., Three Decades of Chloride Intracellular Channel 
Proteins: From Organelle to Organ Physiology. Curr Protoc Pharmacol, 2018. 
80(1): p. 11 21 1-11 21 17. DOI: 10.1002/cpph.36 
5. Argenzio, E. and W.H. Moolenaar, Emerging biological roles of Cl- intracellular 
channel proteins. J Cell Sci, 2016. 129(22): p. 4165-4174. DOI: 
10.1242/jcs.189795 
6. Littler, D.R., et al., The enigma of the CLIC proteins: Ion channels, redox 
proteins, enzymes, scaffolding proteins? FEBS Lett, 2010. 584(10): p. 2093-101. 
DOI: 10.1016/j.febslet.2010.01.027 
7. Valenzuela, S.M., et al., Molecular cloning and expression of a chloride ion 
channel of cell nuclei. J Biol Chem, 1997. 272(19): p. 12575-82.  
8. Fernandez-Salas, E., et al., p53 and tumor necrosis factor alpha regulate the 
expression of a mitochondrial chloride channel protein. J Biol Chem, 1999. 
274(51): p. 36488-97.  
9. Shanks, R.A., et al., AKAP350 at the Golgi apparatus. II. Association of 
AKAP350 with a novel chloride intracellular channel (CLIC) family member. J Biol 
Chem, 2002. 277(43): p. 40973-80. DOI: 10.1074/jbc.M112277200 
10. Duncan, R.R., et al., Rat brain p64H1, expression of a new member of the p64 
chloride channel protein family in endoplasmic reticulum. J Biol Chem, 1997. 
272(38): p. 23880-6.  
11. Suh, K.S., et al., CLIC4 mediates and is required for Ca2+-induced keratinocyte 
differentiation. J Cell Sci, 2007. 120(Pt 15): p. 2631-40. DOI: 10.1242/jcs.002741 
12. Suh, K.S., et al., The organellular chloride channel protein CLIC4/mtCLIC 
translocates to the nucleus in response to cellular stress and accelerates 




13. Gururaja Rao, S., et al., Identification and Characterization of a Bacterial 
Homolog of Chloride Intracellular Channel (CLIC) Protein. Sci Rep, 2017. 7(1): p. 
8500. DOI: 10.1038/s41598-017-08742-z 
14. Littler, D.R., et al., Crystal structure of the soluble form of the redox-regulated 
chloride ion channel protein CLIC4. FEBS J, 2005. 272(19): p. 4996-5007. DOI: 
10.1111/j.1742-4658.2005.04909.x 
15. Littler, D.R., et al., The intracellular chloride ion channel protein CLIC1 
undergoes a redox-controlled structural transition. J Biol Chem, 2004. 279(10): p. 
9298-305. DOI: 10.1074/jbc.M308444200 
16. Goodchild, S.C., et al., Oxidation promotes insertion of the CLIC1 chloride 
intracellular channel into the membrane. Eur Biophys J, 2009. 39(1): p. 129-38. 
DOI: 10.1007/s00249-009-0450-0 
17. Hare, J.E., et al., Interaction of Human Chloride Intracellular Channel Protein 1 
(CLIC1) with Lipid Bilayers: A Fluorescence Study. Biochemistry, 2016. 55(27): 
p. 3825-33. DOI: 10.1021/acs.biochem.6b00080 
18. Goodchild, S.C., et al., Transmembrane extension and oligomerization of the 
CLIC1 chloride intracellular channel protein upon membrane interaction. 
Biochemistry, 2011. 50(50): p. 10887-97. DOI: 10.1021/bi2012564 
19. Singh, H. and R.H. Ashley, CLIC4 (p64H1) and its putative transmembrane 
domain form poorly selective, redox-regulated ion channels. Mol Membr Biol, 
2007. 24(1): p. 41-52. DOI: 10.1080/09687860600927907 
20. Singh, H. and R.H. Ashley, Redox regulation of CLIC1 by cysteine residues 
associated with the putative channel pore. Biophys J, 2006. 90(5): p. 1628-38. 
DOI: 10.1529/biophysj.105.072678 
21. Averaimo, S., et al., Point mutations in the transmembrane region of the clic1 ion 
channel selectively modify its biophysical properties. PLoS One, 2013. 8(9): p. 
e74523. DOI: 10.1371/journal.pone.0074523 
22. Valenzuela, S.M., et al., The nuclear chloride ion channel NCC27 is involved in 
regulation of the cell cycle. J Physiol, 2000. 529 Pt 3: p. 541-52.  
23. Al Khamici, H., et al., Members of the chloride intracellular ion channel protein 
family demonstrate glutaredoxin-like enzymatic activity. PLoS One, 2015. 10(1): 
p. e115699. DOI: 10.1371/journal.pone.0115699 
24. Risau, W. and I. Flamme, Vasculogenesis. Annu Rev Cell Dev Biol, 1995. 11: p. 
 
148  
73-91. DOI: 10.1146/annurev.cb.11.110195.000445 
25. Otrock, Z.K., et al., Understanding the biology of angiogenesis: review of the 
most important molecular mechanisms. Blood Cells Mol Dis, 2007. 39(2): p. 212-
20. DOI: 10.1016/j.bcmd.2007.04.001 
26. Berry, K.L., et al., A C. elegans CLIC-like protein required for intracellular tube 
formation and maintenance. Science, 2003. 302(5653): p. 2134-7. DOI: 
10.1126/science.1087667 
27. Tung, J.J., et al., Chloride intracellular channel 4 is involved in endothelial 
proliferation and morphogenesis in vitro. Angiogenesis, 2009. 12(3): p. 209-20. 
DOI: 10.1007/s10456-009-9139-3 
28. Ulmasov, B., et al., Chloride intracellular channel protein-4 functions in 
angiogenesis by supporting acidification of vacuoles along the intracellular 
tubulogenic pathway. Am J Pathol, 2009. 174(3): p. 1084-96. DOI: 
10.2353/ajpath.2009.080625 
29. Tung, J.J. and J. Kitajewski, Chloride intracellular channel 1 functions in 
endothelial cell growth and migration. J Angiogenes Res, 2010. 2: p. 23. DOI: 
10.1186/2040-2384-2-23 
30. Qiu, M.R., et al., Generation and characterization of mice with null mutation of 
the chloride intracellular channel 1 gene. Genesis, 2010. 48(2): p. 127-36. DOI: 
10.1002/dvg.20590 
31. Chalothorn, D., et al., Chloride intracellular channel-4 is a determinant of native 
collateral formation in skeletal muscle and brain. Circ Res, 2009. 105(1): p. 89-
98. DOI: 10.1161/CIRCRESAHA.109.197145 
32. Edwards, J.C., et al., Absence of chloride intracellular channel 4 (CLIC4) 
predisposes to acute kidney injury but has minimal impact on recovery. BMC 
Nephrol, 2014. 15: p. 54. DOI: 10.1186/1471-2369-15-54 
33. Hauser, A.S., et al., Pharmacogenomics of GPCR Drug Targets. Cell, 2018. 
172(1-2): p. 41-54 e19. DOI: 10.1016/j.cell.2017.11.033 
34. De Francesco, E.M., et al., G Protein-Coupled Receptors at the Crossroad 
between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging 
Concepts. Int J Mol Sci, 2017. 18(12). DOI: 10.3390/ijms18122713 
35. Blaho, V.A. and T. Hla, Regulation of mammalian physiology, development, and 
disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. 
Chem Rev, 2011. 111(10): p. 6299-320. DOI: 10.1021/cr200273u 
 
149  
36. Kono, M., et al., The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 
function coordinately during embryonic angiogenesis. J Biol Chem, 2004. 
279(28): p. 29367-73. DOI: 10.1074/jbc.M403937200 
37. Sanchez, T., et al., Induction of vascular permeability by the sphingosine-1-
phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. 
Arterioscler Thromb Vasc Biol, 2007. 27(6): p. 1312-8. DOI: 
10.1161/ATVBAHA.107.143735 
38. Heller, R., et al., Overlapping and distinct roles for PI3Kbeta and gamma 
isoforms in S1P-induced migration of human and mouse endothelial cells. 
Cardiovasc Res, 2008. 80(1): p. 96-105. DOI: 10.1093/cvr/cvn159 
39. Bayless, K.J. and G.E. Davis, Sphingosine-1-phosphate markedly induces matrix 
metalloproteinase and integrin-dependent human endothelial cell invasion and 
lumen formation in three-dimensional collagen and fibrin matrices. Biochem 
Biophys Res Commun, 2003. 312(4): p. 903-13.  
40. Su, S.C. and K.J. Bayless, Utilizing sphingosine-1-phosphate to stimulate 
sprouting angiogenesis. Methods Mol Biol, 2012. 874: p. 201-13. DOI: 
10.1007/978-1-61779-800-9_16 
41. Visentin, B., et al., Validation of an anti-sphingosine-1-phosphate antibody as a 
potential therapeutic in reducing growth, invasion, and angiogenesis in multiple 
tumor lineages. Cancer Cell, 2006. 9(3): p. 225-38. DOI: 
10.1016/j.ccr.2006.02.023 
42. Mizugishi, K., et al., Essential role for sphingosine kinases in neural and vascular 
development. Mol Cell Biol, 2005. 25(24): p. 11113-21. DOI: 
10.1128/MCB.25.24.11113-11121.2005 
43. Liu, Y., et al., Edg-1, the G protein-coupled receptor for sphingosine-1-
phosphate, is essential for vascular maturation. J Clin Invest, 2000. 106(8): p. 
951-61. DOI: 10.1172/JCI10905 
44. Gaengel, K., et al., The sphingosine-1-phosphate receptor S1PR1 restricts 
sprouting angiogenesis by regulating the interplay between VE-cadherin and 
VEGFR2. Dev Cell, 2012. 23(3): p. 587-99. DOI: 10.1016/j.devcel.2012.08.005 
45. Jung, B., et al., Flow-regulated endothelial S1P receptor-1 signaling sustains 
vascular development. Dev Cell, 2012. 23(3): p. 600-10. DOI: 
10.1016/j.devcel.2012.07.015 
46. Reinhard, N.R., et al., The balance between Galphai-Cdc42/Rac and 
Galpha12/13-RhoA pathways determines endothelial barrier regulation by 




47. Kajimoto, T., et al., Involvement of Gbetagamma subunits of Gi protein coupled 
with S1P receptor on multivesicular endosomes in F-actin formation and cargo 
sorting into exosomes. J Biol Chem, 2018. 293(1): p. 245-253. DOI: 
10.1074/jbc.M117.808733 
48. Niu, J., et al., G Protein betagamma subunits stimulate p114RhoGEF, a guanine 
nucleotide exchange factor for RhoA and Rac1: regulation of cell shape and 
reactive oxygen species production. Circ Res, 2003. 93(9): p. 848-56. DOI: 
10.1161/01.RES.0000097607.14733.0C 
49. Malik, A.B. and J.W. Fenton, 2nd, Thrombin-mediated increase in vascular 
endothelial permeability. Semin Thromb Hemost, 1992. 18(2): p. 193-9. DOI: 
10.1055/s-2007-1002425 
50. Vu, T.K., et al., Molecular cloning of a functional thrombin receptor reveals a 
novel proteolytic mechanism of receptor activation. Cell, 1991. 64(6): p. 1057-68.  
51. Ishihara, H., et al., Protease-activated receptor 3 is a second thrombin receptor 
in humans. Nature, 1997. 386(6624): p. 502-6. DOI: 10.1038/386502a0 
52. Kahn, M.L., et al., A dual thrombin receptor system for platelet activation. Nature, 
1998. 394(6694): p. 690-4. DOI: 10.1038/29325 
53. Kataoka, H., et al., Protease-activated receptors 1 and 4 mediate thrombin 
signaling in endothelial cells. Blood, 2003. 102(9): p. 3224-31. DOI: 
10.1182/blood-2003-04-1130 
54. Alberelli, M.A. and E. De Candia, Functional role of protease activated receptors 
in vascular biology. Vascul Pharmacol, 2014. 62(2): p. 72-81. DOI: 
10.1016/j.vph.2014.06.001 
55. Coughlin, S.R., Protease-activated receptors in hemostasis, thrombosis and 
vascular biology. J Thromb Haemost, 2005. 3(8): p. 1800-14. DOI: 
10.1111/j.1538-7836.2005.01377.x 
56. Moers, A., et al., G13 is an essential mediator of platelet activation in hemostasis 
and thrombosis. Nat Med, 2003. 9(11): p. 1418-22. DOI: 10.1038/nm943 
57. van den Eshof, B.L., et al., Paradigm of Biased PAR1 (Protease-Activated 
Receptor-1) Activation and Inhibition in Endothelial Cells Dissected by 
Phosphoproteomics. Arterioscler Thromb Vasc Biol, 2017. 37(10): p. 1891-1902. 
DOI: 10.1161/ATVBAHA.117.309926 
58. Kim, S., et al., Protease-activated receptors 1 and 4 do not stimulate G(i) 
 
151  
signaling pathways in the absence of secreted ADP and cause human platelet 
aggregation independently of G(i) signaling. Blood, 2002. 99(10): p. 3629-36.  
59. Lova, P., et al., Contribution of protease-activated receptors 1 and 4 and 
glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by 
thrombin. J Biol Chem, 2004. 279(24): p. 25299-306. DOI: 
10.1074/jbc.M313199200 
60. Connolly, A.J., et al., Role of the thrombin receptor in development and evidence 
for a second receptor. Nature, 1996. 381(6582): p. 516-9. DOI: 
10.1038/381516a0 
61. Haralabopoulos, G.C., et al., Thrombin promotes endothelial cell alignment in 
Matrigel in vitro and angiogenesis in vivo. Am J Physiol, 1997. 273(1 Pt 1): p. 
C239-45. DOI: 10.1152/ajpcell.1997.273.1.C239 
62. Tsopanoglou, N.E. and M.E. Maragoudakis, On the mechanism of thrombin-
induced angiogenesis. Potentiation of vascular endothelial growth factor activity 
on endothelial cells by up-regulation of its receptors. J Biol Chem, 1999. 274(34): 
p. 23969-76.  
63. Dupuy, E., et al., Thrombin induces angiogenesis and vascular endothelial 
growth factor expression in human endothelial cells: possible relevance to HIF-
1alpha. J Thromb Haemost, 2003. 1(5): p. 1096-102.  
64. Feistritzer, C. and M. Riewald, Endothelial barrier protection by activated protein 
C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. 
Blood, 2005. 105(8): p. 3178-84. DOI: 10.1182/blood-2004-10-3985 
65. Flentje, A., R. Kalsi, and T.S. Monahan, Small GTPases and Their Role in 
Vascular Disease. Int J Mol Sci, 2019. 20(4). DOI: 10.3390/ijms20040917 
66. Spindler, V., N. Schlegel, and J. Waschke, Role of GTPases in control of 
microvascular permeability. Cardiovasc Res, 2010. 87(2): p. 243-53. DOI: 
10.1093/cvr/cvq086 
67. Didsbury, J., et al., rac, a novel ras-related family of proteins that are botulinum 
toxin substrates. J Biol Chem, 1989. 264(28): p. 16378-82.  
68. Marinkovic, G., et al., The Ins and Outs of Small GTPase Rac1 in the 
Vasculature. J Pharmacol Exp Ther, 2015. 354(2): p. 91-102. DOI: 
10.1124/jpet.115.223610 
69. Hoang, M.V., J.A. Nagy, and D.R. Senger, Active Rac1 improves pathologic 
VEGF neovessel architecture and reduces vascular leak: mechanistic similarities 




70. Baumer, Y., et al., Role of Rac 1 and cAMP in endothelial barrier stabilization 
and thrombin-induced barrier breakdown. J Cell Physiol, 2009. 220(3): p. 716-26. 
DOI: 10.1002/jcp.21819 
71. Maharjan, S., et al., Sac-1004, a novel vascular leakage blocker, enhances 
endothelial barrier through the cAMP/Rac/cortactin pathway. Biochem Biophys 
Res Commun, 2013. 435(3): p. 420-7. DOI: 10.1016/j.bbrc.2013.04.104 
72. Bazzoni, G. and E. Dejana, Endothelial cell-to-cell junctions: molecular 
organization and role in vascular homeostasis. Physiol Rev, 2004. 84(3): p. 869-
901. DOI: 10.1152/physrev.00035.2003 
73. Arce, F.T., et al., Regulation of the micromechanical properties of pulmonary 
endothelium by S1P and thrombin: role of cortactin. Biophys J, 2008. 95(2): p. 
886-94. DOI: 10.1529/biophysj.107.127167 
74. Weed, S.A. and J.T. Parsons, Cortactin: coupling membrane dynamics to cortical 
actin assembly. Oncogene, 2001. 20(44): p. 6418-34. DOI: 
10.1038/sj.onc.1204783 
75. Garrett, T.A., J.D. Van Buul, and K. Burridge, VEGF-induced Rac1 activation in 
endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. 
Exp Cell Res, 2007. 313(15): p. 3285-97. DOI: 10.1016/j.yexcr.2007.05.027 
76. Nohata, N., et al., Temporal-specific roles of Rac1 during vascular development 
and retinal angiogenesis. Dev Biol, 2016. 411(2): p. 183-194. DOI: 
10.1016/j.ydbio.2016.02.005 
77. Tan, W., et al., An essential role for Rac1 in endothelial cell function and vascular 
development. FASEB J, 2008. 22(6): p. 1829-38. DOI: 10.1096/fj.07-096438 
78. Madaule, P. and R. Axel, A novel ras-related gene family. Cell, 1985. 41(1): p. 
31-40.  
79. Flinn, H.M. and A.J. Ridley, Rho stimulates tyrosine phosphorylation of focal 
adhesion kinase, p130 and paxillin. J Cell Sci, 1996. 109 ( Pt 5): p. 1133-41.  
80. Mikelis, C.M., et al., RhoA and ROCK mediate histamine-induced vascular 
leakage and anaphylactic shock. Nat Commun, 2015. 6: p. 6725. DOI: 
10.1038/ncomms7725 
81. Yamaguchi, M., et al., Vascular Normalization by ROCK Inhibitor: Therapeutic 
Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia. 
Invest Ophthalmol Vis Sci, 2016. 57(4): p. 2264-76. DOI: 10.1167/iovs.15-17411 
 
153  
82. Sijnave, D., et al., Inhibition of Rho-Associated Kinase Prevents Pathological 
Wound Healing and Neovascularization After Corneal Trauma. Cornea, 2015. 
34(9): p. 1120-9. DOI: 10.1097/ICO.0000000000000493 
83. Birukova, A.A., et al., Prostaglandins PGE(2) and PGI(2) promote endothelial 
barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Exp 
Cell Res, 2007. 313(11): p. 2504-20. DOI: 10.1016/j.yexcr.2007.03.036 
84. Ramchandran, R., et al., Critical role of Cdc42 in mediating endothelial barrier 
protection in vivo. Am J Physiol Lung Cell Mol Physiol, 2008. 295(2): p. L363-9. 
DOI: 10.1152/ajplung.90241.2008 
85. Hu, G.D., et al., The generation of the endothelial specific cdc42-deficient mice 
and the effect of cdc42 deletion on the angiogenesis and embryonic 
development. Chin Med J (Engl), 2011. 124(24): p. 4155-9.  
86. Griffon, N., et al., CLIC6, a member of the intracellular chloride channel family, 
interacts with dopamine D(2)-like receptors. Brain Res Mol Brain Res, 2003. 
117(1): p. 47-57.  
87. Maeda, K., et al., CLIC4 interacts with histamine H3 receptor and enhances the 
receptor cell surface expression. Biochem Biophys Res Commun, 2008. 369(2): 
p. 603-8. DOI: 10.1016/j.bbrc.2008.02.071 
88. Lecat, S., et al., A Fluorescent Live Imaging Screening Assay Based on 
Translocation Criteria Identifies Novel Cytoplasmic Proteins Implicated in G 
Protein-coupled Receptor Signaling Pathways. Mol Cell Proteomics, 2015. 14(5): 
p. 1385-99. DOI: 10.1074/mcp.M114.046698 
89. Ponsioen, B., et al., Spatiotemporal regulation of chloride intracellular channel 
protein CLIC4 by RhoA. Mol Biol Cell, 2009. 20(22): p. 4664-72. DOI: 
10.1091/mbc.E09-06-0529 
90. Jaffe, E.A., et al., Culture of human endothelial cells derived from umbilical veins. 
Identification by morphologic and immunologic criteria. J Clin Invest, 1973. 
52(11): p. 2745-56. DOI: 10.1172/JCI107470 
91. Bayless, K.J., H.I. Kwak, and S.C. Su, Investigating endothelial invasion and 
sprouting behavior in three-dimensional collagen matrices. Nat Protoc, 2009. 
4(12): p. 1888-98. DOI: 10.1038/nprot.2009.221 
92. Harrop, S.J., et al., Crystal structure of a soluble form of the intracellular chloride 
ion channel CLIC1 (NCC27) at 1.4-A resolution. J Biol Chem, 2001. 276(48): p. 
44993-5000. DOI: 10.1074/jbc.M107804200 
93. Shukla, A., et al., Elevating CLIC4 in Multiple Cell Types Reveals a TGF- 
 
154  
Dependent Induction of a Dominant Negative Smad7 Splice Variant. PLoS One, 
2016. 11(8): p. e0161410. DOI: 10.1371/journal.pone.0161410 
94. Means, C.K., et al., S1P1 receptor localization confers selectivity for Gi-mediated 
cAMP and contractile responses. J Biol Chem, 2008. 283(18): p. 11954-63. DOI: 
10.1074/jbc.M707422200 
95. Okamoto, H., et al., EDG1 is a functional sphingosine-1-phosphate receptor that 
is linked via a Gi/o to multiple signaling pathways, including phospholipase C 
activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, 
and adenylate cyclase inhibition. J Biol Chem, 1998. 273(42): p. 27104-10.  
96. Alford, S.K., et al., Prediction of sphingosine 1-phosphate-stimulated endothelial 
cell migration rates using biochemical measurements. Ann Biomed Eng, 2010. 
38(8): p. 2775-90. DOI: 10.1007/s10439-010-0014-6 
97. Ji, Y., et al., The role of beta-adrenergic receptor signaling in the proliferation of 
hemangioma-derived endothelial cells. Cell Div, 2013. 8(1): p. 1. DOI: 
10.1186/1747-1028-8-1 
98. Chou, S.Y., et al., CLIC4 regulates apical exocytosis and renal tube 
luminogenesis through retromer- and actin-mediated endocytic trafficking. Nat 
Commun, 2016. 7: p. 10412. DOI: 10.1038/ncomms10412 
99. Jiang, L., et al., Intracellular chloride channel protein CLIC1 regulates 
macrophage function through modulation of phagosomal acidification. J Cell Sci, 
2012. 125(Pt 22): p. 5479-88. DOI: 10.1242/jcs.110072 
100. Salao, K., et al., CLIC1 regulates dendritic cell antigen processing and 
presentation by modulating phagosome acidification and proteolysis. Biol Open, 
2016. 5(5): p. 620-30. DOI: 10.1242/bio.018119 
101. Li, Y., et al., Trimeric structure of the wild soluble chloride intracellular ion 
channel CLIC4 observed in crystals. Biochem Biophys Res Commun, 2006. 
343(4): p. 1272-8. DOI: 10.1016/j.bbrc.2006.03.099 
102. Abdul-Salam, V.B., et al., CLIC4/Arf6 Pathway. Circ Res, 2019. 124(1): p. 52-65. 
DOI: 10.1161/CIRCRESAHA.118.313705 
103. Singleton, P.A., et al., Regulation of sphingosine 1-phosphate-induced 
endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 
receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J, 2005. 19(12): p. 
1646-56. DOI: 10.1096/fj.05-3928com 
104. Gonzalez, E., R. Kou, and T. Michel, Rac1 modulates sphingosine 1-phosphate-
mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in 
 
155  
vascular endothelial cells. J Biol Chem, 2006. 281(6): p. 3210-6. DOI: 
10.1074/jbc.M510434200 
105. Li, Z., et al., Role of guanine nucleotide exchange factor P-Rex-2b in sphingosine 
1-phosphate-induced Rac1 activation and cell migration in endothelial cells. 
Prostaglandins Other Lipid Mediat, 2005. 76(1-4): p. 95-104. DOI: 
10.1016/j.prostaglandins.2005.02.002 
106. Mynott, A.V., et al., Crystal structure of importin-alpha bound to a peptide bearing 
the nuclear localisation signal from chloride intracellular channel protein 4. FEBS 
J, 2011. 278(10): p. 1662-75. DOI: 10.1111/j.1742-4658.2011.08086.x 
107. Ashley, R.H., Challenging accepted ion channel biology: p64 and the CLIC family 
of putative intracellular anion channel proteins (Review). Mol Membr Biol, 2003. 
20(1): p. 1-11. DOI: 10.1080/0968768021000042746 
108. Thomas, J.W., et al., SH2- and SH3-mediated interactions between focal 
adhesion kinase and Src. J Biol Chem, 1998. 273(1): p. 577-83.  
109. Cain, R.J., B. Vanhaesebroeck, and A.J. Ridley, The PI3K p110alpha isoform 
regulates endothelial adherens junctions via Pyk2 and Rac1. J Cell Biol, 2010. 
188(6): p. 863-76. DOI: 10.1083/jcb.200907135 
110. Ito, Y., P.K. Vogt, and J.R. Hart, Domain analysis reveals striking functional 
differences between the regulatory subunits of phosphatidylinositol 3-kinase 
(PI3K), p85alpha and p85beta. Oncotarget, 2017. 8(34): p. 55863-55876. DOI: 
10.18632/oncotarget.19866 
111. Argenzio, E., et al., Profilin binding couples chloride intracellular channel protein 
CLIC4 to RhoA-mDia2 signaling and filopodium formation. J Biol Chem, 2018. 
293(50): p. 19161-19176. DOI: 10.1074/jbc.RA118.002779 
112. Domingo-Fernandez, R., et al., The intracellular chloride channel proteins CLIC1 
and CLIC4 induce IL-1beta transcription and activate the NLRP3 inflammasome. 
J Biol Chem, 2017. 292(29): p. 12077-12087. DOI: 10.1074/jbc.M117.797126 
113. Milton, R.H., et al., CLIC1 function is required for beta-amyloid-induced 
generation of reactive oxygen species by microglia. J Neurosci, 2008. 28(45): p. 
11488-99. DOI: 10.1523/JNEUROSCI.2431-08.2008 
114. van Unen, J., et al., Kinetics of recruitment and allosteric activation of 
ARHGEF25 isoforms by the heterotrimeric G-protein Galphaq. Sci Rep, 2016. 6: 
p. 36825. DOI: 10.1038/srep36825 
115. Zlatkine, P., B. Mehul, and A.I. Magee, Retargeting of cytosolic proteins to the 
plasma membrane by the Lck protein tyrosine kinase dual acylation motif. J Cell 
 
156  
Sci, 1997. 110 ( Pt 5): p. 673-9.  
116. Chertkova, A.O., Mastop, M., Postma, M., van Bommel, N., van der Niet, S., 
Batenburg, K.L., Joosen, L., Gadella, T.W.J., Okada, Y., Goedhart, J. , Robust 
and Bright Genetically Encoded Fluorescent Markers for Highlighting Structures 
and Compartments in Mammalian Cells. 2017: bioRxiv. 
117. Sugimoto, N., et al., Inhibitory and stimulatory regulation of Rac and cell motility 
by the G12/13-Rho and Gi pathways integrated downstream of a single G 
protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol, 2003. 
23(5): p. 1534-45.  
118. Komarova, Y.A., D. Mehta, and A.B. Malik, Dual regulation of endothelial 
junctional permeability. Sci STKE, 2007. 2007(412): p. re8. DOI: 
10.1126/stke.4122007re8 
119. Griffin, C.T., et al., A role for thrombin receptor signaling in endothelial cells 
during embryonic development. Science, 2001. 293(5535): p. 1666-70. DOI: 
10.1126/science.1061259 
120. Jaiswal, M., et al., Mechanistic insights into specificity, activity, and regulatory 
elements of the regulator of G-protein signaling (RGS)-containing Rho-specific 
guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and 
leukemia-associated RhoGEF (LARG). J Biol Chem, 2011. 286(20): p. 18202-12. 
DOI: 10.1074/jbc.M111.226431 
121. Suzuki, N., N. Hajicek, and T. Kozasa, Regulation and physiological functions of 
G12/13-mediated signaling pathways. Neurosignals, 2009. 17(1): p. 55-70. DOI: 
10.1159/000186690 
122. Birukova, A.A., et al., Role of Rho GTPases in thrombin-induced lung vascular 
endothelial cells barrier dysfunction. Microvasc Res, 2004. 67(1): p. 64-77.  
123. Mikelis, C.M., et al., PDZ-RhoGEF and LARG are essential for embryonic 
development and provide a link between thrombin and LPA receptors and Rho 
activation. J Biol Chem, 2013. 288(17): p. 12232-43. DOI: 
10.1074/jbc.M112.428599 
124. Del Galdo, S., et al., The activation of RhoC in vascular endothelial cells is 
required for the S1P receptor type 2-induced inhibition of angiogenesis. Cell 
Signal, 2013. 25(12): p. 2478-84. DOI: 10.1016/j.cellsig.2013.08.017 
125. Lutz, S., et al., Structure of Galphaq-p63RhoGEF-RhoA complex reveals a 
pathway for the activation of RhoA by GPCRs. Science, 2007. 318(5858): p. 
1923-7. DOI: 10.1126/science.1147554 
 
157  
126. Rojas, R.J., et al., Galphaq directly activates p63RhoGEF and Trio via a 
conserved extension of the Dbl homology-associated pleckstrin homology 
domain. J Biol Chem, 2007. 282(40): p. 29201-10. DOI: 
10.1074/jbc.M703458200 
127. Tavasoli, M., et al., The chloride intracellular channel 5A stimulates podocyte 
Rac1, protecting against hypertension-induced glomerular injury. Kidney Int, 
2016. 89(4): p. 833-47. DOI: 10.1016/j.kint.2016.01.001 
128. Spiekerkoetter, E., et al., S100A4 and bone morphogenetic protein-2 
codependently induce vascular smooth muscle cell migration via phospho-
extracellular signal-regulated kinase and chloride intracellular channel 4. Circ 
Res, 2009. 105(7): p. 639-47, 13 p following 647. DOI: 
10.1161/CIRCRESAHA.109.205120 
129. Bryan, B.A., et al., RhoA/ROCK signaling is essential for multiple aspects of 
VEGF-mediated angiogenesis. FASEB J, 2010. 24(9): p. 3186-95. DOI: 
10.1096/fj.09-145102 
130. Suh, K.S., et al., CLIC4, skin homeostasis and cutaneous cancer: surprising 
connections. Mol Carcinog, 2007. 46(8): p. 599-604. DOI: 10.1002/mc.20324 
131. Hayes, J.D., J.U. Flanagan, and I.R. Jowsey, Glutathione transferases. Annu 
Rev Pharmacol Toxicol, 2005. 45: p. 51-88. DOI: 
10.1146/annurev.pharmtox.45.120403.095857 
132. Tauseef, M., et al., Activation of sphingosine kinase-1 reverses the increase in 
lung vascular permeability through sphingosine-1-phosphate receptor signaling in 
endothelial cells. Circ Res, 2008. 103(10): p. 1164-72. DOI: 
10.1161/01.RES.0000338501.84810.51 
133. Vogel, S.M., et al., Abrogation of thrombin-induced increase in pulmonary 
microvascular permeability in PAR-1 knockout mice. Physiol Genomics, 2000. 
4(2): p. 137-145. DOI: 10.1152/physiolgenomics.2000.4.2.137 
134. Zhao, Y., et al., Protection of LPS-induced murine acute lung injury by 
sphingosine-1-phosphate lyase suppression. Am J Respir Cell Mol Biol, 2011. 
45(2): p. 426-35. DOI: 10.1165/rcmb.2010-0422OC 
 
